<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Gastroenterology Quiz</title>
  
  <!-- Embedded CSS -->
  <style>
    :root {
      --primary-color: #2a9d8f;
      --primary-hover: #21867a;
      --bg-color: #f4f4f4;
      --card-bg: #ffffff;
      --text-color: #333333;
      --sidebar-bg: #264653;
      --sidebar-text: #ffffff;
    }
    * { box-sizing: border-box; }
    body { margin: 0; font-family: 'Roboto', sans-serif; background-color: var(--bg-color); color: var(--text-color); }
    .top-nav {
      position: relative;
      z-index: 1001;
      display: flex; justify-content: space-between; align-items: center;
      background-color: var(--primary-color); color: #ffffff; padding: 0.75rem 1rem;
    }
    .top-nav .nav-actions button { background: none; border: none; color: #ffffff; margin-left: 0.5rem; cursor: pointer; }
    
    /* highlight‐mode button “on” state */
    .top-nav .nav-actions #highlight-btn.active {
      background-color: var(--primary-hover);
    }

    /* the yellow highlight style */
    .highlighted-text {
      background-color: yellow;
    }

    .menu-icon { cursor: pointer; font-size: 1.5rem; }
    /* Sidebar styles */
    .sidebar {
      position: fixed;
      left: -200px;
      width: 200px;
      background-color: var(--sidebar-bg);
      color: var(--sidebar-text);
      padding: 1rem;
      transition: left 0.3s ease;
      z-index: 1000;
      overflow-y: auto;
    }
    .sidebar.open { left: 0; }
    .sidebar ul { list-style: none; padding: 0; margin: 0; }
    .sidebar li { margin-bottom: 0.5rem; }
    .sidebar a { color: var(--sidebar-text); text-decoration: none; display: block; padding: 0.5rem; border-radius: 0.25rem; }
    .sidebar a:hover { background: rgba(255,255,255,0.1); }
    /* Lab Values sidebar */
    .lab-sidebar {
      position: fixed;
      right: -600px;
      width: 600px;
      background-color: var(--sidebar-bg);
      color: var(--sidebar-text);
      padding: 1rem;
      transition: right 0.3s ease;
      z-index: 1000;
      overflow-y: auto;
    }
    .lab-sidebar.open { right: 0; }
    /* Quiz container */
    .question-container {
      background-color: var(--card-bg);
      border: 2px solid var(--primary-color);
      border-radius: 0.5rem;
      max-width: 800px;
      margin: 2rem auto;
      padding: 1.5rem;
    }
    .options-list { display: flex; flex-direction: column; margin-bottom: 1rem; }
    .option-label { padding: 0.5rem; margin-bottom: 0.5rem; border-radius: 4px; border: 1px solid transparent; display: flex; align-items: center; }
    .options-list input { margin-right: 0.5rem; accent-color: var(--primary-color); }
    .correct-answer { background-color: #d4edda; border-color: #28a745; }
    .wrong-answer { background-color: #f8d7da; border-color: #dc3545; }
    .submit-btn, #prev-btn, #next-btn, #end-btn {
      margin-top: 0.5rem;
      background-color: var(--primary-color);
      color: #ffffff;
      border: none;
      padding: 0.5rem 1rem;
      border-radius: 0.25rem;
      cursor: pointer;
    }
    .submit-btn:disabled, #prev-btn:disabled, #next-btn:disabled { opacity: 0.6; cursor: default; }
    .submit-btn:hover:not(:disabled), #prev-btn:hover:not(:disabled), #next-btn:hover:not(:disabled), #end-btn:hover:not(:disabled) { background-color: var(--primary-hover); }
    .explanation {
      margin-top: 1rem;
      background-color: #e8f5e9;
      border-left: 4px solid var(--primary-color);
      padding: 1rem;
      border-radius: 0.5rem;
      white-space: pre-wrap;
    }
    .results-summary {
      margin-top: 1rem;
      background-color: #fff3cd;
      border-left: 4px solid #ffeeba;
      padding: 1rem;
      border-radius: 0.5rem;
    }
  </style>
</head>
<body>

  <nav class="top-nav">
    <div class="menu-icon">&#9776;</div>
    <div id="question-counter">Question 1 of 6</div>
    <div class="nav-actions">
      <button id="prev-btn" disabled>&lt; Previous</button>
      <button id="next-btn" disabled>Next &gt;</button>
      <button id="fullscreen-btn">Full Screen</button>
      <button id="labvals-btn">Lab Values</button>
      <button id="highlight-btn">Highlight</button>
      <button id="end-btn">End Exam</button>
    </div>
  </nav>

  <!-- Left Sidebar -->
  <div id="sidebar" class="sidebar">
    <ul id="sidebar-list"></ul>
  </div>
  <!-- Lab Values Sidebar -->
  <div id="lab-sidebar" class="lab-sidebar">
    <img src="images/Blood.jpg" alt="Blood Values" style="width:100%; margin-bottom:1rem;">
    <img src="images/Blood 2.jpg" alt="Blood Plasma Serum" style="width:100%; margin-bottom:1rem;">
    <img src="images/Hematological.jpg" alt="Hematologic Values" style="width:100%; margin-bottom:1rem;">
    <img src="images/Sweat, Urine, BMI.jpg" alt="Sweat, Urine, BMI" style="width:100%; margin-bottom:1rem;">
    <img src="images/CSF.jpg" alt="Cerebrospinal Fluid" style="width:100%;">
  </div>

  <main>
    <section class="question-container">
      <div id="question-text"></div>
      <form id="options-list" class="options-list"></form>
      <button id="submit-btn" class="submit-btn">Submit Answer</button>
      <div id="explanation" class="explanation"></div>
      <div id="results-summary" class="results-summary" style="display:none;"></div>
    </section>
  </main>

  <!-- Embedded JS -->
  <script>
    // Sidebar toggle & positioning
    const menuIcon   = document.querySelector('.menu-icon');
    const sidebar    = document.getElementById('sidebar');
    const labSidebar = document.getElementById('lab-sidebar');
    const nav        = document.querySelector('.top-nav');
    const navHeight  = nav.offsetHeight;
    [sidebar, labSidebar].forEach(sb => {
      sb.style.top    = navHeight + 'px';
      sb.style.height = `calc(100% - ${navHeight}px)`;
    });
    menuIcon.addEventListener('click', () => sidebar.classList.toggle('open'));
    document.getElementById('labvals-btn')
      .addEventListener('click', () => labSidebar.classList.toggle('open'));

    // Highlight mode toggle + handler
    const highlightBtn = document.getElementById('highlight-btn');
    let highlightMode = false;

    // turn highlight‐mode on/off
    highlightBtn.addEventListener('click', () => {
      highlightMode = !highlightMode;
      highlightBtn.classList.toggle('active', highlightMode);
    });

    // whenever you select text and release the mouse…
    document.addEventListener('mouseup', () => {
      if (!highlightMode) return;                // only when mode is on
      const selection = window.getSelection();
      if (selection.rangeCount === 0 || selection.isCollapsed) return;

      const range = selection.getRangeAt(0);
      try {
        // wrap the chosen text in our yellow‐bg span
        const span = document.createElement('span');
        span.className = 'highlighted-text';
        range.surroundContents(span);
      } catch (e) {
        // fallback for older browsers
        document.execCommand('hiliteColor', false, 'yellow');
      }
      selection.removeAllRanges();
    });

    // ========== New helper function to convert **bold** to <strong>bold</strong> ==========
    function convertMarkdownBold(text) {
      return text.replace(/\*\*(.*?)\*\*/g, '<strong>$1</strong>');
    }

    // Quiz data and logic
    const questions = [
      {
        "text": "A 34-year-old man presents to the emergency department with progressive weakness in both legs over the past three days. He recently recovered from a diarrheal illness two weeks ago. He denies trauma or back pain. On exam, he has 2/5 strength in the lower limbs and 4/5 in the upper limbs, with decreased deep tendon reflexes in all extremities. Sensation is intact. He has difficulty walking unassisted, and on questioning, reports tingling in his feet. His vital signs show a blood pressure of 130/85 mmHg, heart rate of 92 bpm, and respiratory rate of 18. What is the most likely diagnosis?",
        "options": [
          { "label": "A", "text": "Guillain-Barré Syndrome" },
          { "label": "B", "text": "Multiple Sclerosis" },
          { "label": "C", "text": "Myasthenia Gravis" },
          { "label": "D", "text": "Spinal Cord Compression" }
        ],
        "correct": "A",
        "explanation": "**Correct Answer: A. Guillain-Barré Syndrome (GBS)**\n\n**Why it's correct:**\nThis patient presents with classic features of **Guillain-Barré Syndrome**, including recent gastrointestinal infection (suggestive of *Campylobacter jejuni*), **ascending symmetric weakness**, **hyporeflexia**, and **paresthesias** without sensory loss. The absence of upper motor neuron signs and the presence of areflexia help differentiate it from central causes.\n\n---\n\n**Why the other options are incorrect:**\n\n**B. Multiple Sclerosis** – MS usually presents with **asymmetric** neurologic deficits, **optic neuritis**, or **internuclear ophthalmoplegia** in a younger adult. It typically involves the **central nervous system** and often shows **UMN signs** (e.g., spasticity, hyperreflexia), not the areflexia seen here.\n\n**C. Myasthenia Gravis** – MG presents with **fluctuating weakness**, especially affecting the **ocular and bulbar muscles** (e.g., ptosis, dysphagia). Reflexes are preserved, and there's no sensory disturbance or recent infection.\n\n**D. Spinal Cord Compression** – Would typically present with **upper motor neuron signs** below the level of the lesion (increased tone, hyperreflexia), possible **bowel/bladder dysfunction**, and often a **sensory level**. The gradual onset of weakness with preserved sensation and no back pain argues against it.\n\n---\n\n**Diagnostic Approach:**\n\n- **Initial Step:** Clinical diagnosis based on **symptomatology and neurologic exam**.\n- **Best Initial Test:** **Nerve conduction studies (NCS)/Electromyography (EMG)** – shows **demyelination** with slowed nerve conduction velocity.\n- **CSF Analysis (Lumbar Puncture):** Classically shows **albuminocytologic dissociation** – elevated protein with normal WBC count. This is supportive but not required for diagnosis early on.\n- **Monitor Respiratory Function:** Regularly assess **vital capacity** (important in preventing respiratory failure).\n\n---\n\n**Management:**\n\n- **Hospital admission** for close respiratory monitoring.\n- **Plasmapheresis** or **Intravenous Immunoglobulin (IVIG)** – both are equally effective. Do **not combine** them.\n- **Supportive care:** DVT prophylaxis, pain management, physical therapy.\n- **Intubation** if vital capacity drops below 15–20 mL/kg.\n\n---\n\n**Why each symptom occurs in GBS:**\n\n1. **Ascending weakness:** Due to demyelination of peripheral nerves starting distally and progressing proximally.\n2. **Areflexia:** Loss of reflex arcs because of impaired signal conduction.\n3. **Paresthesias:** Nerve damage alters sensory input, even though sensation may appear intact.\n4. **Post-infectious onset:** GBS is often triggered by an autoimmune response to an infection (e.g., *Campylobacter jejuni*, CMV, EBV).\n5. **Autonomic instability (not present here but possible):** Due to involvement of autonomic fibers, leading to fluctuations in BP and heart rate.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Autoimmune demyelination:** Molecular mimicry causes antibodies to attack peripheral nerve myelin.\n2. **T-cell mediated inflammation:** CD4+ cells infiltrate peripheral nerves, worsening the damage.\n3. **Segmental demyelination:** Leads to slowed conduction velocity and conduction block.\n4. **Preserved axons (initially):** Helps explain why recovery is often complete.\n5. **Albuminocytologic dissociation in CSF:** Caused by increased permeability of the blood-nerve barrier.\n\n---\n\n**Summary:** GBS is an acute, immune-mediated polyneuropathy characterized by **ascending weakness**, **areflexia**, and **recent infection**. Prompt diagnosis and treatment are essential to prevent life-threatening respiratory failure."
      },
      
      {
  "text": "A 7-year-old boy presents to the pediatric clinic with a 2-day history of rash and joint pain. His mother reports that he had a mild upper respiratory infection one week ago. On examination, he has palpable, non-blanching purpura over his buttocks and lower extremities, swelling and tenderness of both ankles, and mild colicky abdominal pain with intermittent vomiting. Vital signs are: temperature 37.8°C, heart rate 100 bpm, blood pressure 110/70 mmHg. Urinalysis reveals microscopic hematuria and mild proteinuria. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Immune Thrombocytopenic Purpura (ITP)" },
    { "label": "B", "text": "Meningococcemia" },
    { "label": "C", "text": "Henoch-Schönlein Purpura (IgA Vasculitis)" },
    { "label": "D", "text": "Systemic Lupus Erythematosus (SLE)" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Henoch-Schönlein Purpura (IgA Vasculitis)**\n\n**Why it's correct:**\nThis child presents with the classic tetrad of **palpable purpura**, **arthralgia**, **abdominal pain**, and **renal involvement** after a recent upper respiratory infection. HSP is an IgA-mediated small-vessel vasculitis that typically affects children aged 3–15, with characteristic **IgA deposition** in the vessel walls.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Immune Thrombocytopenic Purpura (ITP)** – ITP presents with isolated thrombocytopenia causing petechiae and mucosal bleeding, but lacks the **palpable purpura** (usually nonpalpable petechiae), **arthralgias**, and **abdominal pain** seen here. The platelet count in ITP is typically very low.\n\n**B. Meningococcemia** – Presents with **fever**, **rapidly spreading petechial rash**, and signs of systemic toxicity (e.g., meningismus, altered mental status). It is associated with **thrombocytopenia** and sepsis, not a small‐vessel IgA vasculitis.\n\n**D. Systemic Lupus Erythematosus (SLE)** – SLE can cause a purpuric rash and arthritis, but usually in older children or adolescents, accompanied by **hematologic abnormalities** (e.g., cytopenias), **renal proteinuria** due to lupus nephritis, and positive serologic markers (ANA, anti-dsDNA). The rash is often malar or photosensitive rather than **palpable purpura** on dependent areas.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Detailed history and physical exam focusing on the **distribution and palpability of purpura**, joint findings, and abdominal tenderness. Order a **CBC** (to rule out thrombocytopenia), **urinalysis** (for hematuria/proteinuria), and basic **renal function tests**.\n- **Best Test:** **Skin biopsy with immunofluorescence**, which shows **granular IgA deposition** in the walls of dermal small vessels. This confirms IgA vasculitis, though HSP is often diagnosed clinically.\n- **Additional Tests:** Check **serum IgA levels** (may be elevated). If severe abdominal pain is present or intussusception is suspected, obtain a **renal ultrasound or abdominal ultrasound**.\n\n---\n\n**Management:**\n\n- **Supportive Care:** Adequate hydration, rest, and pain control with **acetaminophen** or **NSAIDs** (if renal function is normal).\n- **Corticosteroids:** Indicated for severe **abdominal pain**, **scrotal involvement**, or significant **renal disease** (e.g., prednisone 1–2 mg/kg/day for 1–2 weeks, then taper).\n- **Monitor Renal Function:** Regular follow-up with **urinalysis** and **blood pressure** checks, since 20–50% of patients develop nephritis requiring further intervention.\n- **Treat Complications:** If **intussusception** occurs, manage with **air or contrast enema** reduction under radiologic guidance.\n\n---\n\n**Why Each Symptom Occurs in HSP:**\n\n1. **Palpable Purpura:** Immune complex deposition (predominantly IgA) in dermal capillaries causes leukocytoclastic vasculitis, leading to vessel wall damage and red blood cell extravasation into the skin.\n2. **Arthralgia/Arthritis:** Deposition of IgA complexes in synovial vessels triggers local inflammation, resulting in pain and swelling of the joints (usually knees and ankles).\n3. **Abdominal Pain:** Vasculitis of the gastrointestinal tract (small vessels) causes submucosal hemorrhage and edema, leading to colicky pain, vomiting, and risk of intussusception.\n4. **Renal Involvement:** IgA deposition in the glomerular mesangium (similar to IgA nephropathy) leads to hematuria and proteinuria; glomerular inflammation can range from mild to severe.\n5. **Post-Infectious Trigger:** A preceding upper respiratory infection increases mucosal IgA production. Cross-reactivity results in immune complex formation and deposition in vessel walls.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **IgA Immune Complex Formation:** After a mucosal infection, excessive IgA production leads to circulating IgA-containing immune complexes.\n2. **Deposition in Small Vessels:** These immune complexes deposit in the postcapillary venules of skin, GI tract, joints, and kidneys.\n3. **Complement Activation:** Deposition of IgA complexes activates the complement cascade (particularly C3), recruiting neutrophils and causing vascular injury.\n4. **Leukocytoclastic Vasculitis:** Histopathology shows fibrinoid necrosis of vessel walls, neutrophilic infiltration, and nuclear debris (leukocytoclasia).\n5. **Mesangial Proliferation:** In the kidney, IgA deposition in the mesangium induces mesangial cell proliferation and matrix expansion, leading to glomerular inflammation and, in severe cases, crescent formation.\n\n---\n\n**Summary:** Henoch-Schönlein Purpura is an acute, IgA-mediated small-vessel vasculitis in children, characterized by **palpable purpura**, **arthralgias**, **abdominal pain**, and **renal involvement**. Diagnosis is primarily clinical, supported by skin biopsy. Management focuses on supportive care, symptomatic relief, and monitoring for renal complications."
},
{
  "text": "A 10-year-old girl presents to the pediatric rheumatology clinic with a 2-month history of persistent joint pain and swelling. Her mother reports that she wakes up stiff every morning, requiring at least one hour of stretching before being able to walk comfortably. She also has daily low-grade fevers (around 37.5°C) and has lost 2 kg over the past month despite normal appetite. On examination, she has symmetric swelling and limited range of motion of both wrists, both knees, and her left ankle. No skin rash or mucosal ulcers are noted. There is no history of recent infections or trauma. Laboratory studies reveal: hemoglobin 10.5 g/dL, WBC 8,500/µL, platelets 420,000/µL, ESR 50 mm/hr, CRP 20 mg/L, rheumatoid factor (RF) negative, ANA positive at 1:160. Joint aspiration of the right knee shows straw-colored fluid with WBC count 8,000/µL (80% neutrophils), no crystals, and negative bacterial culture. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Systemic Lupus Erythematosus (SLE)" },
    { "label": "B", "text": "Rheumatic Fever" },
    { "label": "C", "text": "Lyme Disease" },
    { "label": "D", "text": "Juvenile Idiopathic Arthritis (JIA)" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Juvenile Idiopathic Arthritis (JIA)**\n\n**Why it’s correct:**\nThis child has a chronic (≥ 6 weeks) history of symmetric arthritis affecting multiple joints, accompanied by morning stiffness and systemic features (low-grade fevers, weight loss). Laboratory findings show elevated inflammatory markers (ESR, CRP), negative RF, and positive ANA—findings consistent with **polyarticular JIA**. The joint aspiration shows inflammatory fluid without infection or crystals. JIA is an autoimmune synovitis that often presents with **morning stiffness**, **joint swelling**, and **systemic symptoms** in children under 16.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Systemic Lupus Erythematosus (SLE)** – Although SLE can present with arthritis, fever, and ANA positivity, SLE typically has other features such as **malar rash**, **photosensitivity**, **oral ulcers**, and often hematologic abnormalities (e.g., leukopenia, thrombocytopenia). This patient’s joint findings are persistently symmetric and primarily inflammatory, without rash, serositis, or renal involvement at presentation.\n\n**B. Rheumatic Fever** – Rheumatic fever causes migratory arthritis, usually of large joints, following a Group A Streptococcus infection. Joints improve in one joint and then move to another, rather than persist in the same joints for months. There is also often carditis, chorea, or erythema marginatum, which are absent here.\n\n**C. Lyme Disease** – Lyme arthritis can cause oligoarthritis (usually one knee) in children from endemic areas, often with a history of tick exposure and possible erythema migrans rash. This patient has **symmetric polyarthritis** affecting multiple joints over months, making Lyme disease unlikely. Serologies for Borrelia burgdorferi would help rule it out.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Detailed **history and physical exam** focusing on duration of arthritis (≥ 6 weeks), number and pattern of joints involved, morning stiffness, and systemic features. Obtain **CBC**, **ESR**, **CRP**, **RF**, and **ANA** to assess for inflammation and autoantibodies.\n- **Rule Out Infection:** Perform **joint aspiration** and fluid analysis (cell count, Gram stain, culture, crystal analysis) to exclude septic arthritis or crystalline arthropathies.\n- **Imaging:** Obtain **plain radiographs** of affected joints to evaluate for joint space narrowing or erosions. An **ultrasound** or **MRI** can detect synovial thickening or early erosive changes, guiding early intervention.\n- **Ophthalmologic Exam:** Screen for **uveitis**, especially in ANA-positive patients, as JIA is associated with asymptomatic anterior uveitis.\n\n---\n\n**Management:**\n\n- **NSAIDs:** First-line symptomatic relief (e.g., ibuprofen or naproxen) to reduce pain and morning stiffness.\n- **Intra-Articular Corticosteroids:** Consider for oligoarticular flares or single large joint involvement.\n- **Disease-Modifying Antirheumatic Drugs (DMARDs):** Methotrexate (10–15 mg/m² weekly) is the anchor therapy for polyarticular or persistent disease to prevent joint damage.\n- **Biologic Agents:** If inadequate response to methotrexate after 3–6 months, add a **TNF-α inhibitor** (e.g., etanercept) or other biologics (IL-1 or IL-6 antagonists) depending on subtype and severity.\n- **Physical Therapy & Occupational Therapy:** Maintain range of motion, strengthen muscles, and prevent contractures.\n- **Regular Monitoring:** Check **CBC**, **LFTs**, and **ESR/CRP** every 3 months while on methotrexate. Perform **annual ophthalmology exams** to monitor for uveitis.\n\n---\n\n**Why Each Symptom Occurs in JIA:**\n\n1. **Morning Stiffness:** Overnight synovial fluid accumulation and inflammatory cytokine release (TNF-α, IL-1, IL-6) lead to decreased joint mobility in the morning, improving with movement.\n2. **Joint Swelling and Pain:** Chronic synovial inflammation (synovitis) causes hypertrophy of the synovial membrane, increased synovial fluid, and pain from chemical mediators stimulating nociceptors.\n3. **Low-Grade Fevers and Weight Loss:** Systemic inflammatory cytokines (especially IL-6) induce fever and anorexia, leading to catabolism and weight loss.\n4. **Anemia of Chronic Disease:** Elevated hepcidin from chronic inflammation reduces iron availability, causing a normocytic, normochromic anemia.\n5. **Symmetric Polyarthritis:** Immune-mediated attack on multiple synovial joints due to loss of self-tolerance, leading to symmetric presentation similar to adult rheumatoid arthritis but in a pediatric population.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Genetic Predisposition:** HLA-DRB1 and other alleles create susceptibility to loss of tolerance and autoimmune targeting of joint antigens.\n2. **Autoimmune Synovitis:** CD4+ T lymphocytes infiltrate the synovium, secrete cytokines (TNF-α, IL-1, IL-6), and recruit macrophages, perpetuating inflammation.\n3. **Pannus Formation:** Inflamed synovial cells hyperproliferate, forming pannus that invades cartilage and bone, leading to joint destruction over time.\n4. **Angiogenesis & Fibroblast Activation:** Synovial fibroblasts release VEGF, promoting new blood vessel growth. Fibroblast-like synoviocytes further secrete matrix metalloproteinases that degrade extracellular matrix.\n5. **Osteoclast Activation:** RANKL expression by synovial fibroblasts and T cells activates osteoclasts, causing bone erosions near inflamed joints.\n\n---\n\n**Summary:** Juvenile Idiopathic Arthritis is an autoimmune inflammatory arthritis in children under 16, characterized by **≥ 6 weeks of joint swelling**, **morning stiffness**, and elevated inflammatory markers. Diagnosis is clinical, supported by labs (ESR, CRP, RF, ANA) and imaging, after excluding infection. Early initiation of **NSAIDs**, **DMARDs**, and possibly **biologics** is crucial to prevent permanent joint damage and preserve function."
},
{
  "text": "A 9-month-old boy is brought to the emergency department with a 2-week history of dry cough that has progressively worsened into violent episodes of coughing several times an hour. His mother reports occasional post-tussive vomiting and “gasping” sounds after cough spells. He had a mild runny nose and low-grade fever two weeks ago, which resolved. He is up to date on immunizations except he missed his 4-month DTaP booster. On exam, his vital signs are: temperature 37.2°C, heart rate 130 bpm, respiratory rate 40/min, and oxygen saturation 94% on room air. He appears fatigued and has intermittent coughing fits during the exam, characterized by rapid series of inspiratory “whoop” sounds. No stridor or wheezing is heard. Chest auscultation is clear between coughs. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Respiratory Syncytial Virus (RSV) Bronchiolitis" },
    { "label": "B", "text": "Viral Croup" },
    { "label": "C", "text": "Pertussis (Whooping Cough)" },
    { "label": "D", "text": "Asthma Exacerbation" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Pertussis (Whooping Cough)**\n\n**Why it’s correct:**\nThis infant’s presentation is characteristic for **pertussis**, with a prolonged course of worsening **paroxysmal cough**, occasional **post-tussive emesis**, and a classic **inspiratory “whoop”** at the end of coughing spells. The history of a mild URI prodrome followed by progressive cough fits the **catarrhal phase** (1–2 weeks) transitioning into the **paroxysmal phase**. He is under-immunized (missed 4-month DTaP), placing him at higher risk. Physical exam between cough spells is often normal, and this child has no wheezing or stridor, making bronchiolitis or croup less likely.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. RSV Bronchiolitis** – RSV in an infant typically presents with a shorter course (3–7 days), with prominent **wheezing**, **crackles**, and **respiratory distress** (tachypnea, retractions). The cough is not usually paroxysmal with a “whoop,” and RSV symptoms peak earlier, without a prolonged 2-week history.\n\n**B. Viral Croup** – Croup (parainfluenza virus) causes a **barking cough**, **hoarse voice**, and **inspiratory stridor**, especially at night. This child has no stridor, and his cough is paroxysmal with whooping, not a brassy cough. Temperature is low-grade or absent in pertussis, whereas moderate fever can accompany croup.\n\n**D. Asthma Exacerbation** – Asthma rarely presents in a 9-month-old; onset is typically older. Asthma exacerbations are characterized by **wheezing**, **prolonged expiratory phase**, and improvement with bronchodilators. This infant has a dry, paroxysmal cough with whoop and no wheezing between coughs.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Obtain a detailed history focusing on **duration of cough**, **presence of whoop**, and **immunization status**. Perform a thorough physical exam to assess for **respiratory distress**, **auscultatory findings**, and **oxygenation**.\n- **CBC:** Early in pertussis, there may be **lymphocytosis** (absolute lymphocyte count > 5,000/µL). This finding is suggestive but not diagnostic.\n- **Nasopharyngeal Swab for PCR:** The **best diagnostic test** is **Bordetella pertussis PCR** on a nasopharyngeal specimen (e.g., nasopharyngeal aspirate or swab) taken during the first 3 weeks of cough. Positioning and technique are crucial to obtain epithelial cells.\n- **Culture on Bordet-Gengou Agar:** Highly specific but less sensitive than PCR and takes 7–10 days for growth. Best used early (within first 2 weeks of cough) if PCR is unavailable.\n- **Serology:** In later stages (>3 weeks of cough), serology for anti-pertussis toxin IgG can support the diagnosis, but it is less useful acutely.\n\n---\n\n**Management:**\n\n- **Macrolide Antibiotics:** **Azithromycin** is first-line (10 mg/kg on day 1, then 5 mg/kg on days 2–5). Alternatives include **clarithromycin** (7.5 mg/kg twice daily for 7 days) or **erythromycin** (less preferred due to pyloric stenosis risk).\n- **Post-Exposure Prophylaxis:** All **household contacts and close caregivers** should receive a macrolide (e.g., azithromycin) regardless of immunization status to eradicate nasopharyngeal carriage and prevent spread.\n- **Supportive Care:** Ensure adequate **hydration** and **nutrition**, especially during bouts of post-tussive vomiting. In severe cases, **hospitalize** for supportive oxygen, hydration, and monitoring of **apnea**, **hypoxemia**, or **apneic spells** in infants.\n- **Immunization Catch-Up:** If pertussis is confirmed, update the child’s DTaP schedule as soon as appropriate, per CDC guidelines (minimum intervals between doses).\n- **Monitoring for Complications:** Watch for **apnea**, **pneumonia**, or **weight loss**. In infants <6 months, consider hospitalization due to risk of **apnea** and **hypoxemia**.\n\n---\n\n**Why Each Symptom Occurs in Pertussis:**\n\n1. **Paroxysmal Cough:** The toxin‐mediated damage (pertussis toxin and tracheal cytotoxin) to respiratory epithelium disrupts the mucociliary escalator, leading to mucus accumulation and repeated cough to clear secretions.\n2. **Inspiratory Whoop:** Following a series of rapid coughs, the forced inspiratory effort against a narrowed, edematous glottis produces the high‐pitched “whoop.”\n3. **Post-Tussive Vomiting:** Violent cough spasms increase intrathoracic and intraabdominal pressure, stimulating vagal afferents and leading to emesis.\n4. **Lymphocytosis:** Pertussis toxin interferes with lymphocyte trafficking, causing lymphocytes to remain in the bloodstream rather than migrate into lymphoid tissues.\n5. **Low-Grade Fever or Afebrile:** The characteristic toxins do not provoke a strong systemic inflammatory response, so fever is generally minimal or absent after the catarrhal phase.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Pertussis Toxin (PTx):** An **AB5 exotoxin** that ADP-ribosylates G proteins, leading to impaired chemotaxis of neutrophils and lymphocytosis due to altered lymphocyte egress from blood.\n2. **Tracheal Cytotoxin (TCT):** A **peptidoglycan fragment** that directly damages ciliated respiratory epithelial cells, causing ciliostasis and mucosal necrosis.\n3. **Filamentous Hemagglutinin (FHA):** A **major adhesin** that allows **Bordetella pertussis** to bind to ciliated epithelial cells in the upper airway, facilitating colonization.\n4. **ADP-Ribosylating Adenylate Cyclase Toxin (ACT):** Increases intracellular cAMP in phagocytes, impairing their function and further dampening effective bacterial clearance.\n5. **Lymphocytosis-Promoting Factor:** PTx-induced inhibition of lymphocyte chemokine receptors causes **peripheral lymphocytosis**, a hallmark lab finding in early pertussis.\n\n---\n\n**Summary:**\nPertussis (whooping cough) in infants often presents after a **catarrhal phase** with a prolonged **paroxysmal coughing** illness, characterized by a classic **whoop**, **post-tussive vomiting**, and possible **apnea**. Diagnosis relies on a high index of suspicion, **PCR** testing (best), and culture. Treatment with **macrolides** and **post-exposure prophylaxis** of contacts are critical to limit spread. Supportive care addresses hydration and monitoring for complications. Pathophysiology centers around **toxin-mediated damage** to respiratory epithelium, immune dysregulation, and impaired clearance of the organism."
},
{
  "text": "A 11-year-old boy is brought to the pediatric clinic with a 1-week history of fever (up to 39°C), migratory joint pain, and new onset shortness of breath. Two weeks ago, he had a sore throat that resolved without antibiotics. On examination, he is febrile, tachycardic (heart rate 120 bpm), and has a 2/6 holosystolic murmur best heard at the apex radiating to the axilla. His left knee and right ankle are swollen, erythematous, and tender, and these joint findings seem to “move” from one joint to another over several days. He also has a faint, nonpruritic, serpiginous rash on his trunk that blanches with pressure, and small, firm, nontender subcutaneous nodules over the extensor surfaces of his elbows. Neurologic exam reveals involuntary, irregular movements of his upper extremities. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Juvenile Idiopathic Arthritis (JIA)" },
    { "label": "B", "text": "Systemic Lupus Erythematosus (SLE)" },
    { "label": "C", "text": "Lyme Arthritis" },
    { "label": "D", "text": "Rheumatic Fever" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Rheumatic Fever**\n\n**Why it’s correct:**\nThis child’s presentation fits the classic features of **acute rheumatic fever (ARF)** following an untreated Group A streptococcal pharyngitis. He exhibits the major Jones criteria: **migratory polyarthritis** (joints involved sequentially), **carditis** (holosystolic murmur suggesting mitral regurgitation), **erythema marginatum** (serpiginous, nonpruritic rash), **subcutaneous nodules**, and **Sydenham chorea** (involuntary movements). The history of a sore throat 2 weeks prior without antibiotic treatment supports a post-streptococcal immune response.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Juvenile Idiopathic Arthritis (JIA)** – JIA can present with fever and arthritis, but typically does not cause migratory joint involvement; instead, arthritis is persistent in affected joints. JIA does not cause carditis, erythema marginatum, subcutaneous nodules in this pattern, or chorea. ANA or RF may be positive, and there is no antecedent untreated strep infection.\n\n**B. Systemic Lupus Erythematosus (SLE)** – SLE in children can present with arthritis, rash, and even carditis, but the rash is usually a **malar rash** or photosensitive rash rather than **erythema marginatum**. SLE arthritis is nonerosive and symmetric, not migratory. Subcutaneous nodules and chorea are uncommon in pediatric SLE. Serologic markers (anti–double-stranded DNA, anti–Smith, complement levels) would be required for diagnosis.\n\n**C. Lyme Arthritis** – Lyme disease causes arthritis, especially of the knee, but typically presents as **oligoarthritis** (often a single swollen knee) in children from endemic areas with a history of tick exposure and possibly erythema migrans. It does not cause migratory polyarthritis in multiple joints over days, rheumatic carditis, subcutaneous nodules, or chorea.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** A thorough history and physical exam focusing on **recent pharyngitis**, fever pattern, migratory arthritis, rash, nodules, and neurologic findings (chorea). Obtain a **throat swab for rapid antigen detection test (RADT)** and/or **throat culture** to confirm recent Group A Streptococcus (GAS) infection if still in the acute phase.\n- **Laboratory Tests:** Check **ASO titers** and **anti-DNase B titers** to document a recent GAS infection (titers rise 2–3 weeks after infection). Obtain **ESR** and **CRP** (both typically elevated). A **CBC** often shows mild leukocytosis and anemia of inflammation.\n- **Cardiac Evaluation:** Perform an **echocardiogram** (best test for diagnosing carditis) to assess for **mitral regurgitation**, **aortic regurgitation**, or pericardial effusion. Also get an **ECG** to look for prolonged PR interval (first-degree heart block).\n- **Jones Criteria Application:** Use the **revised Jones criteria** (Major: migratory arthritis, carditis, subcutaneous nodules, erythema marginatum, Sydenham chorea; Minor: fever, arthralgia, elevated ESR/CRP, prolonged PR interval) along with evidence of recent GAS infection to confirm diagnosis.\n\n---\n\n**Management:**\n\n- **Eradication of GAS:** Administer **intramuscular benzathine penicillin G** (1.2 million units IM once) or, if penicillin-allergic, **erythromycin** orally for 10 days.\n- **Anti-Inflammatory Therapy:** High-dose **aspirin** (80–100 mg/kg/day divided every 6 hours) to control arthritis and fever until ESR/CRP normalizes, then taper over 2–3 weeks to an antiplatelet dose (3–5 mg/kg/day) for 4–6 weeks if carditis is present. For refractory arthritis or severe carditis, consider **corticosteroids** (e.g., prednisone 1–2 mg/kg/day) especially if heart failure signs develop.\n- **Management of Chorea:** Provide **supportive care** and, if chorea interferes with activities of daily living, treat with **valproic acid** or **haloperidol**. Chorea may persist for months despite treatment of ARF.\n- **Long-Term Prophylaxis:** Secondary prophylaxis with **benzathine penicillin G every 4 weeks** for a minimum of 5 years or until age 21 (whichever is longer) if carditis was absent; if carditis with residual valvular disease, extend prophylaxis for at least 10 years or until age 40.\n- **Monitor Cardiac Sequelae:** Regular follow-up with **echocardiography** to assess valvular function. Manage any resulting rheumatic heart disease (e.g., valve repair or replacement) as needed.\n\n---\n\n**Why Each Symptom Occurs in Rheumatic Fever:**\n\n1. **Migratory Arthritis:** Immune-mediated cross-reactivity (molecular mimicry) between GAS antigens and joint tissues leads to **inflammation of synovial membranes**; joints “move” because antibodies target multiple joints in sequence.\n2. **Carditis (Mitral Regurgitation Murmur):** GAS M protein–specific antibodies cross-react with **myocardial and endocardial tissues**, causing pancarditis. Damage to the mitral valve leaflets leads to regurgitation, audible as a holosystolic murmur.\n3. **Erythema Marginatum:** A form of **immune complex–mediated vasculitis** in the skin; deposition of immune complexes in superficial dermal vessels produces the characteristic serpiginous rash that blanches on pressure.\n4. **Subcutaneous Nodules:** Granulomatous inflammation in deep connective tissues, often over **bony prominences**, due to aggregated **Aschoff bodies** (foci of fibrinoid necrosis and inflammatory cells) in the subcutaneous tissues.\n5. **Sydenham Chorea:** Antibodies against the basal ganglia, specifically **anti–streptococcal and anti–neuronal antibodies**, disrupt neurotransmitter function in the caudate nucleus and putamen, resulting in rapid, involuntary movements.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Molecular Mimicry:** Anti–Group A Streptococcus (GAS) antibodies, especially those directed against the **M protein**, cross-react with **myosin and other proteins** in cardiac myocytes, synovium, and neuronal tissue, initiating an autoimmune attack.\n2. **Aschoff Bodies Formation:** In the myocardium, clusters of **macrophages, T lymphocytes, and Anitschkow cells** form granulomatous lesions (Aschoff bodies) that cause tissue destruction and scarring, leading to chronic valvular deformities.\n3. **Immune Complex Deposition:** Circulating immune complexes of streptococcal antigens and host antibodies deposit in small blood vessels (skin, synovium), activating complement and recruiting neutrophils—resulting in vasculitis (erythema marginatum and arthritis).\n4. **Cytokine Surge:** Elevated levels of **TNF-α, IL-1, and IL-6** mediate systemic inflammation—fever, elevated ESR/CRP, and recruitment of inflammatory cells to the heart, joints, skin, and subcutaneous tissues.\n5. **T-Cell–Mediated Damage:** CD4+ T lymphocytes specific for streptococcal peptides infiltrate cardiac tissue, releasing **interferon-γ** and other cytokines that amplify local inflammation and lead to further myocyte injury and fibrosis.\n\n---\n\n**Summary:**\nAcute rheumatic fever is an **immune-mediated sequela** of untreated **Group A streptococcal pharyngitis** characterized by **migratory arthritis, carditis, erythema marginatum, subcutaneous nodules,** and **Sydenham chorea**. Diagnosis relies on the **Jones criteria** plus evidence of recent strep infection. Management includes **eradication of GAS** with penicillin, **anti-inflammatory therapy** (aspirin or steroids), and **long-term penicillin prophylaxis** to prevent recurrent episodes. Pathophysiology revolves around **molecular mimicry, immune complex deposition, cytokine‐driven inflammation, Aschoff bodies,** and **T-cell–mediated cardiac injury**."
},
{
  "text": "A 6-year-old boy presents to the pediatric clinic with a 3-week history of increasing fatigue, intermittent low-grade fevers, and easy bruising. His parents also note that he has complained of leg pain, especially at night, and has refused to walk on his left leg for the past week. He has lost 2 kg over the past month despite a normal appetite. On examination, he appears pale with scattered petechiae on his lower extremities. There is mild, non-tender cervical lymphadenopathy, and his liver and spleen are palpably enlarged 3 cm below the costal margins. His left tibia is tender to palpation without obvious erythema or swelling. No joint effusion is noted. Vital signs are: temperature 37.8°C, heart rate 110 bpm, respiratory rate 22/min, blood pressure 100/60 mmHg. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute Lymphoblastic Leukemia (ALL)" },
    { "label": "B", "text": "Aplastic Anemia" },
    { "label": "C", "text": "Juvenile Idiopathic Arthritis (JIA)" },
    { "label": "D", "text": "Osteomyelitis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Acute Lymphoblastic Leukemia (ALL)**\n\n**Why it’s correct:**\nThis child’s presentation—**pallor**, **petichiae/bruising**, **bone pain**, **hepatosplenomegaly**, and **lymphadenopathy**—is classic for **ALL**, the most common childhood cancer. The combination of **fatigue** (from anemia), **easy bruising** (thrombocytopenia), and **bone pain** (marrow expansion by blasts) strongly suggests a malignant proliferative process in the bone marrow rather than a purely rheumatologic or infectious condition.\n\n---\n\n**Why the other options are incorrect:**\n\n**B. Aplastic Anemia** – Aplastic anemia causes pancytopenia leading to **fatigue** and **bruising**, but it usually presents without **bone pain**, **organomegaly**, or **lymphadenopathy**. The bone marrow is hypocellular rather than packed with blasts. There would also be no focal bone tenderness.\n\n**C. Juvenile Idiopathic Arthritis (JIA)** – JIA can cause **leg pain** and refusal to bear weight if joints are involved, and sometimes mild anemia of chronic disease, but it does not cause **petechiae** or **hepatosplenomegaly**. In JIA, joint exam typically reveals **swelling**, **warmth**, and **effusion**, which are absent here.\n\n**D. Osteomyelitis** – Osteomyelitis can present with **bone pain**, fevers, and refusal to walk, but it usually produces **localized signs** of inflammation (erythema, swelling, warmth) in one area only. It does not cause **pancytopenia**, **petechiae**, or **organomegaly**.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Obtain a **complete blood count (CBC) with differential** and **peripheral blood smear**. In ALL, expect **leukocytosis** or sometimes normal/low WBC, with a high percentage of **lymphoblasts**, as well as **anemia** (low hemoglobin) and **thrombocytopenia** (low platelets).\n- **Next Step:** If the smear shows blasts, perform a **bone marrow aspiration and biopsy**. This is the **gold standard** for diagnosis. Flow cytometry on marrow cells will confirm B-cell or T-cell lineage and identify immunophenotypic markers (e.g., TdT+, CD10+ in B-ALL).\n- **Cytogenetic and Molecular Studies:** Obtain **karyotyping** and **FISH** to detect common genetic abnormalities (e.g., **t(12;21)** TEL-AML1, **t(9;22)** BCR-ABL) for risk stratification.\n- **Additional Tests:** Check **lumbar puncture** with CSF analysis to evaluate for **CNS involvement**. Perform a **chest X-ray** to look for mediastinal mass in T-ALL. Evaluate **renal and liver function** for baseline organ status.\n\n---\n\n**Management:**\n\n- **Induction Chemotherapy:** Begin a standardized pediatric ALL protocol (e.g., **Vincristine**, **Prednisone**, **L-asparaginase**, and **Daunorubicin**). The goal is to achieve **complete remission** (i.e., <5% blasts in marrow).\n- **Central Nervous System (CNS) Prophylaxis:** Intrathecal **Methotrexate** (with or without Cytarabine) to prevent or treat CNS leukemia, given at diagnosis and periodically during therapy.\n- **Consolidation/Intensification:** High-dose **Methotrexate** or **Cytarabine** depending on risk group; continue systemic treatment to eradicate minimal residual disease.\n- **Maintenance Therapy:** Lower-intensity regimen for 2–3 years (e.g., **6-Mercaptopurine**, **Methotrexate**, low-dose **Vincristine** and **Prednisone** pulses) to prevent relapse.\n- **Supportive Care:** \n  - **Tumor Lysis Syndrome (TLS) Prophylaxis:** Administer **allopurinol** or **rasburicase** before induction if WBC is very high (>100,000/µL). Monitor electrolytes (uric acid, phosphate, potassium, calcium) and renal function.\n  - **Transfusions:** Give **packed RBCs** for symptomatic anemia and **platelet transfusions** if platelets <10,000/µL or <20,000/µL with bleeding.\n  - **Infection Prophylaxis:** Patients are immunosuppressed; use **antibacterial**, **antiviral**, and **antifungal** prophylaxis as indicated. Pay attention to central line care.\n  - **Pain Management:** Manage **bone pain** with **acetaminophen** and **opioids** if severe. Provide **mucositis** prophylaxis during high-dose chemotherapy.\n- **Stem Cell Transplant:** Consider in **high-risk** or **relapsed** ALL based on cytogenetics and response to therapy.\n\n---\n\n**Why Each Symptom Occurs in ALL:**\n\n1. **Fatigue and Pallor:** Leukemic blasts crowd out normal erythroid precursors in the bone marrow, causing **anemia** and reduced oxygen-carrying capacity.\n2. **Easy Bruising and Petechiae:** Thrombocytopenia results from Blast infiltration of the marrow, reducing platelet production and causing bleeding manifestations.\n3. **Bone Pain:** Rapid proliferation of leukemic blasts expands the marrow cavity and stretches the periosteum, leading to **bone and joint pain**, often worse at night.\n4. **Hepatosplenomegaly & Lymphadenopathy:** Extramedullary infiltration by malignant lymphoblasts leads to **organomegaly** and **lymph node enlargement**.\n5. **Low-Grade Fevers:** Cytokine release by malignant cells and frequent infections (due to neutropenia and dysfunctional leukocytes) contribute to **fever**.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Clonal Proliferation of Lymphoid Progenitors:** A genetic mutation in a **hematopoietic stem cell** leads to uncontrolled proliferation of immature B- or T-lymphoblasts that accumulate in the bone marrow.\n2. **Block in Differentiation:** Mutations (e.g., in **TEL-AML1**, **PAX5**, **IKZF1**) impair normal differentiation, causing progenitors to remain in an immature blast state and fail to mature into functional leukocytes.\n3. **Marrow Replacement:** Accumulating lymphoblasts displace normal hematopoietic elements (erythrocytes, megakaryocytes, myelocytes), resulting in **pancytopenia** (anemia, thrombocytopenia, neutropenia).\n4. **Genetic Aberrations:** Chromosomal translocations such as **t(12;21)** or **t(9;22)** create fusion genes (TEL-AML1 or BCR-ABL) that drive leukemogenesis through **aberrant tyrosine kinase activity** or transcriptional dysregulation.\n5. **CNS Sanctuary Sites:** Leukemic blasts can cross the **blood–brain barrier** and reside in the cerebrospinal fluid, necessitating **intrathecal chemotherapy** for effective eradication and prevention of CNS relapse.\n\n---\n\n**Summary:**\nAcute Lymphoblastic Leukemia in children presents with **pancytopenia** (fatigue, pallor, bruising), **bone pain**, and **hepatosplenomegaly**. Diagnosis is confirmed by **peripheral smear** and **bone marrow biopsy/flow cytometry**. Treatment involves **multi-agent chemotherapy**, **CNS prophylaxis**, and careful supportive care (TLS prevention, transfusions, infection prophylaxis). The pathophysiology centers on **clonal expansion of lymphoid blasts**, **block in differentiation**, and **genetic fusion events** driving malignant transformation."
},
{
  "text": "An 8-year-old girl is brought to the pediatric clinic with a 3-day history of intensely pruritic, raised red welts on her trunk and extremities. Each lesion appears suddenly, enlarges over several hours, then fades within 24 hours, only to be replaced by new lesions in different locations. She denies fever, joint pain, or systemic symptoms. Two weeks ago, she had a viral upper respiratory infection that resolved without treatment. There is no history of new foods, medications, or insect bites. On examination, she has multiple, well-defined, erythematous wheals of varying sizes scattered across her back and arms. No angioedema of the lips or eyes is noted. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Atopic Dermatitis" },
    { "label": "B", "text": "Urticaria" },
    { "label": "C", "text": "Erythema Multiforme" },
    { "label": "D", "text": "Serum Sickness–Like Reaction" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Urticaria**\n\n**Why it’s correct:**\nThe hallmark of **urticaria** is transient, pruritic wheals that **appear suddenly**, **enlarge over hours**, and **resolve within 24 hours**, with new lesions appearing elsewhere. These wheals result from **localized dermal edema** due to mast cell degranulation and histamine release. In this child, the absence of mucosal involvement, fixed lesions, or target lesions points to urticaria after a recent viral illness, which is a common trigger in pediatric cases.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Atopic Dermatitis** – Presents with **chronic**, scaly, eczematous patches in flexural areas, often with lichenification. Lesions in atopic dermatitis are **persistent**, not fleeting wheals that resolve within a day.\n\n**C. Erythema Multiforme** – Characterized by **target lesions** (concentric rings with central clearing) often on palms, soles, and extensor surfaces. Lesions in erythema multiforme last longer than 24 hours and are not intensely pruritic wheals.\n\n**D. Serum Sickness–Like Reaction** – Involves **fever**, **arthralgias**, and a **urticarial rash** that is usually more persistent (lasting multiple days before resolution) and often accompanied by **lymphadenopathy** or **renal involvement**. This child has no systemic symptoms or joint pain.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Take a detailed history focusing on **lesion duration**, **pruritus**, **trigger exposures**, and **recent infections**. Perform a **thorough skin exam** to confirm that individual wheals resolve within 24 hours.\n- **Laboratory Tests:** In acute, limited urticaria with no systemic signs, **no laboratory tests** are required initially. If lesions persist beyond 6 weeks (chronic urticaria), obtain **CBC**, **ESR/CRP**, and thyroid function tests to rule out underlying autoimmune or inflammatory conditions.\n- **Allergy Testing:** If a specific allergen is suspected (e.g., food, medication), perform **skin prick testing** or **specific IgE assays**. However, most pediatric urticaria cases are idiopathic or post-viral.\n- **Lesional Biopsy (Best Test to Exclude Vasculitis):** If individual lesions last >24 hours or bruise on resolution, perform a **skin biopsy** to differentiate **urticarial vasculitis** (demonstrates leukocytoclastic vasculitis) from simple urticaria.\n\n---\n\n**Management:**\n\n- **Avoid Known Triggers:** Counsel the family to avoid identified triggers (foods, medications) if any, and recommend **cool showers** or **loose clothing** to minimize irritation.\n- **Second-Generation H₁ Antihistamines:** Start with a **nonsedating antihistamine** (e.g., cetirizine or loratadine) once daily. If symptoms persist, increase the dose up to **2–4 times** the standard pediatric dose under physician supervision.\n- **H₂ Antagonists (Optional Add-On):** Consider adding an **H₂ blocker** (e.g., ranitidine) if symptoms are refractory to H₁ blockade alone.\n- **Short-Course Systemic Corticosteroids:** In severe cases with widespread lesions or significant pruritus, use a **3–5 day course** of **oral prednisone** (1–2 mg/kg) to quickly suppress mast cell activation.\n- **Refractory Chronic Urticaria:** If symptoms persist >6 weeks despite high-dose antihistamines, consider **omalizumab** (anti-IgE) in children ≥12 years or **cyclic corticosteroids** under specialist guidance.\n\n---\n\n**Why Each Symptom Occurs in Urticaria:**\n\n1. **Pruritus:** Histamine and other mediators released from mast cells stimulate **C-fibers**, causing intense itching.\n2. **Raised Wheals:** Histamine increases **vascular permeability**, leading to localized fluid leakage into the dermis (dermal edema), which forms a palpable, raised lesion.\n3. **Erythema:** Histamine-mediated **vasodilation** of dermal capillaries causes the central redness of each wheal.\n4. **Transient Nature (<24 hours):** Histamine’s short half-life and rapid reabsorption of fluid resolve individual wheals within a day, distinguishing urticaria from fixed eruptions.\n5. **Migratory Appearance:** New mast cell degranulation in adjacent areas produces fresh wheals, giving the appearance that lesions move over time.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Mast Cell Degranulation:** An **IgE-mediated** or **non–IgE-mediated** trigger causes mast cells to release **histamine**, **leukotrienes**, and **prostaglandins** into the surrounding dermis.\n2. **Histamine Receptor Activation:** Histamine binds to **H₁ receptors** on endothelial cells, causing vasodilation and increased permeability of postcapillary venules, leading to **plasma leakage** and wheal formation.\n3. **Complement and Bradykinin Pathway:** In some cases, activation of the **complement cascade** (e.g., C₅a) or the **kallikrein–kinin system** (producing bradykinin) further amplifies **vascular permeability** and edema.\n4. **Neuropeptide Release:** Substance P and other neuropeptides released from sensory nerves can **induce mast cell degranulation** and potentiate pruritus, creating a **neurogenic inflammation** loop.\n5. **Basopenia and Eosinopenia:** During acute episodes, **basophils** and **eosinophils** migrate into tissues, leading to transient peripheral basopenia/eosinopenia seen on CBC in some cases of urticaria.\n\n---\n\n**Summary:**\nAcute urticaria in children presents with **pruritic, transient wheals** that resolve within 24 hours and reappear in new areas. Diagnosis is clinical—no tests are required if lesions fit this pattern and no systemic signs are present. Management focuses on **second-generation H₁ antihistamines**, trigger avoidance, and short-course **corticosteroids** for severe flares. The key pathophysiologic steps involve **mast cell degranulation**, **histamine-mediated vascular changes**, and **neuropeptide amplification** resulting in the classic ephemeral, itchy, erythematous wheals."
},
{
  "text": "A 13-year-old girl is brought to the pediatric rheumatology clinic with a 2-month history of fatigue, low-grade fevers, and migratory joint pains. Her mother reports that she has also noticed a red rash on her cheeks that worsens with sun exposure, as well as painless ulcers in her mouth. She has lost 4 kg over the past month despite a normal appetite and has developed swelling around both ankles. There is no history of recent infections. On examination, her temperature is 37.8°C, blood pressure is 125/80 mmHg, and heart rate is 95 bpm. She has a **butterfly-shaped erythematous rash** over her malar areas sparing the nasolabial folds, **symmetric swelling and tenderness** of the wrists and ankles, and **2+ pitting edema** of both lower legs. Oral exam reveals **two painless ulcers** on the hard palate. Laboratory studies show: hemoglobin 9.8 g/dL, WBC 3,200/µL, platelets 90,000/µL, ESR 65 mm/hr, CRP 18 mg/L, creatinine 1.1 mg/dL (elevated for age), urinalysis with **3+ proteinuria** and **10–15 RBCs/hpf**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Juvenile Idiopathic Arthritis (JIA)" },
    { "label": "B", "text": "Juvenile Dermatomyositis" },
    { "label": "C", "text": "Henoch-Schönlein Purpura (IgA Vasculitis)" },
    { "label": "D", "text": "Systemic Lupus Erythematosus (SLE)" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Systemic Lupus Erythematosus (SLE)**\n\n**Why it’s correct:**\nThis adolescent girl demonstrates multiple classic features of **pediatric SLE**, including a **malar rash** that spares the nasolabial folds and worsens with sun exposure, **arthritis** (symmetric joint swelling and tenderness), **oral ulcers**, **renal involvement** (proteinuria with hematuria), and **hematologic abnormalities** (anemia, leukopenia, thrombocytopenia). The combination of **constitutional symptoms** (fatigue, low-grade fevers, weight loss), **renal findings**, and a characteristic rash strongly supports the diagnosis of SLE.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Juvenile Idiopathic Arthritis (JIA)** – JIA can cause chronic arthritis and sometimes systemic symptoms, but it does not typically produce a **butterfly rash**, **oral ulcers**, or **significant renal disease**. In JIA, laboratory studies may show mild anemia of chronic disease and elevated inflammatory markers, but the cytopenias (WBC 3,200/µL, platelets 90,000/µL) and proteinuria with hematuria are not characteristic.\n\n**B. Juvenile Dermatomyositis** – Dermatomyositis presents with **heliotrope rash**, **Gottron’s papules**, and **proximal muscle weakness** rather than a malar rash. Muscle enzymes (CK, aldolase) are elevated, and patients have difficulty climbing stairs or rising from a chair. This patient has no evidence of muscle weakness or elevated muscle enzymes.\n\n**C. Henoch-Schönlein Purpura (IgA Vasculitis)** – HSP is characterized by **palpable purpura** on dependent areas (buttocks/legs), **arthralgias**, **abdominal pain**, and **renal manifestations** (hematuria). However, this patient has no purpuric rash, and her rash is malar, not palpable purpura. Additionally, HSP renal involvement usually manifests as IgA-mediated glomerulonephritis with limited systemic features, whereas this patient has cytopenias and mucocutaneous ulcers.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Obtain a **detailed history** (onset, rash pattern, photosensitivity, ulcers, systemic symptoms) and perform a **thorough physical exam** (rash distribution, joint exam, mucosal inspection, edema). Order a **CBC with differential**, **ESR**, **CRP**, **renal function tests**, and **urinalysis** to evaluate for hematologic, inflammatory, and renal involvement.\n- **Autoantibody Testing (Best Initial Immunologic Screen):** Check **ANA** (positive in > 95% of pediatric SLE), **anti–double-stranded DNA (anti-dsDNA)** (specific for SLE, correlates with renal disease), and **anti–Smith (anti-Sm)** antibodies (highly specific). Also obtain **anti–RNP**, **anti–SSA/SSB**, and **complement levels** (C3, C4 often low in active disease).\n- **Complement Levels:** Low **C3 and C4** support active immune complex formation in SLE.\n- **Renal Evaluation:** If urinalysis shows proteinuria and hematuria, quantify proteinuria with **urine protein/creatinine ratio** and perform a **renal ultrasound** if indicated. The **gold standard** for diagnosing lupus nephritis is a **renal biopsy**, which classifies histologic class and guides therapy.\n- **Additional Tests:** Evaluate for **cardiac involvement** with **echocardiogram** (pericarditis or Libman-Sacks endocarditis), and if neurologic symptoms appear, consider **MRI** or **CSF analysis** for neuropsychiatric SLE.\n\n---\n\n**Management:**\n\n- **Acute Therapy:** \n  - **High-Dose Corticosteroids:** For moderate-to-severe flares (e.g., renal involvement), use **IV methylprednisolone pulses** (30 mg/kg, max 1 g daily for 3 days), then transition to **oral prednisone** (1–2 mg/kg/day) with a gradual taper as disease activity decreases.\n  - **Hydroxychloroquine:** All pediatric SLE patients should start **hydroxychloroquine** (5 mg/kg/day) unless contraindicated; it reduces flares and protects against organ damage.\n\n- **Immunosuppressive Agents:** \n  - **Mycophenolate Mofetil (MMF)** is first-line for **lupus nephritis** (class III–V) in children (600 mg/m² twice daily) as it is less toxic than cyclophosphamide.\n  - **Cyclophosphamide** (monthly IV pulses) may be used for severe proliferative nephritis if MMF is contraindicated or if the patient fails to respond.\n  - **Azathioprine** (2 mg/kg/day) can be used as a **steroid-sparing** agent after induction therapy or for milder systemic disease.\n\n- **Supportive Care:** \n  - **Blood Pressure Control:** Use **ACE inhibitors** or **ARBs** to reduce proteinuria and slow renal progression.\n  - **Calcium and Vitamin D Supplementation:** To prevent corticosteroid-induced osteoporosis.\n  - **Sun Protection:** Advise daily **broad-spectrum sunscreen** and **sun-protective clothing** to avoid photosensitive flares.\n  - **Pneumococcal and Influenza Vaccination:** Recommended before initiating immunosuppression; live vaccines are contraindicated if on high-dose steroids or cyclophosphamide.\n\n- **Long-Term Monitoring:** \n  - **Regular Follow-Up:** Check **CBC**, **renal function**, **urinalysis**, **complement levels**, and **anti-dsDNA titers** every 1–3 months during active disease.\n  - **Ophthalmologic Exam:** Annual screening for **hydroxychloroquine** retinopathy after 5 years of use (or sooner if high risk).\n  - **Bone Density Monitoring:** In patients on long-term steroids, consider **DXA scan** periodically.\n\n---\n\n**Why Each Symptom Occurs in SLE:**\n\n1. **Malar Rash:** UV exposure induces **apoptosis of keratinocytes**, leading to nuclear antigen exposure. Immune complexes deposit in dermal vessels and skin, activating complement and causing inflammation.\n2. **Arthritis/Arthralgias:** Immune complex deposition in joint synovium triggers **complement activation**, neutrophil recruitment, and synovial inflammation, leading to joint pain and swelling (usually nonerosive).\n3. **Oral Ulcers:** Vasculitis and immune complex–mediated damage of small blood vessels in the mucosa lead to painless mucosal ulcerations.\n4. **Renal Involvement (Proteinuria, Hematuria):** Circulating immune complexes (anti-dsDNA bound to nucleosomes) deposit in glomerular basement membrane, initiating **complement activation**, inflammation, and glomerulonephritis (lupus nephritis).\n5. **Cytopenias (Anemia, Leukopenia, Thrombocytopenia):** **Autoantibody-mediated destruction** of blood cells (e.g., anti–erythrocyte/antiplatelet antibodies), as well as **bone marrow suppression** from chronic inflammation.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Loss of Self-Tolerance:** Genetic predisposition (e.g., HLA-DR2/3) plus environmental triggers (UV light, infections) lead to defective **apoptotic cell clearance**, exposing intracellular antigens.\n2. **Autoantibody Production:** **B cells** produce autoantibodies (e.g., anti-dsDNA, anti-Sm) that form **immune complexes** which deposit in tissues and activate complement, causing inflammation.\n3. **Type III Hypersensitivity:** Immune complexes deposit in **skin, joints, kidneys, and vessels**, leading to complement activation (C3a, C5a) and recruitment of inflammatory cells.\n4. **Complement Consumption:** Persistent immune complex formation leads to **hypocomplementemia** (low C3, C4), which correlates with disease activity.\n5. **T-Cell Dysfunction:** **CD4+ T helper cells** provide aberrant help to B cells (excessive IL-10, IL-6), and **regulatory T-cell dysfunction** fails to suppress autoreactive lymphocytes, perpetuating autoimmunity.\n\n---\n\n**Summary:**\nPediatric SLE often presents with **constitutional symptoms**, **malar rash**, **arthritis**, **oral ulcers**, **cytopenias**, and **renal disease**. Diagnosis relies on clinical criteria supported by **autoantibody profiles** (ANA, anti-dsDNA, anti-Sm) and complement levels. Management centers on **immunosuppression** (corticosteroids, hydroxychloroquine, MMF or cyclophosphamide for nephritis), **supportive care** (sun protection, bone health), and **long-term monitoring** for organ involvement and medication toxicity."
},
{
  "text": "A 10-year-old boy presents to the pediatric emergency department with a 2-day history of intermittent, dull periumbilical pain that suddenly localized to the right lower quadrant 6 hours ago. He has had decreased appetite, mild nausea, and a single episode of non-bilious vomiting. Yesterday, he experienced two loose stools without blood. He had a low-grade fever at home (38.0°C) but no chills. On examination, his vital signs are: temperature 38.1°C, heart rate 100 bpm, respiratory rate 20/min, blood pressure 105/65 mmHg. His abdomen is soft but tender to palpation at McBurney’s point with mild guarding; there is a positive Rovsing’s sign and a mild psoas sign. No rebound is appreciated. Bowel sounds are present and normal. Laboratory studies reveal: WBC 14,200/µL with 85% neutrophils, CRP 24 mg/L. A right lower quadrant ultrasound shows a noncompressible tubular structure measuring 7 mm in diameter, but also multiple enlarged mesenteric lymph nodes (up to 1.2 cm), making the diagnosis uncertain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Mesenteric Adenitis" },
    { "label": "B", "text": "Acute Gastroenteritis" },
    { "label": "C", "text": "Acute Appendicitis" },
    { "label": "D", "text": "Crohn’s Disease" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Acute Appendicitis**\n\n**Why it’s correct:**\nThis patient’s history of vague periumbilical pain migrating to the right lower quadrant, accompanied by anorexia, nausea, low-grade fever, neutrophilic leukocytosis, and elevated CRP, is classic for **acute appendicitis**. The ultrasound finding of a noncompressible tubular structure >6 mm in diameter is highly suggestive of an inflamed appendix, even though enlarged mesenteric lymph nodes may be present as a reactive finding.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Mesenteric Adenitis** – Often presents similarly with RLQ tenderness and can follow a viral upper respiratory infection. However, mesenteric adenitis typically features more diffuse abdominal discomfort, prominent lymphadenopathy on imaging without a definitively enlarged appendix, and usually normal or only mildly elevated inflammatory markers. In this case, the ultrasound demonstration of a noncompressible appendiceal diameter of 7 mm points to appendiceal inflammation rather than isolated lymph node enlargement.\n\n**B. Acute Gastroenteritis** – Presents with diffuse crampy abdominal pain, frequent loose or watery stools, and can cause low-grade fever. However, gastroenteritis usually does not localize to RLQ nor produce signs such as a positive Rovsing’s or psoas sign. The presence of a specific inflamed appendiceal structure on ultrasound also rules out simple viral or bacterial gastroenteritis.\n\n**D. Crohn’s Disease** – Can cause RLQ pain, diarrhea, weight loss, and low-grade fever, but usually has a more chronic course with growth concerns, perianal disease, and possibly fistulae. In Crohn’s, imaging (ultrasound or MRI) would show bowel wall thickening, skip lesions, or mesenteric fat creeping; acute appendiceal enlargement alone—in the absence of other bowel changes—makes Crohn’s unlikely.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Obtain a **detailed history** (pain migration, anorexia, vomiting, diarrhea) and perform a **thorough physical exam** focusing on localization (McBurney’s point), signs (Rovsing’s, psoas, obturator), and check for peritoneal irritation. Order a **CBC** and **CRP/ESR** to assess for inflammation.\n- **Imaging (Best Initial Test):** In a pediatric patient, **ultrasound** of the right lower quadrant is ideal. Key findings are a **noncompressible tubular structure >6 mm** in diameter, an appendicolith, or increased Doppler flow. Ultrasound is operator-dependent; equivocal studies often necessitate further imaging.\n- **Next Best Test:** If ultrasound is inconclusive and clinical suspicion remains high, proceed to **contrast-enhanced MRI** (preferred to avoid radiation) or **CT scan** if MRI is unavailable. Imaging will confirm appendiceal inflammation, rule out perforation, and assess for abscess.\n- **Laboratory Adjuncts:** A **urinalysis** to exclude a urinary tract infection or ureteral stone, and a **pregnancy test** in post-menarcheal females to exclude gynecologic pathology.\n\n---\n\n**Management:**\n\n- **Preoperative Care:** Initiate **IV fluids** to correct any dehydration and maintain electrolyte balance. Start **IV broad-spectrum antibiotics** covering gram-negative rods and anaerobes (e.g., ceftriaxone plus metronidazole, or a single-agent β-lactam/β-lactamase inhibitor) to reduce the risk of postoperative infection.\n- **Definitive Treatment:** **Laparoscopic appendectomy** is the treatment of choice in uncomplicated appendicitis. If imaging or intraoperative findings show a contained abscess or phlegmon, consider **percutaneous drainage** and interval appendectomy in 6–8 weeks.\n- **Postoperative Care:** Continue **IV antibiotics** for 24 hours postoperatively if the appendix is nonperforated. If perforation or abscess was present, extend broad-spectrum coverage for 5–7 days based on clinical response and culture results. Provide **pain control** with weight-based analgesics, advance diet as tolerated, and encourage **early ambulation**.\n- **Nonoperative Management (Selective):** In selected cases of uncomplicated appendicitis, **nonoperative antibiotic therapy** (e.g., a 5–7 day course of IV followed by oral antibiotics) may be considered, with close outpatient follow-up and a 30%–40% recurrence rate requiring eventual appendectomy.\n\n---\n\n**Why Each Symptom Occurs in Acute Appendicitis:**\n\n1. **Periumbilical Pain Migrating to RLQ:** Early inflammation irritates visceral peritoneum via T10 dermatome, producing poorly localized mid-abdominal pain. As the parietal peritoneum becomes inflamed (somatic innervation), pain localizes to the right lower quadrant (McBurney’s point).\n2. **Anorexia and Nausea:** Inflammatory mediators (e.g., cytokines like IL-6) affect the vomiting center in the medulla and suppress appetite, leading to nausea and anorexia early in the disease.\n3. **Low-Grade Fever:** Localized inflammation and cytokine release elevate the set point in the hypothalamus, producing mild pyrexia but not high-grade fevers unless perforation occurs.\n4. **Tenderness with Guarding:** Parietal peritoneal irritation triggers a reflexive protective contraction of the abdominal wall musculature, known as guarding, and pain on palpation over the inflamed area.\n5. **Rebound Tenderness (if present later):** As inflammation worsens, pressing on the abdominal wall and releasing quickly stretches the peritoneum, causing a sharp pain—rebound tenderness signifies advancing peritoneal irritation.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Obstruction of Appendiceal Lumen:** Most commonly due to a **lymphoid follicle hyperplasia** (in children) or a **fecalith** (in adolescents/adults). Luminal obstruction leads to mucus accumulation, increased intraluminal pressure, and compromised venous outflow.\n2. **Ischemia and Bacterial Overgrowth:** Elevated intraluminal pressure and venous stasis reduce mucosal perfusion, fostering local ischemia. Bacterial proliferation (e.g., Escherichia coli, Bacteroides species) invades the compromised appendiceal wall.\n3. **Inflammatory Cascade:** Neutrophils migrate to the site, releasing proteolytic enzymes and reactive oxygen species that exacerbate mucosal injury and transmural inflammation, involving both visceral and parietal peritoneum.\n4. **Perforation Risk:** As transmural necrosis progresses, an epithelial breach allows enteric bacteria and luminal contents to spill into the peritoneal cavity, leading to localized abscess formation or diffuse peritonitis if untreated.\n5. **Reactive Lymphadenopathy:** Mesenteric lymph nodes enlarge in response to inflammation or concurrent viral gastroenteritis, which may confound imaging findings but are secondary to appendiceal inflammation rather than a primary cause of pain.\n\n---\n\n**Summary:**\nAcute appendicitis in children often begins with visceral periumbilical discomfort that migrates to the RLQ as the parietal peritoneum becomes inflamed. Diagnosis relies on a combination of **history**, **physical exam** (McBurney’s point tenderness, Rovsing’s sign, psoas sign), laboratory markers of inflammation, and **ultrasound** as the initial imaging choice. **Appendectomy** remains the definitive treatment, though nonoperative antibiotic management may be considered in select uncomplicated cases. Pathophysiology centers on **luminal obstruction**, **bacterial overgrowth**, **ischemic mucosal injury**, and the ensuing **inflammatory response** that can progress to perforation if untreated."
},
{
  "text": "A 5-week-old male infant is brought to the pediatric clinic with a 4-day history of progressively worsening vomiting. His mother reports that the vomiting is **nonbilious**, **forceful**, and occurs **immediately after almost every feed**. He has fewer wet diapers and seems **hungry shortly after vomiting**. He was born at term and has been feeding well until about a week ago. On examination, his weight is at the 10th percentile (down from 50th percentile two weeks ago), his vital signs show mild tachycardia, and he appears mildly dehydrated. Abdominal exam reveals a visible peristaltic wave moving from left to right across the epigastrum and a small, firm, “olive-like” mass palpated in the right upper quadrant just lateral to the midline. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Gastroesophageal Reflux Disease (GERD)" },
    { "label": "B", "text": "Intestinal Malrotation with Midgut Volvulus" },
    { "label": "C", "text": "Pyloric Stenosis" },
    { "label": "D", "text": "Milk Protein Allergy" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Pyloric Stenosis**\n\n**Why it’s correct:**\nThis infant’s presentation—**projectile, nonbilious vomiting** shortly after feeding, **visible gastric peristalsis**, an **olive-like abdominal mass**, and signs of **dehydration**—is classic for **infantile hypertrophic pyloric stenosis (IHPS)**. The progressive weight loss and persistent hunger despite vomiting further support a mechanical gastric outlet obstruction at the pylorus. These findings in a 4–6 week old male infant are highly specific for pyloric stenosis.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Gastroesophageal Reflux Disease (GERD)** – GERD in infants typically presents with **spitting up** that is often effortless and not forceful or projectile. GERD vomiting is rarely severe enough to cause an olive-like mass or visible peristalsis, and infants usually do not become as dehydrated or lose significant weight if reflux alone.\n\n**B. Intestinal Malrotation with Midgut Volvulus** – Midgut volvulus causes **acute, bilious vomiting**, irritability, abdominal distension, and rapid deterioration. In this case, the vomiting is **nonbilious**, and the infant’s course is more gradual (days rather than hours), making volvulus far less likely.\n\n**D. Milk Protein Allergy** – This can present with vomiting and poor weight gain, but it usually causes **irritability**, **blood or mucus in the stool**, or **eczema**. Vomiting in milk protein allergy is not typically **projectile**, and there would be no palpable pyloric mass or visible peristaltic waves.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Obtain a **detailed history** (onset, frequency, and character of vomiting, feeding patterns, weight trends) and perform a **thorough physical exam**, focusing on **hydration status**, palpation for an **olive-like mass** in the right upper quadrant, and **visible peristalsis**.\n- **Laboratory Tests:** Check **serum electrolytes**, **blood urea nitrogen (BUN)**, and **creatinine**. Expect to find **hypochloremic, hypokalemic metabolic alkalosis**, elevated BUN, and signs of dehydration.\n- **Best Test:** Perform an **abdominal ultrasound**, which will demonstrate a **hypertrophied pylorus** with a **muscle thickness >4 mm**, **pyloric channel length >16 mm**, and an **elongated, narrow gastric outlet**. The “target sign” or “doughnut sign” on transverse view and the “railroad track sign” on longitudinal view confirm IHPS.\n- **Alternative Imaging:** If ultrasound is equivocal, a **barium upper gastrointestinal series** (contrast study) can show the classic **string sign**—a thin stream of contrast passing through a narrowed pyloric channel.\n\n---\n\n**Management:**\n\n- **Stabilization:** Correct **dehydration** and **electrolyte abnormalities** with **IV fluids** (e.g., isotonic saline) and **potassium supplementation** once urine output is adequate. **Metabolic alkalosis** often requires fluid resuscitation before electrolyte correction.\n- **Definitive Treatment:** Perform a **Fredet–Ramstedt pyloromyotomy** (surgical splitting of the hypertrophied pyloric muscle). This can be done via **open** or **laparoscopic** approach; it relieves the obstruction and allows feedings to resume.\n- **Preoperative Care:** Keep the infant **nil per os (NPO)**, maintain **IV fluids**, and place a **nasogastric tube** for gastric decompression if needed.\n- **Postoperative Care:** Start **small, frequent feedings** (e.g., 5–10 mL of electrolyte solution or breastmilk every 2–3 hours) and gradually advance as tolerated. Monitor for vomiting, infection, and ensure weight gain. Most infants tolerate feeds within 12–24 hours post-op.\n\n---\n\n**Why Each Symptom Occurs in Pyloric Stenosis:**\n\n1. **Projectile, Nonbilious Vomiting:** Hypertrophy of the pyloric muscle creates a **narrowed gastric outlet**, requiring strong gastric contractions to force contents through, resulting in forceful, nonbilious emesis since the obstruction is proximal to the duodenum.\n2. **Visible Peristaltic Waves:** As the stomach attempts to overcome the obstructed pylorus, **strong peristaltic waves** become visible moving from left to right across the epigastrium.\n3. **Olive-Like Mass:** The hypertrophied pyloric muscle forms a **firm, mobile, olive-shaped mass** palpable at the right upper quadrant (or epigastrium) lateral to the midline.\n4. **Dehydration and Weight Loss:** Repeated vomiting leads to **fluid and electrolyte losses**, resulting in **hypovolemia**, dehydration, and **failure to thrive**.\n5. **Persistent Hunger:** Despite vomiting, gastric emptying is only delayed, not completely obstructed; gastric emptying still occurs intermittently, so infants remain hungry soon after vomiting episodes.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Hypertrophy and Hyperplasia of Pyloric Muscle:** An increase in the size and number of smooth muscle fibers in the pylorus narrows the lumen, often triggered by **unknown genetic and environmental factors**, including neonatal injury to the gastric mucosa.\n2. **Gastric Outlet Obstruction:** Progressive thickening of the pyloric muscle causes a **mechanical blockage** at the pyloric channel, preventing normal flow of gastric contents into the duodenum.\n3. **Hypochloremic, Hypokalemic Metabolic Alkalosis:** Chronic vomiting leads to **loss of gastric acid (HCl)**, resulting in a metabolic alkalosis. Renal compensation (increased bicarbonate reabsorption) and volume depletion lead to **hypokalemia** and **hypochloremia**.\n4. **Hormonal Influences (Gastrin):** Elevated **gastrin levels** may contribute to muscle hypertrophy and delayed gastric emptying, perpetuating the cycle of obstruction.\n5. **Genetic Predisposition:** Higher incidence in **first-born male infants**, with familial clustering suggesting a **multifactorial inheritance**. The role of **nitric oxide synthase deficiency** may impair pyloric relaxation.\n\n---\n\n**Summary:**\nInfantile hypertrophic pyloric stenosis presents in **3–6-week-old** infants with **projectile, nonbilious vomiting**, **visible peristalsis**, **olive-like pyloric mass**, and **dehydration**. Diagnosis is confirmed by **abdominal ultrasound** showing a thickened pylorus; **barium studies** can be used if needed. Management begins with **fluid and electrolyte correction**, followed by **pyloromyotomy**. Pathophysiology centers on **pyloric muscle hypertrophy**, **gastric outlet obstruction**, and **vagal/hormonal dysregulation**, leading to the characteristic clinical and laboratory findings."
},
{
  "text": "A 3-month-old male infant is brought to the pediatric gastroenterology clinic with a 2-month history of progressive abdominal distension and chronic constipation. His parents report that he has not passed a bowel movement more than once a week since birth, and when he does, the stool is very hard and pellet-like. He has had intermittent episodes of bilious vomiting over the past week and is falling below growth percentiles despite adequate feeds. On examination, his abdomen is markedly distended and tympanic, with visible bowel loops. Palpation reveals fecal impaction in the left lower quadrant. A digital rectal exam elicits a gush of stool and flatus. Vital signs are: temperature 37.2°C, heart rate 120 bpm, respiratory rate 30/min, and blood pressure 90/60 mmHg. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Intestinal Malrotation with Volvulus" },
    { "label": "B", "text": "Congenital Hypothyroidism" },
    { "label": "C", "text": "Hirschsprung Disease" },
    { "label": "D", "text": "Pyloric Stenosis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Hirschsprung Disease**\n\n**Why it’s correct:**\nThis infant’s presentation is classic for **Hirschsprung Disease (aganglionic megacolon)**. Key features include:  \n- **Delayed passage of meconium** and chronic constipation since birth.  \n- **Progressive abdominal distension** due to proximal bowel dilation.  \n- **Bilious vomiting**, indicating functional obstruction distal to the duodenum.  \n- **Explosive release of stool and flatus** on digital rectal exam (the “squirt” or “blast” sign) reflecting a narrow aganglionic distal segment with stool trapped proximally.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Intestinal Malrotation with Volvulus**  \n- Malrotation with volvulus presents with **acute, severe bilious vomiting**, rapid onset of abdominal distension, and often signs of peritonitis.  \n- This scenario is more **chronic** with constipation and intermittent bilious vomiting, not an acute surgical emergency.  \n- Additionally, malrotation would not cause the classic “squirt” of stool on rectal exam.\n\n**B. Congenital Hypothyroidism**  \n- Hypothyroidism may produce **constipation**, poor weight gain, and lethargy, but it typically presents with **prolonged jaundice**, dry skin, and macroglossia.  \n- Vomiting in congenital hypothyroidism is uncommon, and rectal exam would not produce an explosive stool stream.\n\n**D. Pyloric Stenosis**  \n- Pyloric stenosis causes **nonbilious, projectile vomiting** in a 3–6 week-old infant, with **visible peristaltic waves** and an “olive-like” epigastric mass.  \n- It does **not** cause chronic constipation or explosive stool on rectal exam, because the obstruction is **proximal** in the stomach, not the colon.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:**  \n  - Take a **thorough history**: note delayed meconium passage, pattern of constipation, vomiting character, and growth trajectory.  \n  - Perform a **physical exam**: inspect for abdominal distension, palpate for fecal mass, and perform a **digital rectal exam** to assess for explosive release of stool and flatus.\n\n- **Laboratory Tests:**  \n  - Obtain a **CBC** to check for anemia or leukocytosis (possible enterocolitis).  \n  - Check **electrolytes** for dehydration or metabolic derangements due to vomiting.\n\n- **Imaging (Best Initial Test):**  \n  - **Contrast enema** (barium or water-soluble) shows a **transition zone** between the narrow distal aganglionic segment and the dilated proximal colon.  \n  - In some infants, plain abdominal **radiographs** demonstrate **massive colonic dilation** with multiple air-fluid levels and absence of gas in the rectum.\n\n- **Definitive Test (Gold Standard):**  \n  - **Rectal suction biopsy** demonstrating **absence of ganglion cells** in the submucosal (Meissner) and myenteric (Auerbach) plexuses and increased acetylcholinesterase-positive nerve fibers.\n\n---\n\n**Management:**\n\n- **Initial Stabilization:**  \n  - **Fluid resuscitation and electrolyte correction** to address dehydration and possible electrolyte derangements from vomiting and decreased intake.  \n  - Place a **nasogastric tube** for decompression if severe distension or vomiting persists.  \n  - Begin **broad-spectrum antibiotics** if there is concern for enterocolitis (fever, bloody diarrhea, systemic toxicity).\n\n- **Surgical Treatment:**  \n  - The **definitive management** is surgical resection of the aganglionic segment with a **pull-through procedure** (e.g., **Soave**, **Swenson**, or **Duhamel** pull-through), reconnecting normally innervated colon to the rectum.  \n  - In **emergent cases** (e.g., septic enterocolitis), perform a **diverting colostomy or ileostomy** to decompress the colon, followed by definitive pull-through once stabilized.\n\n- **Postoperative Care:**  \n  - Monitor for **anastomotic leaks**, **strictures**, and **enterocolitis**.  \n  - Gradually advance feeds as tolerated and manage postoperative pain.  \n  - Provide **bowel regimen education** for caregivers to detect early signs of obstruction or enterocolitis.\n\n---\n\n**Why Each Symptom Occurs in Hirschsprung Disease:**\n\n1. **Chronic Constipation & Delayed Meconium Passage:**  \n   - **Aganglionic segment** (usually rectosigmoid) cannot relax due to absence of enteric ganglion cells, leading to functional obstruction and inability to pass stool normally.  \n\n2. **Abdominal Distension:**  \n   - **Proximal colon** becomes massively dilated (megacolon) as peristalsis attempts to move fecal contents against a narrow, nonrelaxing distal segment.  \n\n3. **Bilious Vomiting:**  \n   - Backflow from **small bowel** into the stomach occurs when colonic obstruction is severe, producing bilious emesis typical of lower GI obstruction.  \n\n4. **Explosive Release on Rectal Exam (Squirt Sign):**  \n   - Digital exam relieves built-up pressure, allowing feces and gas to be forcefully expelled through the narrowed aganglionic segment.  \n\n5. **Failure to Thrive:**  \n   - Ongoing obstruction causes decreased nutrient absorption, anorexia from discomfort, and increased metabolic demands from chronic distension, leading to poor weight gain.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Failure of Neural Crest Cell Migration:**  \n   - During embryogenesis (5th–12th week), **neural crest–derived cells** fail to migrate caudally to form **submucosal (Meissner) and myenteric (Auerbach) plexuses** in the distal colon.\n\n2. **Aganglionic Distal Segment:**  \n   - The **aganglionic bowel** cannot generate coordinated peristalsis, resulting in a functional obstruction of stool and gas movement.\n\n3. **Proximal Colonic Dilation (Megacolon):**  \n   - Persistent peristaltic activity against a nonrelaxing distal segment causes **progressive dilation** of the proximal colon, thinning the muscular wall and predisposing to stasis.\n\n4. **Risk of Enterocolitis:**  \n   - Stasis of fecal contents and bacterial overgrowth in the dilated colon leads to **inflammation**, **mucosal injury**, and risk of **enterocolitis**, which can present with fever, diarrhea, and risk of sepsis.\n\n5. **Altered Neurotransmitter Signaling:**  \n   - Increased **acetylcholinesterase activity** in the submucosa of the aganglionic segment leads to **cholinergic hyperactivity** in the hypertrophied nerve trunks, further preventing relaxation.\n\n---\n\n**Summary:**  \nHirschsprung Disease presents in infancy with **failed meconium passage**, **chronic constipation**, **abdominal distension**, and **explosive stool on rectal exam**. Diagnosis involves **contrast enema** to identify a transition zone and the **gold standard rectal suction biopsy** to confirm absence of ganglion cells. Definitive treatment is a **surgical pull-through** of the normally innervated bowel. The underlying pathophysiology is a **failure of neural crest migration** leading to a distal aganglionic segment, with subsequent **megacolon**, risk of **enterocolitis**, and clinical obstruction."
},
{
  "text": "A 4-year-old boy presents to the emergency department with a 7-day history of high fever (up to 39.5 °C) unresponsive to antipyretics. His parents note red eyes without discharge, cracked lips, a “strawberry” tongue, and swelling of his hands and feet. On exam he has bilateral non-purulent conjunctivitis, a polymorphous rash over his trunk and groin, a 2.5 cm tender left cervical lymph node, and periungual desquamation beginning on his fingertips. Vital signs: heart rate 130 bpm, blood pressure 95/60 mmHg. Labs: WBC 18,000/µL (neutrophil predominant), ESR 85 mm/hr, CRP 120 mg/L, platelets 600,000/µL. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Scarlet Fever" },
    { "label": "B", "text": "Measles" },
    { "label": "C", "text": "Toxic Shock Syndrome" },
    { "label": "D", "text": "Kawasaki Disease" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Kawasaki Disease**\n\n**Why it’s correct:**  \nThis child fulfills the classic criteria for **complete Kawasaki Disease**: **≥5 days of high fever**, **bilateral non-purulent conjunctivitis**, **mucous membrane changes** (cracked lips, strawberry tongue), **polymorphous rash**, **extremity changes** (swelling, periungual desquamation), and **cervical lymphadenopathy**. The marked **elevation of inflammatory markers** (ESR, CRP), **thrombocytosis**, and **neutrophilic leukocytosis** further support an acute systemic vasculitis.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Scarlet Fever**  \n– Presents with a **sandpaper rash**, **Pastia’s lines**, and a **“strawberry” tongue**, but also **strep-positive throat culture** or rapid antigen test and **pastia’s lines** in the antecubital fossae. Conjunctivitis and extremity swelling/desquamation are not typical.\n\n**B. Measles**  \n– Features **Koplik spots**, a “brick-red” maculopapular rash that starts on the face and spreads downward, and significant **cough, coryza, and photophobia**. This patient has localized cervical lymphadenopathy and extremity changes not seen in measles.\n\n**C. Toxic Shock Syndrome**  \n– Manifests with **acute high fever**, **hypotension**, **multiorgan involvement**, and a **diffuse desquamating rash** often with evidence of a bacterial toxin (Staph aureus or Strep pyogenes). Our patient is hemodynamically stable and lacks clear evidence of toxin-producing infection.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Detailed history (fever duration, mucocutaneous changes), exam for **principal clinical criteria**, and basic labs: **CBC**, **ESR/CRP**, **LFTs**, **urinalysis** (sterile pyuria common).\n- **Best Test:** **Echocardiogram** is essential to assess for **coronary artery aneurysms**, **myocarditis**, or **pericardial effusion**. Perform at diagnosis, at 2 weeks, and at 6–8 weeks.\n- **Additional Tests:** Consider **BNP/NT-proBNP** (elevated in myocardial involvement) and **electrolytes** to monitor hydration and cardiac strain.\n\n---\n\n**Management:**\n\n- **First-line Therapy:** **IVIG** (2 g/kg as a single infusion) administered ideally within **10 days of fever onset** to reduce aneurysm risk.  \n- **Anti-inflammatory:** **Aspirin** high-dose (30–50 mg/kg/day in divided doses) until afebrile for 48 hours, then low-dose (3–5 mg/kg/day) for 6–8 weeks or until inflammatory markers normalize and coronaries are stable.  \n- **Refractory Cases:** For IVIG-resistant patients, consider a **second IVIG dose**, **corticosteroids**, or **biologics** (e.g., infliximab or anakinra).\n- **Follow-up:** Serial **echocardiograms** and cardiology referral. Counsel on **long-term cardiac monitoring** if aneurysms develop.\n\n---\n\n**Why Each Symptom Occurs in Kawasaki Disease:**\n\n1. **Prolonged Fever:** Cytokine storm from **medium-vessel vasculitis** drives persistent high fever.  \n2. **Conjunctivitis:** Vasculitis of the **conjunctival vessels** leads to non-exudative injection.  \n3. **Mucosal Changes (Strawberry Tongue, Cracked Lips):** Inflammation and edema of the **oral mucosa** and capillary fragility.  \n4. **Rash:** **Immune complex deposition** and vasculitis in dermal vessels cause a polymorphous eruption.  \n5. **Extremity Changes:** **Edema** and **periungual peeling** result from inflammation of small vessels in the skin and subcutaneous tissues.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Medium-Vessel Vasculitis:** Autoimmune attack on **arterial walls**, especially **coronary arteries**, driven by activated T cells and macrophages.  \n2. **Cytokine Release:** Elevated **IL-1, IL-6, TNF-α** orchestrate systemic inflammation and endotheliitis.  \n3. **Endothelial Dysfunction:** Upregulation of **adhesion molecules** (VCAM, ICAM) promotes leukocyte infiltration into vessel walls.  \n4. **Coronary Aneurysm Formation:** Destruction of **tunica media** by matrix metalloproteinases leads to arterial dilation.  \n5. **Platelet Activation:** Thrombocytosis and platelet aggregation occur in the **subacute phase**, contributing to thrombotic risk in aneurysms.\n\n---\n\n**Summary:**  \nKawasaki Disease is a pediatric medium-vessel vasculitis presenting with **≥5 days of fever** plus **conjunctivitis**, **mucocutaneous changes**, **rash**, **extremity changes**, and **lymphadenopathy**. Early **IVIG** and **aspirin** reduce coronary complications. Diagnosis relies on clinical criteria and **echocardiography**, with pathophysiology centered on **cytokine-mediated endothelial injury** and **aneurysm formation**."
},
{
  "text": "An 11-year-old boy with a history of intermittent asthma presents with a 3-day history of progressive shortness of breath, chest tightness, and a persistent dry cough. He had a mild viral upper respiratory infection last week. He reports difficulty speaking in full sentences and waking at night with coughing. On exam, he is tachypneic (respiratory rate 30/min), tachycardic (heart rate 120 bpm), and has an oxygen saturation of 92% on room air. You note **bilateral diffuse wheezes**, **prolonged expiratory phase**, and use of **accessory muscles**. Peak expiratory flow is 55% of his personal best. A chest x-ray shows **hyperinflation** without focal consolidation. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute Asthma Exacerbation" },
    { "label": "B", "text": "Acute Bronchitis" },
    { "label": "C", "text": "Foreign Body Aspiration" },
    { "label": "D", "text": "Community-Acquired Pneumonia" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Acute Asthma Exacerbation**\n\n**Why it’s correct:**  \nThis patient with known asthma has classic features of an **acute exacerbation**: **viral trigger**, **progressive dyspnea**, **chest tightness**, **nocturnal symptoms**, **accessory muscle use**, **prolonged expiration**, and a **PEF < 80%** of personal best. Chest x-ray shows only **hyperinflation**, consistent with airflow obstruction rather than consolidation.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Acute Bronchitis** – Presents with a productive cough following a viral illness but typically has **no significant wheezing**, **normal PEF**, and clear lung fields on exam; chest x-ray is normal without hyperinflation.\n\n**C. Foreign Body Aspiration** – Usually has **sudden onset** of cough or choking, often in a toddler. Exam reveals **asymmetric breath sounds** or localized wheeze, and imaging may show hyperlucent lung or focal air trapping, not diffuse hyperinflation.\n\n**D. Community-Acquired Pneumonia** – Often presents with **fever**, **productive cough**, **focal crackles** or bronchial breath sounds, and chest x-ray shows **lobar consolidation** rather than uniform hyperinflation.\n\n---\n\n**Diagnostic Steps:**  \n\n- **Initial Step:** Obtain a focused **history** (symptom timeline, triggers, medication adherence) and **physical exam**, assessing respiratory rate, effort, and lung sounds.\n- **Best Test:** Measure **peak expiratory flow (PEF)** or **spirometry** to quantify airflow obstruction; PEF < 80% indicates an exacerbation, < 50% indicates severe exacerbation.\n- **Adjuncts:** A **chest x-ray** to exclude complications (pneumothorax, pneumonia) if the presentation is atypical or severe. **ABG** in severe cases to assess gas exchange and guide management.\n\n---\n\n**Management:**  \n\n1. **Short-Acting β₂-Agonist (SABA):** Inhaled **albuterol** via nebulizer or MDI with spacer, repeated every 20 minutes for the first hour.  \n2. **Inhaled Ipratropium:** Add in moderate-to-severe exacerbations to improve bronchodilation.  \n3. **Systemic Corticosteroids:** Oral **prednisone** (1–2 mg/kg/day) or IV **methylprednisolone** for severe exacerbations, to reduce airway inflammation.  \n4. **Oxygen Therapy:** Maintain SpO₂ ≥ 94% with humidified oxygen.  \n5. **Adjunctive Therapies:** Consider **IV magnesium sulfate** for life-threatening exacerbations or **heliox** if unresponsive to initial therapy.  \n6. **Monitoring & Disposition:** Observe peak flow and clinical response; admit if PEF remains < 50% or if there is persistent distress, hypoxia, or inability to tolerate oral medications.\n\n---\n\n**Why Each Symptom Occurs in an Asthma Exacerbation:**  \n1. **Shortness of Breath & Chest Tightness:** Bronchoconstriction and airway narrowing increase resistance, making exhalation difficult.  \n2. **Prolonged Expiration:** Airway obstruction traps air, requiring more time to exhale.  \n3. **Wheezing:** Turbulent airflow through narrowed bronchi produces high-pitched wheezes on auscultation.  \n4. **Accessory Muscle Use:** Increased work of breathing recruits sternocleidomastoids and intercostals to maintain ventilation.  \n5. **Nocturnal Symptoms:** Circadian variations (lower cortisol, higher histamine) worsen airway inflammation and bronchoconstriction at night.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Airway Inflammation:** Eosinophils, mast cells, and T-helper 2 lymphocytes release cytokines (IL-4, IL-5, IL-13) that drive chronic inflammation.  \n2. **Bronchial Hyperresponsiveness:** Inflamed airways contract excessively to triggers (viral infections, allergens).  \n3. **Smooth Muscle Constriction:** Activation of vagal reflexes and mediator release cause bronchospasm.  \n4. **Mucus Hypersecretion:** Goblet cell hyperplasia and submucosal gland enlargement lead to mucus plugging.  \n5. **Airway Remodeling:** Repeated exacerbations cause structural changes—subepithelial fibrosis, smooth muscle hypertrophy, and extracellular matrix deposition—leading to fixed airflow limitation over time.\n\n---\n\n**Summary:**  \nAn acute asthma exacerbation in a child presents with **viral trigger**, **progressive dyspnea**, **wheezing**, **prolonged expiration**, and **reduced peak flow**. Diagnosis is clinical, supported by **PEF/spirometry** and occasionally imaging. Prompt treatment with **inhaled bronchodilators**, **systemic steroids**, and **oxygen** reduces morbidity and prevents respiratory failure."
},
{
  "text": "A 3-year-old boy presents to the pediatric clinic with a 2-day history of persistent cough, wheezing, and intermittent choking episodes. He is afebrile but had a sudden choking spell while eating peanuts 3 days ago. On exam, his vital signs are normal. Chest auscultation reveals **unilateral** decreased breath sounds over the right lung field, focal wheezes, and inspiratory stridor. A chest x-ray is unremarkable. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Asthma Exacerbation" },
    { "label": "B", "text": "Viral Bronchiolitis" },
    { "label": "C", "text": "Croup (Laryngotracheobronchitis)" },
    { "label": "D", "text": "Foreign Body Aspiration" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Foreign Body Aspiration**\n\n**Why it's correct:**\nThis toddler’s sudden choking event followed by **persistent unilateral** wheezing, decreased breath sounds, and stridor—despite a normal chest x-ray—strongly indicates a lodged airway foreign body. The focal nature of his findings (not diffuse) and lack of fever or viral prodrome distinguish it from other causes of wheeze.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Asthma Exacerbation** – Asthma typically presents with **bilateral** wheezing, a history of recurrent episodes, and improvement with bronchodilators. There is no choking trigger and findings are diffuse, not focal.\n\n**B. Viral Bronchiolitis** – Bronchiolitis affects infants under 2 years old, follows a viral prodrome, and causes **diffuse crackles and wheezes**. It rarely produces inspiratory stridor or a focal exam.\n\n**C. Croup (Laryngotracheobronchitis)** – Croup causes a **barking cough**, **hoarseness**, and **subglottic narrowing** on x-ray (steeple sign). It presents with inspiratory stridor but no unilateral decreased breath sounds.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Obtain a detailed **history** focusing on the choking episode and perform a **focused exam** to identify focal versus diffuse respiratory findings.\n- **Best Initial Test:** **Inspiratory and expiratory chest x-rays** may show **air trapping** (hyperlucent lung) on the affected side, even if a standard film appears normal.\n- **Definitive Test:** **Rigid bronchoscopy** is both diagnostic and therapeutic, allowing direct visualization and removal of the foreign body under anesthesia.\n- **Adjuncts:** If bronchoscopy is delayed, consider **computed tomography (CT)** of the chest with low radiation dose to localize radiolucent objects.\n\n---\n\n**Management:**\n\n1. **Airway Stabilization:** Ensure the child’s airway is secure. Provide humidified oxygen if needed and monitor oxygen saturation.\n2. **Avoid Blind Procedures:** Do not perform blind finger sweeps; risk of pushing the object further down.\n3. **Rigid Bronchoscopy:** Performed under general anesthesia by an experienced pediatric bronchoscopist to **remove the foreign body** safely.\n4. **Post-Removal Care:** Monitor for **bronchospasm**, **laryngospasm**, or **pneumonia**. Administer bronchodilators and, if indicated, a short course of antibiotics for secondary infection.\n5. **Prevention & Education:** Counsel caregivers on age-appropriate foods and choking hazards (avoid peanuts, grapes, small toys) to prevent recurrence.\n\n---\n\n**Why Each Symptom Occurs in Foreign Body Aspiration:**\n\n1. **Unilateral Wheezing/Decreased Breath Sounds:** The lodged object creates a **ball-valve effect**, allowing air entry but trapping it, leading to obstruction and localized hyperinflation or collapse.\n2. **Persistent Cough:** Reflex stimulation of airway **cough receptors** as the foreign body irritates the mucosa.\n3. **Inspiratory Stridor:** When the object is in the upper airway or larynx, airflow turbulence produces high-pitched stridor on inspiration.\n4. **Intermittent Choking Episodes:** The object may shift slightly, causing transient complete obstruction or partial relief, leading to variable symptoms.\n5. **Normal Initial Chest X-Ray:** Many foreign bodies (organic materials, plastics) are **radiolucent**, so standard radiographs can appear normal.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Mechanical Airway Obstruction:** The aspirated object physically blocks airway lumens, reducing airflow distal to the obstruction.\n2. **Ball-Valve Mechanism:** Partial obstruction permits air entry during inspiration but impedes expiration, causing **air trapping** and hyperinflation.\n3. **Ventilation-Perfusion Mismatch:** The affected lung region receives perfusion without adequate ventilation, leading to **hypoxemia**.\n4. **Local Inflammation:** Mucosal injury around the lodged object triggers **edema** and **secretions**, worsening obstruction and promoting infection.\n5. **Risk of Secondary Infection:** Stagnant secretions distal to the obstruction foster bacterial overgrowth, predisposing to **pneumonia** or **abscess formation** if not promptly removed.\n\n---\n\n**Summary:**\nForeign body aspiration in toddlers often follows a choking event and presents with **focal respiratory signs**, persistent cough, and possible normal initial imaging. Diagnosis hinges on **history**, **focused exam**, and **bronchoscopic evaluation**. Prompt **rigid bronchoscopy** is both diagnostic and curative, while supportive care and prevention counseling reduce morbidity and recurrence."
},
{
  "text": "A 7-year-old girl presents to the pediatric clinic with a 4-day history of low-grade fever and a pink rash that began on her face and rapidly spread to her trunk and extremities. She reports mild headache, sore throat, and hand joint aches. On examination, her temperature is 38.3°C, and she has tender occipital and posterior auricular lymphadenopathy, nonpurulent conjunctival injection, and a pink maculopapular rash on her face, trunk, and extremities. Small petechial spots are seen on her soft palate. She has mild arthralgia of the wrists without swelling. Her immunization record is incomplete, missing the MMR vaccine. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Measles (Rubeola)" },
    { "label": "B", "text": "Scarlet Fever" },
    { "label": "C", "text": "Rubella" },
    { "label": "D", "text": "Erythema Infectiosum (Fifth Disease)" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Rubella**\n\n**Why it’s correct:**\nThis patient has classic features of rubella including **tender occipital and posterior auricular lymphadenopathy**, a **pink maculopapular rash** that starts on the face and rapidly spreads, **petechial spots on the soft palate** (Forchheimer spots), and **mild fever with arthralgia**. Her incomplete MMR immunization further supports susceptibility.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Measles (Rubeola)** – Presents with **high fever**, **cough**, **coryza**, **conjunctivitis**, and **Koplik spots**, followed by a confluent, blotchy rash beginning at the hairline. This patient’s milder fever, lack of cough or Koplik spots, and tender posterior lymph nodes favor rubella.\n\n**B. Scarlet Fever** – Causes a **sandpaper rash**, **Pastia’s lines**, and **strawberry tongue** after streptococcal pharyngitis. This patient’s rash is not sandpaper-like, and there is no strawberry tongue or positive strep test.\n\n**D. Erythema Infectiosum (Fifth Disease)** – Features a **slapped-cheek rash** and **lacy reticular exanthem** on the trunk, without lymphadenopathy, conjunctivitis, or soft palate petechiae seen here.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Detailed history of **vaccine status**, rash progression, and prodromal symptoms. Thorough exam focusing on **lymph nodes**, **mucosa**, and **rash distribution**.\n- **Laboratory Tests:** **Serology** for rubella-specific **IgM** and **IgG**; a positive IgM confirms recent infection.\n- **Best Test:** **RT-PCR** on a throat swab or serum in the first week of rash to detect rubella viral RNA.\n- **Additional Tests:** In pregnant contacts, perform **rubella IgG avidity** and consider **viral culture** to assess fetal risk.\n\n---\n\n**Management:**\n\n- **Supportive Care:** Antipyretics (acetaminophen), hydration, and rest.\n- **Isolation:** Droplet precautions for 7 days after rash onset to prevent spread.\n- **Post-Exposure Prophylaxis:** Administer **immune globulin** to susceptible high-risk contacts (e.g., pregnant women) within 6 days of exposure.\n- **Vaccination:** Ensure **MMR** series completion for patient and susceptible household members.\n\n---\n\n**Why Each Symptom Occurs in Rubella:**\n\n1. **Lymphadenopathy:** Virus replicates in **lymphoid tissues**, especially posterior auricular and occipital nodes, causing tender enlargement.  \n2. **Maculopapular Rash:** **Immune complex deposition** in dermal vessels triggers a pink rash starting on the face and spreading downward.  \n3. **Forchheimer Spots:** Petechiae on the soft palate arise from **capillary fragility** and local mucosal vasculitis.  \n4. **Conjunctival Injection:** Mild conjunctivitis results from **viral inflammation** of conjunctival epithelium.  \n5. **Arthralgia:** Immune-mediated inflammation in **joint synovium** causes mild joint aches.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Togavirus Entry:** Rubella virus infects **respiratory epithelium**, then spreads to regional lymph nodes.  \n2. **Viremia:** Viral replication leads to systemic spread by day 5–7, infecting skin and other organs.  \n3. **Immune Complex Formation:** Circulating antigen–antibody complexes deposit in vessel walls, activating complement and causing rash.  \n4. **Placental Transmission:** In pregnancy, rubella crosses the placenta, infects the fetus, and disrupts organogenesis.  \n5. **Adaptive Immunity:** Neutralizing antibodies and memory T cells confer lifelong immunity post-infection or vaccination.\n\n---\n\n**Summary:**\nRubella presents with **low-grade fever**, **posterior auricular lymphadenopathy**, **Forchheimer spots**, and a **pink maculopapular rash** beginning on the face. Diagnosis is confirmed by **rubella IgM** or **RT-PCR**. Management is supportive with **isolation** and **post-exposure prophylaxis**, and prevention relies on **MMR vaccination**."
},
{
  "text": "A 13-year-old girl with no past medical history is brought to the emergency department by her mother for a 3-day history of worsening fatigue, polyuria, polydipsia, and nausea. She has had intermittent abdominal pain and two episodes of non-bilious vomiting. Her mother also notes that over the past month she has lost about 4 kg despite a normal appetite. On exam, her vital signs are: temperature 37.2 °C, heart rate 120 bpm, blood pressure 90/60 mmHg, respiratory rate 28 breaths/min with deep, labored breathing. She appears dehydrated with dry mucous membranes and has an **acetone (‘fruity’) odor** on her breath. Abdominal exam is benign. A bedside finger-stick glucose reads **28 mmol/L**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Viral Gastroenteritis" },
    { "label": "B", "text": "Septic Shock" },
    { "label": "C", "text": "Diabetic Ketoacidosis (DKA)" },
    { "label": "D", "text": "Primary Adrenal Insufficiency (Addisonian Crisis)" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Diabetic Ketoacidosis (DKA)**\n\n**Why it’s correct:**  \nThis adolescent presents with **new-onset polyuria, polydipsia, weight loss**, and signs of **dehydration**. The presence of **abdominal pain**, **vomiting**, **Kussmaul respirations** (deep, labored breathing), and a **fruity breath odor** in the setting of a very high blood glucose strongly indicate **ketoacidosis** due to absolute insulin deficiency.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Viral Gastroenteritis** – While gastroenteritis can cause vomiting and dehydration, it does not explain **polyuria, polydipsia**, **fruity breath**, or marked hyperglycemia.\n\n**B. Septic Shock** – Sepsis may cause tachycardia and hypotension, but would usually present with **fever**, **signs of infection** (e.g., source of sepsis), and not with **extreme hyperglycemia** and **ketosis** unless in very late stages.\n\n**D. Addisonian Crisis** – Adrenal insufficiency can present with dehydration, abdominal pain, and hypotension, but typically causes **hyponatremia**, **hyperkalemia**, and **hypoglycemia**, not hyperglycemia or ketonemia.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** **Bedside finger-stick glucose** to confirm hyperglycemia.  \n- **Laboratory Evaluation:** Obtain **serum electrolytes**, **blood urea nitrogen**, **creatinine**, **venous blood gas** (to assess pH and bicarbonate), **serum ketones**, and a **complete blood count**.  \n- **Best Test:** **Venous blood gas** showing **anion gap metabolic acidosis** (pH < 7.30, bicarbonate < 15 mmol/L) plus **positive serum ketones** confirms DKA.  \n- **Additional Tests:** **HbA1c** to assess chronic hyperglycemia and **autoantibody panel** (anti-GAD, IA2) if type 1 diabetes is suspected.\n\n---\n\n**Management:**  \n1. **Fluid Resuscitation:** Start with **0.9% saline**—10–20 mL/kg over the first 1–2 hours—to restore perfusion.  \n2. **Insulin Therapy:** Once initial fluids begun, start a **low-dose insulin infusion** (0.05–0.1 units/kg/hr) to gradually lower glucose and suppress ketogenesis.  \n3. **Electrolyte Replacement:** Monitor and correct **potassium** (often total body K⁺ is depleted despite normal/high serum levels), **phosphate**, and **sodium** (corrected for hyperglycemia).  \n4. **Acid-Base Monitoring:** Recheck **blood gases** every 2–4 hours; avoid rapid bicarbonate infusion unless pH < 6.9.  \n5. **Transition to Subcutaneous Insulin:** When the anion gap closes, acidosis corrects, and oral intake returns, transition to **basal-bolus insulin** regimen and educate on **diabetes self-management**.\n\n---\n\n**Why Each Symptom Occurs in DKA:**  \n1. **Polyuria & Polydipsia:** **Osmotic diuresis** from hyperglycemia causes loss of free water and electrolytes, leading to dehydration and intense thirst.  \n2. **Weight Loss:** **Catabolism of fat and muscle** for energy in the absence of insulin leads to rapid weight loss.  \n3. **Abdominal Pain & Vomiting:** **Ketone bodies** and **acidosis** irritate the gastrointestinal tract, causing pain and emesis.  \n4. **Kussmaul Respirations:** Respiratory compensation for metabolic acidosis through **hyperventilation** to blow off CO₂.  \n5. **Fruity Breath Odor:** Volatile **acetone**, a byproduct of ketone metabolism, is exhaled.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Absolute Insulin Deficiency:** Autoimmune destruction of pancreatic β-cells (type 1 diabetes) prevents glucose uptake, leading to hyperglycemia.  \n2. **Increased Lipolysis:** Lack of insulin permits **hormone-sensitive lipase** activity, releasing free fatty acids for hepatic ketone production.  \n3. **Ketogenesis:** The liver converts fatty acids into **acetoacetate** and **β-hydroxybutyrate**, causing metabolic acidosis.  \n4. **Osmotic Diuresis:** High serum glucose exceeds renal threshold, causing glycosuria, polyuria, and dehydration.  \n5. **Electrolyte Shifts:** Acidosis and osmotic diuresis cause **potassium to shift** out of cells and total body depletion, risking severe hypokalemia when insulin therapy is begun.\n\n---\n\n**Summary:**  \nDKA is a life-threatening complication of new or established type 1 diabetes, characterized by **hyperglycemia**, **ketosis**, and **anion gap metabolic acidosis**. Prompt recognition, **fluid and electrolyte replacement**, and **insulin therapy** are critical to reverse metabolic derangements and prevent complications."
},
{
  "text": "A 10-day-old male newborn presents to the neonatal intensive care unit with a 12-hour history of **recurrent bilious vomiting**, **abdominal distension**, and **lethargy**. He was born at term via uncomplicated vaginal delivery. He has not passed stool in the past 8 hours and appears dehydrated. On exam, he is tachycardic, hypotensive, has cool, mottled skin, a distended and tender abdomen, and diminished bowel sounds. An orogastric tube returns greenish fluid. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Intussusception" },
    { "label": "B", "text": "Hirschsprung Disease" },
    { "label": "C", "text": "Midgut Volvulus due to Malrotation" },
    { "label": "D", "text": "Pyloric Stenosis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Midgut Volvulus due to Malrotation**\n\n**Why it’s correct:**  \nThis neonate has a classic presentation of **malrotation with midgut volvulus**: acute onset of **bilious vomiting**, **abdominal distension**, **feeding intolerance**, and signs of **hemodynamic instability**. The greenish return on orogastric suction indicates an obstruction distal to the ampulla of Vater. The combination of volvulus-induced **vascular compromise** and obstruction matches this diagnosis.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Intussusception** – Presents in older infants (6–36 months) with **colicky abdominal pain**, **currant jelly stools**, and a palpable “sausage” mass. Bilious vomiting in a 10-day-old is atypical.  \n\n**B. Hirschsprung Disease** – Causes **chronic constipation**, **delayed meconium**, and abdominal distension from birth. Vomiting is nonbilious and presentation is more insidious, without acute hemodynamic collapse.  \n\n**D. Pyloric Stenosis** – Occurs at 3–6 weeks of age with **projectile nonbilious vomiting**, visible peristalsis, and an “olive” mass. Bilious vomiting and shock are not features.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Fluid resuscitation** and **electrolyte correction** (IV isotonic fluids), place **NG tube** for decompression, and stabilize airway/breathing/circulation.  \n2. **Plain Abdominal Radiograph:** Assess for **air-fluid levels**, **free air**, and **generalized obstruction**.  \n3. **Upper Gastrointestinal (UGI) Series (Best Test):** Demonstrates a **corkscrew** appearance of the duodenum and jejunum, confirming malrotation with volvulus.  \n4. **Abdominal Ultrasound:** May show the **whirlpool sign** (twisted superior mesenteric vessels) if UGI is unavailable or in unstable infants.  \n5. **Laboratory Tests:** Monitor **blood count**, **lactate**, and **coagulation** to assess for ischemia and sepsis.\n\n---\n\n**Management:**  \n1. **Emergency Ladd Procedure:** Surgical detorsion of the volvulus, division of Ladd bands, broadening of the mesenteric base, and placement of the small bowel on the right and colon on the left.  \n2. **Resection of Necrotic Bowel:** If ischemic segments are nonviable, perform resection with primary anastomosis or stoma formation.  \n3. **Preoperative Care:** Continue **IV fluids**, **antibiotics** (covering gram-negative enterics and anaerobes), and **nasogastric decompression**.  \n4. **Postoperative Care:** Monitor for **short-bowel syndrome**, ensure **nutritional support**, and prevent **adhesive obstruction**.  \n5. **Follow-Up:** Serial growth assessments and evaluation for **malabsorption** if extensive resection occurred.\n\n---\n\n**Why Each Symptom Occurs in Midgut Volvulus:**  \n1. **Bilious Vomiting:** Obstruction distal to the ampulla prevents bile from entering the intestine, causing green vomitus.  \n2. **Abdominal Distension:** Trapped gas and fluid proximal to the volvulus dilate the stomach and small bowel.  \n3. **Feeding Intolerance & Lethargy:** Ischemia reduces perfusion, leading to systemic toxicity and poor feeding.  \n4. **Hemodynamic Instability:** Bowel necrosis and bacterial translocation induce **sepsis** and **hypovolemia**.  \n5. **Diminished Bowel Sounds:** Ischemic bowel becomes atonic, reducing peristalsis and audible sounds.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Malrotation:** Failure of the midgut to rotate **270° counterclockwise** around the superior mesenteric artery (SMA) during embryogenesis results in a **narrow mesenteric base**.  \n2. **Ladd Bands:** Fibrous peritoneal bands from the cecum cross and obstruct the distal duodenum.  \n3. **Volvulus:** A narrow mesenteric pedicle allows the small intestine to twist around the SMA, causing **arterial occlusion** and ischemia.  \n4. **Ischemia–Reperfusion Injury:** Twisting and untwisting generate free radicals, exacerbating mucosal damage and risk of necrosis.  \n5. **Bacterial Translocation:** Mucosal barrier breakdown allows gut flora into the bloodstream, leading to **sepsis** and **multiorgan dysfunction**.\n\n---\n\n**Summary:**  \nMidgut volvulus due to malrotation presents in neonates with **acute bilious vomiting**, **abdominal distension**, and **signs of shock**. Rapid diagnosis via **UGI series** and emergent **Ladd procedure** with possible bowel resection are essential to prevent high morbidity and mortality."
},
{
  "text": "An 8-month-old girl is brought to the clinic for a 2-month history of an intensely pruritic rash. It began on her cheeks and has spread to her neck, wrists, and the creases of her elbows and knees. She is irritable, has difficulty sleeping, and occasionally scratches until her skin bleeds. Her mother has a history of eczema and allergic asthma. On exam, the skin is **xerotic** with **erythematous, scaly patches** and **excoriations**, especially in the **antecubital** and **popliteal fossae**, and there is early **lichenification**. No mucosal or systemic signs are present. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Allergic Contact Dermatitis" },
    { "label": "B", "text": "Scabies" },
    { "label": "C", "text": "Atopic Dermatitis" },
    { "label": "D", "text": "Psoriasis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Atopic Dermatitis**\n\n**Why it’s correct:**  \nThis infant presents with the classic features of **atopic dermatitis** (eczema): intense **pruritus**, **xerosis**, a **flexural distribution** (antecubital and popliteal fossae), a strong **family history of atopy**, and progression from erythematous papules to **lichenification** due to chronic scratching. The absence of burrows, widespread papules, or sharply demarcated plaques distinguishes it from other dermatoses.\n\n---  \n**Why the other options are incorrect:**  \n\n**A. Allergic Contact Dermatitis** – Usually has a **localized** distribution exactly corresponding to contact with an allergen (e.g., shoes, jewelry), with **sharply demarcated** redness and vesicles. It is less commonly generalized in infants and lacks the chronic flexural pattern.\n\n**B. Scabies** – Presents with **intense nocturnal pruritus**, papules and burrows in the **finger webs**, wrists, and axillae, but not primarily flexural eczema with xerosis. Scratching in scabies often leads to secondary crusted papules rather than lichenification.\n\n**D. Psoriasis** – Infantile psoriasis can appear as **well-demarcated, silvery-scaling plaques** on extensor surfaces and scalp. It does not cause severe pruritus or excoriations to the same extent, and the distribution differs (extensor > flexural).\n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** (onset, family atopy, triggers) and **physical exam** focusing on rash distribution and severity.  \n2. **Clinical Diagnosis:** Atopic dermatitis is a **clinical diagnosis**; no lab test is required for typical cases.  \n3. **Serum IgE/Allergy Testing:** If severe or unclear, measure **total and specific IgE** or perform **skin prick tests** to identify triggers.  \n4. **Patch Testing:** For suspected contact allergens if distribution is atypical.  \n5. **Skin Biopsy:** Reserved for **atypical** or treatment-resistant cases to exclude other dermatoses.\n\n---  \n**Management:**  \n1. **Emollients:** Liberal, **fragrance-free moisturizers** twice daily to restore skin barrier.  \n2. **Topical Corticosteroids:** **Low- to mid-potency** (e.g., hydrocortisone 1%) applied to active lesions for short courses.  \n3. **Topical Calcineurin Inhibitors:** **Tacrolimus** or **pimecrolimus** for sensitive areas (face, folds) to reduce steroid exposure.  \n4. **Antihistamines:** **Sedating H1-blockers** (e.g., diphenhydramine at bedtime) to reduce nocturnal scratching.  \n5. **Trigger Avoidance & Wet Wraps:** Identify and avoid irritants (wool, harsh soaps); use **wet wrap therapy** in severe flares.  \n6. **Systemic Therapy:** For refractory cases, consider **dupilumab** (≥6 years) or **systemic immunosuppressants** under specialist care.\n\n---  \n**Why Each Symptom Occurs in Atopic Dermatitis:**  \n1. **Pruritus:** **Histamine** and **IL-31** from Th2 cells stimulate itch fibers.  \n2. **Xerosis:** **Filaggrin mutation** and lipid deficiency increase **transepidermal water loss**.  \n3. **Erythema & Scaling:** **Inflammatory cytokines** (IL-4, IL-13) induce keratinocyte proliferation and scaling.  \n4. **Excoriations & Lichenification:** Chronic **itch–scratch cycle** leads to skin thickening and accentuated skin markings.  \n5. **Flexural Distribution:** Constant **skin-fold friction** and moisture retention exacerbate lesions in flexural areas.\n\n---  \n**Pathophysiology Highlights:**  \n1. **Skin Barrier Dysfunction:** **Filaggrin gene mutations** weaken the stratum corneum, allowing allergen and microbe penetration.  \n2. **Type 2 Immune Skewing:** **Th2 cytokines** (IL-4, IL-5, IL-13) drive IgE production and eosinophil recruitment.  \n3. **Microbial Dysbiosis:** **Staphylococcus aureus colonization** exacerbates inflammation via superantigens.  \n4. **Neuroimmune Itch Pathway:** **IL-31** and **substance P** sensitize peripheral nerves, perpetuating itching.  \n5. **Chronic Inflammation & Remodeling:** Repeated flares lead to **fibroblast activation**, **fibrosis**, and persistent hyperreactivity of the skin."
},
{
  "text": "A 4-year-old boy presents with a 3-day history of high fever (up to 39.8 °C), tenesmus, and progressively worsening abdominal cramps. He attends daycare, where several children recently had “stomach flu.” His mother reports the onset of **small-volume, mucoid, bloody stools** (8–10 times/day) and an episode of a generalized tonic–clonic seizure last night. On exam, he appears ill, is tachycardic, and has diffuse abdominal tenderness without peritoneal signs. He is mildly dehydrated. A stool guaiac test is positive, and fecal leukocytes are noted. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Enterohemorrhagic Escherichia coli (EHEC) infection" },
    { "label": "B", "text": "Salmonella Typhi infection" },
    { "label": "C", "text": "Shigella dysenteriae infection" },
    { "label": "D", "text": "Campylobacter jejuni infection" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Shigella dysenteriae infection**\n\n**Why it’s correct:**  \nShigella causes an **invasive colitis** characterized by **high fever**, **tenesmus**, **frequent small-volume bloody–mucoid stools**, and can trigger **febrile seizures** in young children. The presence of fecal leukocytes and recent daycare exposure further support Shigella.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. EHEC infection** – Presents with **bloody diarrhea** but usually **low-grade or no fever** and carries a risk of **hemolytic uremic syndrome**; fecal leukocytes may be absent and seizures are less common acutely.  \n\n**B. Salmonella Typhi infection** – Causes **step-wise fevers**, **abdominal pain**, and **rose spots**, with **nonbloody** diarrhea or constipation. It typically has **no fecal leukocytes** and seizures are uncommon.  \n\n**D. Campylobacter jejuni infection** – Produces **bloody diarrhea** and fever but stool is often **larger volume**, with more prominent **crampy pain** and an incubation of ~2–5 days; tenesmus and seizures are less characteristic.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Obtain a **thorough history** (daycare exposure, onset, stool characteristics) and perform a **physical exam** focusing on hydration and abdominal findings.  \n2. **Stool Studies:** Send for **stool culture**, **enteric pathogen PCR**, and **fecal leukocyte analysis**.  \n3. **Best Test:** **Stool culture on Hektoen enteric agar** to isolate Shigella and perform **serotyping**; PCR panels offer rapid identification.  \n4. **Adjunct Tests:** Check **complete blood count** and **electrolytes** to assess dehydration and systemic response; monitor for **HUS** with platelet count, LDH, and renal function if EHEC is suspected.\n\n---\n\n**Management:**  \n1. **Rehydration:** **Oral rehydration solution** for mild dehydration; **IV fluids** if severe.  \n2. **Antibiotics:** In severe Shigella, treat with **trimethoprim–sulfamethoxazole** or **azithromycin** to shorten duration and prevent shedding.  \n3. **Symptomatic Care:** Antipyretics for fever and **avoid antimotility agents** (e.g., loperamide) which can worsen invasive diarrhea.  \n4. **Seizure Management:** Treat febrile seizures per protocol; monitor neurological status.  \n5. **Infection Control:** **Strict hand hygiene** and exclusion from daycare until **48 hours after antibiotic initiation** to prevent spread.\n\n---\n\n**Why Each Symptom Occurs in Shigella Infection:**  \n1. **High Fever:** **Inflammatory cytokines** (IL-1, TNF-α) released in response to mucosal invasion.  \n2. **Tenesmus:** **Rectal mucosal ulceration** and inflammation trigger painful straining.  \n3. **Mucoid, Bloody Stools:** **Invasion of colonic epithelium** leads to mucosal necrosis, bleeding, and exudate.  \n4. **Abdominal Cramps:** **Enterotoxin and cytotoxin** production irritates enteric nerves and smooth muscle.  \n5. **Febrile Seizure:** **High fever** and **endotoxin release** can lower the seizure threshold in young children.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Mucosal Invasion:** Shigella uses a **type III secretion system** to invade **M cells** in Peyer’s patches and enter enterocytes.  \n2. **Cell-to-Cell Spread:** **IcsA-mediated actin polymerization** allows bacteria to move laterally, evading immune detection.  \n3. **Shiga Toxin:** S. dysenteriae produces **Shiga toxin** that inhibits protein synthesis in epithelial cells and can cause **HUS**.  \n4. **Inflammatory Response:** Neutrophil recruitment to the lamina propria leads to **crypt abscesses** and tissue destruction.  \n5. **Mucosal Ulceration:** Focal areas of necrosis and ulceration result from **direct cytotoxicity** and immune-mediated injury.\n\n---\n\n**Summary:**  \nShigella dysenteriae infection presents with **high fever**, **tenesmus**, **small-volume bloody–mucoid diarrhea**, and potential **febrile seizures** in young children. Diagnosis is via **stool culture** or **PCR**, and management includes **rehydration**, **appropriate antibiotics**, and **supportive care**, with emphasis on **infectious precautions**."
},
{
  "text": "A 6-year-old boy with known sickle cell disease (functional asplenia) presents with a 2-day history of high fever (39.5 °C), severe headache, and one witnessed generalized tonic‐clonic seizure. He now complains of neck stiffness and photophobia. On exam, he is febrile, tachycardic, and irritable. He holds his head stiffly and has a positive Kernig’s sign. There is no rash. A non‐contrast head CT is normal. Lumbar puncture yields cloudy CSF with opening pressure 260 mmH₂O, WBC 2,200/µL (92% neutrophils), protein 210 mg/dL, glucose 30 mg/dL (serum glucose 100 mg/dL), and Gram‐positive, α‐hemolytic, optochin‐sensitive, lancet‐shaped diplococci on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Streptococcus pneumoniae meningitis" },
    { "label": "C", "text": "Haemophilus influenzae type b meningitis" },
    { "label": "D", "text": "Enteroviral meningitis" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Streptococcus pneumoniae meningitis**\n\n**Why it’s correct:**  \nThis child’s **acute presentation** with **fever**, **seizure**, **meningeal signs** (neck stiffness, photophobia), and CSF showing **neutrophilic pleocytosis**, **high protein**, **low glucose**, and **Gram-positive, α-hemolytic, optochin-sensitive lancet diplococci** is diagnostic for **pneumococcal meningitis**. His **functional asplenia** from sickle cell disease further increases susceptibility to encapsulated organisms like *S. pneumoniae*.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis meningitis** – Presents similarly but Gram stain shows **kidney-bean shaped, Gram-negative diplococci**, not Gram-positive organisms.  \n\n**C. Haemophilus influenzae type b meningitis** – Would show **pleomorphic Gram-negative coccobacilli** on CSF smear; also Hib incidence is very low in immunized children (and prophylaxis in asplenic).  \n\n**D. Enteroviral meningitis** – Causes a **lymphocytic pleocytosis**, **normal glucose**, and **normal or mildly elevated protein**, with no organisms on Gram stain.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize ABCs, obtain **blood cultures**, and perform a **neurologic exam** for signs of increased intracranial pressure (ICP).  \n2. **Neuroimaging (if indicated):** Non-contrast head CT before LP if focal deficits or papilledema are present.  \n3. **Lumbar Puncture (Best Test):** CSF cell count/differential, glucose, protein, Gram stain, and culture.  \n4. **Rapid Antigen Testing:** **BinaxNOW®** for pneumococcal antigen can expedite diagnosis.  \n5. **Antibiotic Sensitivity:** Once cultured, perform **MIC testing** to guide definitive therapy.\n\n---\n\n**Management:**  \n1. **Empiric Antibiotics:** IV **vancomycin** plus a **third-generation cephalosporin** (ceftriaxone or cefotaxime) to cover resistant *S. pneumoniae* and other pathogens.  \n2. **Targeted Therapy:** De-escalate to high-dose **ceftriaxone** alone once susceptibility confirms.  \n3. **Adjunctive Dexamethasone:** Administer before or with the first antibiotic dose to reduce **inflammatory neurologic injury**.  \n4. **Supportive Care:** IV fluids, fever control, seizure management, and ICP monitoring.  \n5. **Prevention:** For asplenic patients, ensure **pneumococcal conjugate and polysaccharide vaccines**, plus **penicillin prophylaxis** as indicated.\n\n---\n\n**Why Each Symptom Occurs in Pneumococcal Meningitis:**  \n1. **High Fever & Irritability:** Bacterial **cell wall components** (teichoic acids, peptidoglycan) provoke **cytokine release** (IL-1, TNF-α).  \n2. **Seizure:** **Inflammation** lowers the seizure threshold via **cytokines and increased ICP**.  \n3. **Neck Stiffness & Photophobia:** **Meningeal inflammation** irritates pain-sensitive structures around the brain.  \n4. **CSF Changes:** **Bacterial metabolism** consumes glucose and damages the blood–CSF barrier, raising protein.  \n5. **Lancet Diplococci on Gram Stain:** Characteristic *S. pneumoniae* morphology and α-hemolysis on blood agar.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** *S. pneumoniae* adheres via **pili and choline-binding proteins**, evading local defenses.  \n2. **Invasion & Bacteremia:** Encapsulated strains resist phagocytosis, enter bloodstream, and seed the meninges.  \n3. **Blood–Brain Barrier Crossing:** Bacterial **pneumolysin** and **hydrogen peroxide** disrupt tight junctions, allowing entry into CSF.  \n4. **Inflammatory Cascade:** CSF invasion triggers release of **cytokines** and **chemoattractants**, recruiting neutrophils that release **matrix metalloproteinases**, exacerbating damage.  \n5. **Complications:** Inflammatory edema and vasculitis can lead to **hydrocephalus**, **infarction**, and **sensorineural hearing loss** if not promptly treated.\n\n---\n\n**Summary:**  \nPneumococcal meningitis in asplenic children presents acutely with **fever**, **seizures**, **meningeal signs**, and CSF revealing **neutrophils**, **low glucose**, and **lancet diplococci**. Rapid **CSF analysis**, **empiric antibiotics** (vancomycin + cephalosporin), and **dexamethasone** are critical. **Vaccination** and **prophylaxis** are key preventive measures in high-risk patients."
},
{
  "text": "A 4-year-old girl, recently emigrated from India, presents with a 2-week history of low-grade fever, headache, and intermittent vomiting. Over the past 3 days she has become increasingly lethargic and has begun stumbling when she walks. There is no neck stiffness or photophobia. On exam, her temperature is 38.0 °C, heart rate 110 bpm, and respiratory rate 20/min. She is somnolent but arousable, with **cranial nerve VI palsy** on the right, ataxic gait, and papilledema. A contrast-enhanced MRI shows **basal meningeal enhancement** and **hydrocephalus**. A lumbar puncture yields clear fluid with opening pressure 300 mm H₂O, WBC 120 µL (85% lymphocytes), protein 220 mg/dL, glucose 35 mg/dL (serum glucose 100 mg/dL), and acid-fast bacilli on Ziehl–Neelsen stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Enteroviral (aseptic) meningitis" },
    { "label": "C", "text": "Tuberculous meningitis" },
    { "label": "D", "text": "Listeria monocytogenes meningitis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Tuberculous meningitis**  \n\n**Why it’s correct:**  \nThis child’s **subacute onset** over weeks, **basal meningeal enhancement**, **hydrocephalus**, **cranial nerve palsy**, and CSF showing **lymphocytic pleocytosis**, **high protein**, **low glucose**, and **acid-fast bacilli** are pathognomonic for **Mycobacterium tuberculosis** infection of the meninges.  \n\n---  \n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis meningitis** – Presents **acutely** with high fever, nuchal rigidity, and often a petechial rash. CSF shows **neutrophilic pleocytosis**, **very low glucose**, and **Gram-negative diplococci**, not lymphocytes or AFB.  \n\n**B. Enteroviral (aseptic) meningitis** – Usually presents with fever and headache but is **self-limited**, with **normal or mildly elevated protein**, **normal glucose**, and **lymphocytic pleocytosis** without enhancement on MRI or AFB.  \n\n**D. Listeria monocytogenes meningitis** – Occurs in neonates or immunocompromised hosts, presents more acutely, and CSF shows **Gram-positive rods**, not AFB; also lacks basal enhancement and hydrocephalus.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize airway/breathing/circulation, obtain **travel and exposure history**, and perform a **neurologic exam** (cranial nerves, gait, papilledema).  \n2. **Neuroimaging (Best Initial Test):** **Contrast MRI or CT** before LP when raised intracranial pressure or focal signs (cranial palsy, hydrocephalus) are present.  \n3. **Lumbar Puncture:** Measure **opening pressure**, send CSF for **cell count**, **protein**, **glucose**, **AFB smear**, **culture**, and **PCR for MTB**.  \n4. **Chest Imaging:** **Chest x-ray** to look for a primary pulmonary focus or miliary pattern.  \n5. **Tuberculin Skin Test / IGRA:** To support systemic TB infection, though may be negative early.  \n\n---  \n**Management:**  \n1. **RIPE Therapy:** **Rifampin, Isoniazid (with pyridoxine), Pyrazinamide, and Ethambutol** for at least **2 months**, followed by **INH + RIF** for **10 more months**.  \n2. **Adjunctive Corticosteroids:** **Dexamethasone** for 4–6 weeks to reduce meningeal inflammation and risk of neurologic sequelae.  \n3. **Neurosurgical Intervention:** **Ventriculoperitoneal shunt** if hydrocephalus is severe or medical management fails.  \n4. **Supportive Care:** Manage **electrolytes**, **nutrition**, and monitor for **drug toxicity** (hepatic, ocular).  \n5. **Public Health Measures:** **Contact tracing** and **INH prophylaxis** for close contacts.  \n\n---  \n**Why Each Symptom Occurs in Tuberculous Meningitis:**  \n1. **Basal Meningeal Enhancement & Cranial Palsies:** **Granulomatous inflammation** at the base of the brain leads to exudate in the cisterns, compressing cranial nerves.  \n2. **Hydrocephalus:** Exudate obstructs **CSF flow** in the basal cisterns and aqueduct, raising intracranial pressure.  \n3. **Lymphocytic Pleocytosis:** **Cell-mediated immune response** predominated by T lymphocytes and macrophages.  \n4. **High Protein & Low Glucose:** **Increased BBB permeability** allows proteins into CSF; glucose is consumed by both bacteria and infiltrating cells.  \n5. **Myoclonic Jerks/Ataxia:** **Inflammation** of cerebellar and cortical pathways produces motor signs.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Hematogenous Spread:** MTB infects lungs, then spreads via bloodstream to the **meninges**, forming **Rich foci** in the subpial space.  \n2. **Granuloma Formation:** Activated macrophages and Th1 cells form **tuberculous granulomas**, which can rupture into CSF.  \n3. **Caseous Exudate:** The **caseous necrosis** of granulomas yields a thick basal exudate that impairs CSF circulation.  \n4. **Cytokine-Mediated Damage:** **IFN-γ**, **TNF-α**, and other cytokines perpetuate inflammation, leading to **neuronal injury**.  \n5. **Fibrosis & Scarring:** Chronic inflammation causes **arachnoid fibrosis**, worsening hydrocephalus and vascular compromise.  \n\n---  \n**Summary:**  \nPediatric tuberculous meningitis presents subacutely with **basal exudates**, **cranial nerve palsies**, **hydrocephalus**, and **lymphocytic CSF** with **acid-fast bacilli**. Early **neuroimaging**, **CSF analysis**, and prompt **RIPE therapy** plus **corticosteroids** are critical to reduce mortality and permanent neurologic deficits."
},
{
  "text": "A 2-year-old boy, incompletely immunized (missing Hib booster), presents with a 1-day history of high fever (39.8 °C), irritability, and refusal to stand. His parents note several episodes of non‐bilious vomiting and that he cries inconsolably when his neck is moved. On exam, he is febrile, tachycardic, and has a full, bulging fontanelle. He holds his neck stiffly and resists passive flexion (positive Brudzinski’s sign). There is no rash. A non‐contrast head CT is normal. Lumbar puncture yields turbid CSF with an opening pressure of 280 mmH₂O, WBC 2,800/µL (90% neutrophils), protein 230 mg/dL, glucose 25 mg/dL (serum glucose 100 mg/dL), and pleomorphic small gram‐negative coccobacilli on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Haemophilus influenzae type b meningitis" },
    { "label": "C", "text": "Enteroviral meningitis" },
    { "label": "D", "text": "Group B Streptococcus meningitis" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Haemophilus influenzae type b meningitis**\n\n**Why it’s correct:**  \nThis toddler’s **acute high fever**, **meningeal signs** (neck stiffness, irritability), **bulging fontanelle**, and CSF findings of **neutrophilic pleocytosis**, **low glucose**, **high protein**, and **pleomorphic gram‐negative coccobacilli** are classic for **H. influenzae type b**. His **incomplete Hib immunization** puts him at risk.  \n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis** – Presents similarly but Gram stain shows **kidney‐bean diplococci**, not pleomorphic coccobacilli.  \n\n**C. Enteroviral meningitis** – Yields **clear CSF**, **lymphocytic pleocytosis**, **normal glucose**, and no organisms on Gram stain.  \n\n**D. Group B Streptococcus** – Causes neonatal meningitis in infants **<3 months**, with **Gram‐positive cocci in chains**; this child is 2 years old with Gram‐negative rods.  \n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize ABCs, obtain **blood cultures**, then perform **lumbar puncture** unless contraindicated.  \n2. **CSF Analysis:** Cell count/differential, protein, glucose, and Gram stain.  \n3. **Culture & Identification:** Grow on **chocolate agar with X (hemin) and V (NAD)** factors; confirm with **capsular PRP antigen** or **PCR**.  \n4. **Antigen Detection:** **Latex agglutination** for Hib PRP in CSF can provide rapid diagnosis.  \n\n---\n\n**Management:**  \n1. **Empiric Antibiotics:** IV **ceftriaxone** or **cefotaxime** plus **vancomycin** until pathogen identified.  \n2. **Targeted Therapy:** Once Hib is confirmed, continue **ceftriaxone** alone for **7–10 days**.  \n3. **Adjunctive Dexamethasone:** Administer before or with first antibiotic dose to reduce **neurologic sequelae**.  \n4. **Supportive Care:** Maintain hydration, manage fever, and monitor intracranial pressure.  \n5. **Chemoprophylaxis of Contacts:** Give **rifampin** to household and daycare contacts to eradicate nasopharyngeal carriage.  \n\n---\n\n**Why Each Symptom Occurs in Hib Meningitis:**  \n1. **High Fever:** Bacterial endotoxin and cytokines (IL-1, TNF-α) elevate hypothalamic set point.  \n2. **Neck Stiffness & Irritability:** **Meningeal inflammation** irritates pain‐sensitive structures.  \n3. **Bulging Fontanelle:** Increased **intracranial pressure** from purulent exudate.  \n4. **Vomiting:** **Raised intracranial pressure** and meningeal irritation stimulate the vomiting center.  \n5. **Tachycardia & Hypotension:** Systemic inflammatory response and possible early **septicemia**.  \n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** Hib adheres to mucosa via **polysaccharide capsule (PRP)**, evading phagocytosis.  \n2. **Invasion & Bacteremia:** Organism crosses epithelium into bloodstream, resisting complement.  \n3. **Blood–Brain Barrier Penetration:** Hib uses **outer membrane proteins** to traverse endothelial cells into CSF.  \n4. **CSF Inflammation:** Bacterial components (LPS) trigger **neutrophil recruitment**, release of proteases, and increased **BBB permeability**.  \n5. **Potential for Sequelae:** Inflammatory mediators damage neurons and vasculature, leading to **hearing loss**, **seizures**, or **hydrocephalus** if untreated.  \n\n---\n\n**Summary:**  \nH. influenzae type b meningitis presents in incompletely vaccinated toddlers with **acute meningeal irritation**, **neutrophilic CSF pleocytosis**, and **pleomorphic gram‐negative coccobacilli**. Diagnosis relies on **CSF culture/PCR** and **antigen detection**; treatment includes **third‐generation cephalosporins**, **dexamethasone**, and **rifampin prophylaxis** for contacts."
},
{
  "text": "A 10-day-old male neonate is brought to the neonatal intensive care unit with a 2-day history of poor feeding, irritability, and episodes of high-pitched crying. His mother reports she consumed unpasteurized soft cheese during pregnancy. On exam, his temperature is 38.5 °C, heart rate 180 bpm, and respiratory rate 60/min. He has a bulging anterior fontanelle, mottled skin, and generalized hypotonia. He has occasional myoclonic jerks but no focal neurologic deficits. A blood culture is drawn, and lumbar puncture yields cloudy CSF with opening pressure 30 cm H₂O, WBC 1,200/µL (90% neutrophils), protein 350 mg/dL, glucose 20 mg/dL (serum glucose 80 mg/dL), and Gram-positive rods on direct smear. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Listeria monocytogenes meningitis" },
    { "label": "B", "text": "Group B Streptococcus meningitis" },
    { "label": "C", "text": "Escherichia coli K1 meningitis" },
    { "label": "D", "text": "Enterovirus meningitis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Listeria monocytogenes meningitis**\n\n**Why it’s correct:**  \nThis neonate’s **presentation in the second week of life**, **bulging fontanelle**, **neutrophilic CSF pleocytosis**, **low CSF glucose**, and **Gram-positive rods** point to **Listeria monocytogenes**, particularly given the history of **unpasteurized dairy exposure** in the mother and the organism’s ability to invade via the gastrointestinal tract and cross the blood–brain barrier in neonates.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Group B Streptococcus meningitis** – GBS is the most common cause of early-onset neonatal meningitis (within 0–6 days of life), but presents sooner than day 10 and shows **Gram-positive cocci in chains** on smear, not rods.\n\n**C. Escherichia coli K1 meningitis** – E. coli (Gram-negative rods) is a common late-onset pathogen but shows **Gram-negative bacilli** on CSF smear. Our smear reveals **Gram-positive rods**, ruling out E. coli.\n\n**D. Enterovirus meningitis** – Presents at 1–4 weeks of age with fever and irritability but typically yields **lymphocytic** rather than neutrophilic CSF pleocytosis, **normal glucose**, and **no organisms** on Gram stain.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize ABCs, obtain **blood cultures**, and perform a **focused neurologic exam** (fontanelle tension, irritability).  \n2. **Lumbar Puncture (Best Test):** CSF analysis for **cell count**, **differential**, **protein**, **glucose**, and **Gram stain** to identify the pathogen and pattern of inflammation.  \n3. **Blood and CSF Cultures:** Essential for definitive organism identification and antibiotic susceptibility.  \n4. **PCR Testing:** CSF **PCR for Listeria genes** can confirm diagnosis rapidly if available.  \n5. **Additional Labs:** **Complete blood count** (look for neutrophilia), **electrolytes**, and **liver function tests** to guide supportive care.\n\n---\n\n**Management:**  \n1. **Empiric Antibiotics:** **Ampicillin** plus **an aminoglycoside (gentamicin)** to cover Listeria and other neonatal pathogens pending culture results.  \n2. **Adjust Therapy:** Once Listeria is confirmed, continue **ampicillin** for at least **21 days**; may add **gentamicin** for the first 7–10 days for synergy.  \n3. **Supportive Care:** Maintain **normothermia**, **fluid and electrolyte balance**, and **seizure control** if needed.  \n4. **Monitor for Complications:** Watch for **hydrocephalus**, **abscess formation**, and **hearing loss**; obtain **cranial ultrasound** or MRI if complications are suspected.  \n5. **Prevention:** Educate pregnant women to **avoid unpasteurized dairy** and ensure appropriate **maternal screening** when indicated.\n\n---\n\n**Why Each Symptom Occurs in Listeria Meningitis:**  \n1. **Bulging Fontanelle:** Increased **intracranial pressure** from purulent CSF accumulation.  \n2. **Hypotonia & Irritability:** **Meningeal inflammation** and direct bacterial toxins irritate CNS tissues.  \n3. **Myoclonic Jerks:** **Neuronal hyperexcitability** in inflamed meninges can trigger seizures.  \n4. **Neutrophilic Pleocytosis:** **Bacterial invasion** stimulates innate immune response with neutrophil recruitment.  \n5. **Low CSF Glucose & High Protein:** **Consumption of glucose** by bacteria and increased **vascular permeability** allow protein-rich plasma to leak into CSF.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Ingestion & Translocation:** Listeria enters via the **gastrointestinal tract**, crosses the epithelial barrier using **internalin** proteins.  \n2. **Cell-to-Cell Spread:** The bacterium escapes the phagosome and uses **actin polymerization** (ActA) to propel itself into adjacent cells, evading humoral immunity.  \n3. **Placental & Blood–Brain Barrier Crossing:** Listeriolysin O disrupts host cell membranes, allowing **transcytosis** into the CNS and placenta.  \n4. **Intracellular Survival:** Listeria resists killing by **macrophages** and **neutrophils**, leading to sustained infection.  \n5. **Inflammatory Damage:** Host response releases **TNF-α**, **IL-1**, and **IFN-γ**, which, while controlling infection, also contribute to **meningeal injury** and increased intracranial pressure.\n\n---\n\n**Summary:**  \nNeonatal Listeria monocytogenes meningitis presents in the **second to third week** of life with **fever**, **bulging fontanelle**, **neutrophilic CSF**, and **Gram-positive rods**. Early recognition, **ampicillin-based therapy**, and supportive care are critical to reduce morbidity and mortality."
},
{
  "text": "A 5-year-old boy, incompletely immunized, presents with a 2-day history of high fever (up to 40 °C), severe headache, and two episodes of non‐bilious vomiting. He now complains of neck pain and photophobia, and his mother notes a new petechial rash on his trunk and lower extremities that does not blanch. On exam he is febrile, tachycardic, and hypotensive. He is alert but irritable, holds his neck stiffly (positive Brudzinski’s sign), and has scattered petechiae. A non‐contrast head CT is unremarkable. Lumbar puncture yields turbid fluid with opening pressure 280 mmH₂O, WBC 3,500/µL (95% neutrophils), protein 240 mg/dL, glucose 18 mg/dL (serum glucose 100 mg/dL), and gram‐negative kidney‐bean shaped diplococci on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Enterovirus meningitis" },
    { "label": "C", "text": "Herpes simplex encephalitis" },
    { "label": "D", "text": "Kawasaki Disease" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Neisseria meningitidis meningitis**\n\n**Why it’s correct:**  \nThis child’s **acute presentation** with **high fever**, **meningeal signs** (neck stiffness, photophobia), **non‐blanching petechial rash**, and CSF showing **neutrophilic pleocytosis**, **low glucose**, **high protein**, and **gram‐negative diplococci** is classic for **meningococcal meningitis**.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Enterovirus meningitis** – Typically causes a **lymphocytic** CSF pleocytosis, normal or mildly elevated protein, normal glucose, and no bacteria on Gram stain. Rash, if present, is maculopapular and blanching.  \n\n**C. Herpes simplex encephalitis** – Presents with **altered mental status**, **focal neurologic deficits**, and often seizures. CSF shows lymphocytic predominance, RBCs, and PCR detection of HSV DNA.  \n\n**D. Kawasaki Disease** – Manifests with **prolonged fever**, **conjunctivitis**, **mucosal changes**, **rash**, and **cervical lymphadenopathy**, not with meningismus, neutrophilic CSF, or gram‐negative diplococci.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Stabilize airway, breathing, circulation**; obtain **blood cultures** before antibiotics; perform **rapid neurologic assessment**.  \n2. **Pneumatic Otoscopy & Skin Exam:** Evaluate for otitis media or petichiae.  \n3. **Lumbar Puncture (Best Test):** CSF analysis with cell count, differential, glucose, protein, Gram stain, and culture.  \n4. **CSF PCR:** For confirmation and identification of Neisseria meningitidis polysaccharide capsule.  \n5. **Adjunct Imaging:** CT head only if signs of raised intracranial pressure or focal neurologic deficits exist prior to LP.\n\n---\n\n**Management:**  \n1. **Empiric IV Antibiotics:** **Ceftriaxone** (100 mg/kg/day) plus **vancomycin** immediately after cultures, then narrow to ceftriaxone alone when sensitivity confirmed.  \n2. **Adjunctive Dexamethasone:** Administer before or with the first antibiotic dose to reduce neurologic complications.  \n3. **Supportive Care:** IV fluids, hemodynamic support for hypotension, seizure prophylaxis if needed, and monitoring in the ICU.  \n4. **Chemoprophylaxis for Contacts:** **Rifampin** or **ciprofloxacin** for close household and childcare contacts.  \n5. **Vaccination:** Ensure age‐appropriate **meningococcal conjugate vaccine** once acute illness resolves.\n\n---\n\n**Why Each Symptom Occurs in Meningococcal Meningitis:**  \n1. **Fever:** **Endotoxin (LPS)** triggers massive cytokine release (TNF-α, IL-1) raising hypothalamic set point.  \n2. **Neck Stiffness & Photophobia:** **Inflammation of the meninges** irritates pain-sensitive structures around the brain and spinal cord.  \n3. **Headache & Vomiting:** Increased **intracranial pressure** from inflammatory exudate stimulates the vomiting center.  \n4. **Petechial Rash:** **Endothelial damage** by meningococcal endotoxin leads to small‐vessel thrombosis and petechiae.  \n5. **Neutrophilic Pleocytosis & Hypoglycorrhachia:** **Bacterial metabolism** consumes CSF glucose, and neutrophils infiltrate to combat infection.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** Neisseria meningitidis adheres to mucosal cells via **type IV pili**, evading mucosal defenses.  \n2. **Invasion & Bacteremia:** Bacteria cross the epithelial barrier into the bloodstream, resisting complement via **capsular polysaccharide**.  \n3. **Meningeal Penetration:** Bacteremia allows passage across the **blood–brain barrier**, aided by bacterial proteases.  \n4. **Inflammatory Cascade:** CSF invasion triggers release of **proinflammatory cytokines**, increasing BBB permeability and recruiting leukocytes.  \n5. **Endothelial Injury & DIC:** Endotoxin‐mediated activation of coagulation leads to **microthrombi**, hemorrhage, and **petechiae**.\n\n---\n\n**Summary:**  \nMeningococcal meningitis presents acutely with **fever**, **meningeal signs**, **petechial rash**, and **neutrophilic CSF** with **gram‐negative diplococci**. Rapid diagnosis via **CSF analysis** and early empiric antibiotics with **ceftriaxone** and **vancomycin**, plus **dexamethasone**, are critical. **Contact prophylaxis** and **vaccination** are essential to prevent secondary cases."
},
{
  "text": "An 8-year-old girl presents with a 3-month history of daily sneezing, clear rhinorrhea, and recurrent itchy, watery eyes. Symptoms are worst in spring and when she plays outside in the grass. She also complains of an itchy nose and palate. She has no fever, purulent discharge, or cough. Her mother has eczema and allergic asthma. On exam, she has **pale, boggy nasal turbinates**, **allergic shiners**, and a transverse nasal crease. Lung exam is clear. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Chronic Sinusitis" },
    { "label": "B", "text": "Vasomotor (Nonallergic) Rhinitis" },
    { "label": "C", "text": "Allergic Rhinitis" },
    { "label": "D", "text": "Adenoid Hypertrophy" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Allergic Rhinitis**  \n\n**Why it’s correct:**  \nThis child’s **seasonal symptoms** of **sneezing**, **itchy nose and palate**, **clear rhinorrhea**, and **watery eyes**, combined with a family history of atopy, **pale boggy turbinates**, and allergic shiners, are classic for **IgE-mediated allergic rhinitis** triggered by pollens.  \n\n---  \n**Why the other options are incorrect:**  \n\n**A. Chronic Sinusitis** – Presents with **facial pain/pressure**, **purulent nasal discharge**, and often **fever**. Exam shows opaque turbinates and sinus tenderness, not pale boggy mucosa or itching.  \n\n**B. Vasomotor (Nonallergic) Rhinitis** – Causes **year-round congestion** and watery rhinorrhea, but **no itching**, ocular symptoms, or atopic exam findings. Triggers are non-allergic (e.g., temperature changes), not seasonal pollens.  \n\n**D. Adenoid Hypertrophy** – Leads to **nasal obstruction**, **mouth breathing**, and **snoring**, often in younger children. Turbinates may be normal, and there is no sneezing, itching, or ocular involvement.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** of symptom timing, triggers, and **family atopy**; thorough **nasal exam** with otoscope or endoscope.  \n2. **Best Test:** **Skin prick testing** for seasonal and perennial allergens to identify specific IgE sensitivities.  \n3. **Alternative Test:** **Serum-specific IgE (RAST)** if skin testing is contraindicated.  \n4. **Adjunct:** **Nasal cytology** (eosinophils on smear) supports allergic etiology if positive.  \n\n---  \n**Management:**  \n1. **Allergen Avoidance:** Keep windows closed during high pollen counts; use HEPA filters; wash clothes after outdoor play.  \n2. **Intranasal Corticosteroids:** **Fluticasone** or **mometasone** daily to reduce mucosal inflammation.  \n3. **Second-Generation Oral Antihistamines:** **Cetirizine** or **loratadine** for symptom relief, taken before pollen exposure.  \n4. **Intranasal Antihistamines/Decongestants:** For breakthrough symptoms (use decongestants <3 days to avoid rebound).  \n5. **Allergen Immunotherapy:** Subcutaneous or sublingual for persistent symptoms and prevention of asthma onset.  \n\n---  \n**Why Each Symptom Occurs in Allergic Rhinitis:**  \n1. **Sneezing:** Histamine stimulates **nasal sensory receptors**, triggering reflexive sneezing.  \n2. **Itchy Nose/Palate:** Mast cell degranulation releases **histamine** and **leukotrienes**, exciting itch fibers.  \n3. **Clear Rhinorrhea:** **Vascular permeability** causes plasma exudation into nasal passages.  \n4. **Watery Eyes:** **Conjunctival mast cells** degranulate, causing lacrimation.  \n5. **Nasal Congestion:** **Vasodilation** and **edema** of mucosal vessels block airflow.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Sensitization:** Allergen exposure leads to **Th2 cell activation** and **IgE class switching** in B cells.  \n2. **Mast Cell Degranulation:** Re-exposure causes cross-linking of IgE on mast cells, releasing **histamine**, **tryptase**, and **prostaglandins**.  \n3. **Early-Phase Response:** Mediators cause **vasodilation**, **vascular leak**, and **smooth muscle contraction** within minutes.  \n4. **Late-Phase Response:** **Eosinophils**, **basophils**, and **Th2 lymphocytes** infiltrate the mucosa hours later, perpetuating inflammation.  \n5. **Mucosal Remodeling:** Chronic inflammation leads to **glandular hyperplasia**, **fibrosis**, and persistent hyperresponsiveness."
},
{
  "text": "A 7-year-old boy presents with a 4-day history of **dark, tea-colored urine**, swelling around his eyes in the morning, and a headache. Three weeks ago he had an untreated skin infection on his leg that resolved spontaneously. On exam his blood pressure is 145/95 mmHg, he has **periorbital edema**, and 1+ pitting edema of his ankles. Urinalysis shows **3+ blood**, **2+ protein**, and numerous **RBC casts**. Serum C3 is low, C4 is normal, and anti–streptolysin O titer is elevated. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "IgA Nephropathy (Berger’s Disease)" },
    { "label": "B", "text": "Henoch–Schönlein Purpura" },
    { "label": "C", "text": "Post-streptococcal Glomerulonephritis (PSGN)" },
    { "label": "D", "text": "Membranoproliferative Glomerulonephritis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Post-streptococcal Glomerulonephritis (PSGN)**\n\n**Why it’s correct:**  \nThis child’s presentation of **tea-colored urine**, **periorbital edema**, **hypertension**, and **RBC casts**, occurring **2–4 weeks** after a resolved streptococcal skin infection, with **low C3** and elevated ASO titer, is classic for PSGN. The timing after infection and complement consumption distinguish it from other glomerulopathies.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. IgA Nephropathy** – Presents with **synpharyngitic hematuria** (occurring concurrently with a URI), not weeks later. C3 levels are normal, and there is no latency period.  \n\n**B. Henoch–Schönlein Purpura** – Causes a small-vessel vasculitis with **palpable purpura**, **abdominal pain**, and **arthralgias**, along with IgA deposition in glomeruli. Our patient has no rash or GI symptoms.  \n\n**D. Membranoproliferative GN** – Presents insidiously with **persistent low C3**, **nephritic-nephrotic syndrome**, and often hypocomplementemia of both C3 and C4. The post-infectious latency and normalization of C3 in 6–8 weeks favor PSGN.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed history of recent infections and **blood pressure measurement**. Perform **urinalysis** to identify hematuria, proteinuria, and RBC casts.  \n2. **Complement Levels:** Measure **C3** and **C4**; isolated low C3 suggests PSGN.  \n3. **Serologies:** Check **ASO** and **anti–DNase B titers** to document recent streptococcal infection.  \n4. **Renal Ultrasound:** To exclude obstruction and assess kidney size if hypertension is severe or renal function is impaired.  \n5. **Renal Biopsy (Best Test):** Reserved for atypical cases; shows **granular “starry-sky” IgG/C3 deposition** on immunofluorescence and **subepithelial “hump”** deposits on electron microscopy.\n\n---\n\n**Management:**  \n- **Supportive Care:** **Salt restriction**, **diuretics** (e.g., furosemide) for edema, and **antihypertensives** (e.g., ACE inhibitors) to control blood pressure.  \n- **Fluid Management:** Careful fluid balance to avoid fluid overload or hypovolemia.  \n- **Antibiotic Therapy:** Treat any persistent streptococcal carriage with penicillin to prevent spread, though it does not alter PSGN course.  \n- **Monitoring:** Follow **renal function**, **blood pressure**, and **complement levels**; most children recover fully.  \n- **Referral:** Nephrology consultation for severe or rapidly progressive cases.\n\n---\n\n**Why Each Symptom Occurs in PSGN:**  \n1. **Tea-Colored Urine:** RBCs and hemoglobin leak through the glomerular basement membrane due to immune complex–mediated damage.  \n2. **Periorbital Edema:** Sodium and water retention from reduced glomerular filtration leads to fluid accumulation in dependent tissues.  \n3. **Hypertension:** Reduced GFR and salt retention activate the **renin–angiotensin–aldosterone system**, raising blood pressure.  \n4. **RBC Casts:** Damaged glomerular capillaries allow red cells to enter the tubules and form casts in the distal nephron.  \n5. **Low C3 Levels:** Complement is consumed by immune complex deposition in the glomeruli.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Immune Complex Deposition:** Antigen–antibody complexes from streptococcal antigens deposit in the **subepithelial space**, triggering inflammation.  \n2. **Complement Activation:** Classical pathway activation consumes **C3**, resulting in hypocomplementemia.  \n3. **Glomerular Hypercellularity:** Neutrophils and mesangial cells proliferate, causing **lobular glomerular appearance** on light microscopy.  \n4. **Subepithelial Humps:** Electron-dense deposits form characteristic **“humps”** on electron microscopy.  \n5. **Endothelial Injury:** Complement fragments (C3a, C5a) recruit inflammatory cells, leading to **capillary wall damage** and protein leakage.\n\n---\n\n**Summary:**  \nPost-streptococcal glomerulonephritis presents in children with **nephritic syndrome** several weeks after a streptococcal infection, featuring **hematuria**, **edema**, **hypertension**, and **low C3**. Diagnosis is clinical, supported by serology and, if needed, renal biopsy. Management is primarily **supportive**, focusing on blood pressure control, diuresis, and monitoring, with most patients achieving full recovery."
},
{
  "text": "An 18-month-old boy presents with a 3-day history of high fever (up to 39.5 °C), irritability, and incessant right ear tugging. He attends daycare and had a runny nose last week that resolved. He has difficulty sleeping and refuses to feed when lying flat. On exam, he is febrile and fussy. External ears are normal. Otoscopic examination of the right ear shows a **bulging, erythematous tympanic membrane** with **loss of landmarks** and **decreased mobility** on pneumatic otoscopy. The left ear is normal. There is no mastoid tenderness or lymphadenopathy. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute Otitis Media" },
    { "label": "B", "text": "Otitis Externa" },
    { "label": "C", "text": "Serous Otitis Media (Otitis Media with Effusion)" },
    { "label": "D", "text": "Acute Mastoiditis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Acute Otitis Media**  \n\n**Why it’s correct:**  \nThe child’s presentation of **high fever**, **ear tugging**, **bulging/erythematous tympanic membrane**, and **decreased mobility** on pneumatic otoscopy are classic for **acute otitis media**, indicating pus behind the TM and middle ear inflammation.  \n\n---  \n**Why the other options are incorrect:**  \n\n**B. Otitis Externa** – Involves the **external canal**, with pain on tragal pressure, canal erythema, and often discharge. The TM is normal and pneumatic otoscopy is normal.  \n\n**C. Serous Otitis Media** – Characterized by a **retracted TM** with air-fluid levels or bubbles, but without erythema, bulging, or systemic signs (fever, irritability).  \n\n**D. Acute Mastoiditis** – Presents as a complication of AOM with **postauricular swelling**, **erythema**, and **tenderness** over the mastoid. Our patient has no mastoid findings.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** (onset, fever, URI prodrome, daycare exposure) and **otoscopic exam** of both ears.  \n2. **Best Test:** **Pneumatic otoscopy** to assess TM mobility—poor mobility confirms middle ear effusion.  \n3. **Adjunct Test:** **Tympanometry** can quantify middle ear pressure if otoscopy is inconclusive.  \n4. **Culture/Tympanocentesis:** Reserved for severe, recurrent, or treatment-resistant cases to guide antibiotic therapy.  \n\n---  \n**Management:**  \n1. **Analgesia:** **Acetaminophen** or **ibuprofen** for pain and fever.  \n2. **Antibiotics:** **High-dose amoxicillin** (80–90 mg/kg/day divided BID) for 7–10 days. If recent amoxicillin use or resistant organisms suspected, add **clavulanate** or use **ceftriaxone** IM.  \n3. **Observation:** In children ≥2 years with mild symptoms, consider 48-hour watchful waiting if close follow-up is guaranteed.  \n4. **Follow-Up:** Re-examine in 48–72 hours to ensure resolution.  \n5. **Prevention:** Encourage **pneumococcal and influenza vaccination**, and consider **ear tubes** for ≥3 episodes in 6 months or ≥4 in 12 months.  \n\n---  \n**Why Each Symptom Occurs in AOM:**  \n1. **Fever:** Inflammatory cytokines (IL-1, TNF-α) released in response to middle ear infection raise the hypothalamic set point.  \n2. **Ear Tugging/Irritability:** Plication of the TM and pressure on the malleus irritate sensory branches of the trigeminal nerve.  \n3. **Bulging TM:** Accumulation of purulent fluid in the middle ear increases pressure behind the membrane.  \n4. **Decreased TM Mobility:** Effusion prevents normal TM vibration and movement when pressure is applied.  \n5. **Refusal to Feed Supine:** Lying flat increases middle ear pressure and pain.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Eustachian Tube Dysfunction:** In young children, a **horizontal, short tube** fails to drain middle ear fluid, predisposing to stasis.  \n2. **URI-Induced Inflammation:** Viral infections cause **mucosal edema**, blocking the Eustachian tube and allowing bacteria to ascend.  \n3. **Bacterial Overgrowth:** Common pathogens (S. pneumoniae, H. influenzae, M. catarrhalis) proliferate in the trapped fluid.  \n4. **Neutrophil Recruitment:** Innate immune cells migrate into the middle ear space, releasing enzymes and ROS that contribute to membrane damage.  \n5. **Biofilm Formation:** Recurrent infections lead to bacterial biofilms on the middle ear mucosa, promoting chronicity and antibiotic resistance."
},
{
  "text": "A 9-year-old girl from Southeast Asia presents with a 6-week history of insidious onset **productive cough**, **night sweats**, and **unintentional weight loss** (4 kg). She has intermittent low-grade fevers and complains of mild chest tightness. Her grandfather was treated for tuberculosis last year. On exam, she appears thin, with digital clubbing and **focal crackles** in the right upper lung field. Oxygen saturation is 96% on room air. A chest x-ray reveals **right upper lobe cavitation** with **hilar lymphadenopathy**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Streptococcus pneumoniae pneumonia" },
    { "label": "B", "text": "Mycoplasma pneumoniae infection" },
    { "label": "C", "text": "Primary Mycobacterium tuberculosis pneumonia" },
    { "label": "D", "text": "Aspiration pneumonia" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Primary Mycobacterium tuberculosis pneumonia**\n\n**Why it’s correct:**  \nThis child’s **chronic course** (6 weeks), systemic symptoms (**night sweats**, **weight loss**), **exposure history**, and **upper lobe cavitation** with hilar lymphadenopathy are classic for **primary tuberculosis**. The indolent nature, lack of response to broad-spectrum antibiotics, and radiographic findings point to M. tuberculosis rather than acute pathogens.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Streptococcus pneumoniae pneumonia** – Presents with **acute onset** high fever, pleuritic chest pain, and **lobar consolidation** without cavitation in immunocompetent children. This patient’s subacute timeline and cavitary lesion are atypical.\n\n**B. Mycoplasma pneumoniae infection** – Causes a **subacute dry cough**, low-grade fever, and **interstitial infiltrates** rather than cavitary consolidation. Exposure history and weight loss are also not typical.\n\n**D. Aspiration pneumonia** – Occurs in children with **neurologic impairment** or swallowing dysfunction and usually affects **dependent lung zones** (right lower lobe) with **localized consolidation** but not typically cavitation in a previously healthy child.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Detailed **history** (TB exposure, BCG status, symptom duration) and targeted **physical exam** (lymph nodes, clubbing).  \n- **Laboratory Tests:** **Tuberculin skin test (TST)** or **interferon-gamma release assay (IGRA)** to assess sensitization.  \n- **Best Test:** **Sputum or gastric aspirate PCR/culture** for M. tuberculosis—highly specific and confirms diagnosis.  \n- **Additional Tests:** **CT chest** if available, to delineate cavitary lesions and lymphadenopathy; **HIV testing** to assess immune status if risk factors present.\n\n---\n\n**Management:**  \n1. **First-Line Antitubercular Therapy:** **RIPE regimen**—Rifampin, Isoniazid, Pyrazinamide, and Ethambutol for 2 months, followed by Rifampin and Isoniazid for 4 months.  \n2. **Directly Observed Therapy (DOT):** Ensure adherence and monitor for side effects (e.g., hepatotoxicity).  \n3. **Supportive Care:** Nutritional support, vitamin D and pyridoxine (to prevent isoniazid neuropathy).  \n4. **Contact Tracing & Prophylaxis:** Screen household contacts and provide **isoniazid prophylaxis** for TST-positive or high-risk individuals.  \n5. **Follow-Up Imaging:** Repeat chest x-ray at 2 and 6 months to document radiographic improvement.\n\n---\n\n**Why Each Symptom Occurs in TB Pneumonia:**  \n1. **Chronic Productive Cough:** Mycobacterial infection induces **granulomatous inflammation** in airways.  \n2. **Night Sweats & Low-Grade Fevers:** **Cytokine release** (TNF-α, IL-1) during granuloma formation raises nighttime temperature.  \n3. **Weight Loss & Anorexia:** **Cachexia** from chronic inflammation and increased metabolic demand.  \n4. **Cavitation:** **Caseous necrosis** of lung parenchyma leads to cavity formation in upper lobes where oxygen tension is high.  \n5. **Hilar Lymphadenopathy:** **Primary Ghon focus** drains to regional lymph nodes, causing enlargement.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Inhalation of Droplet Nuclei:** M. tuberculosis is taken up by **alveolar macrophages** in the lung apex.  \n2. **Intracellular Survival:** The bacterium **prevents phagosome-lysosome fusion**, replicating within macrophages.  \n3. **Cell-Mediated Immunity:** **Th1 response** (IFN-γ, IL-12) activates macrophages and forms **granulomas** to contain infection.  \n4. **Caseous Necrosis:** Chronic inflammation leads to **tissue necrosis** and formation of the “cheese-like” core in granulomas.  \n5. **Reactivation Potential:** Cavities harbor viable bacilli that can reactivate if host immunity wanes.\n\n---\n\n**Summary:**  \nPrimary tuberculosis in children presents insidiously with **chronic cough**, **constitutional symptoms**, and characteristic **upper lobe cavitation** with **hilar adenopathy** on imaging. Diagnosis relies on **TST/IGRA** and **microbiologic confirmation**. Treatment with the **RIPE regimen** plus DOT and contact prophylaxis is essential to cure and prevent spread."
},
{
  "text": "A 6-month-old boy with known perinatal HIV infection (CD4 count 8%) who has not received Pneumocystis prophylaxis presents with a 2-week history of progressive **dry cough**, **tachypnea**, and **poor weight gain**. His mother reports low-grade fevers and intermittent **oral thrush**. On exam, he is tachypneic (respiratory rate 60/min), with subcostal retractions, nasal flaring, and oxygen saturation 88% on room air. Lung auscultation reveals **diffuse fine crackles** bilaterally without wheezing. A chest x-ray demonstrates **bilateral diffuse ground-glass opacities**. Serum LDH is elevated. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "RSV Bronchiolitis" },
    { "label": "B", "text": "Streptococcus pneumoniae Pneumonia" },
    { "label": "C", "text": "Pneumocystis jirovecii Pneumonia" },
    { "label": "D", "text": "Pulmonary Tuberculosis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Pneumocystis jirovecii Pneumonia**\n\n**Why it’s correct:**  \nIn an **immunocompromised** infant with HIV and no prophylaxis, a **subacute dry cough**, **hypoxemia**, **diffuse crackles**, and **ground-glass opacities** on CXR, along with **elevated LDH**, are classic for **Pneumocystis jirovecii** infection.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. RSV Bronchiolitis** – Typically affects infants <2 months after a brief viral prodrome, presents with wheezing and focal crackles rather than diffuse ground-glass changes, and is usually self-limited.\n\n**B. Streptococcus pneumoniae Pneumonia** – Presents acutely with high fever, toxic appearance, lobar consolidation on imaging, and neutrophilic leukocytosis, not a subacute interstitial pattern.\n\n**D. Pulmonary Tuberculosis** – In infants, TB presents with chronic cough, weight loss, and focal lymphadenopathy or miliary pattern on CXR; exposure history and positive PPD/IGRA would be expected.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Obtain a thorough **history** (HIV status, prophylaxis) and **respiratory exam** (rate, effort, crackles).  \n- **Laboratory Tests:** Check **arterial blood gas** (to assess hypoxemia), **serum LDH** (often elevated), and **complete blood count** (may show lymphopenia).  \n- **Best Test:** Perform **induced sputum** or **bronchoalveolar lavage (BAL)** with **silver (Gomori) stain** or **PCR** for Pneumocystis DNA, which is the definitive diagnostic method.  \n- **Additional Tests:** Consider **CT scan** if CXR is inconclusive, showing diffuse ground-glass attenuation.\n\n---\n\n**Management:**  \n1. **First‐line Therapy:** **Trimethoprim–sulfamethoxazole** (15–20 mg/kg/day TMP component divided q6h) for 21 days.  \n2. **Adjunctive Corticosteroids:** If PaO₂ <70 mmHg or A–a gradient >35 mmHg, add **prednisone** to reduce inflammation and mortality.  \n3. **Oxygen & Supportive Care:** Provide **supplemental oxygen**, monitor fluid balance, and treat any concurrent infections (e.g., oral thrush).  \n4. **Secondary Prophylaxis:** Continue **TMP–SMX** thrice weekly until CD4 count recovers (>200 cells/mm³).  \n5. **Antiretroviral Therapy (ART):** Ensure **ART optimization** to restore immune function and prevent recurrence.\n\n---\n\n**Why Each Symptom Occurs in PCP:**  \n1. **Dry Cough & Crackles:** Alveolar–interstitial inflammation and exudate impair gas exchange, producing crackles and a nonproductive cough.  \n2. **Tachypnea & Retractions:** Hypoxemia from V/Q mismatch drives increased respiratory effort and use of accessory muscles.  \n3. **Hypoxemia:** Thick intra-alveolar exudate increases diffusion barrier for oxygen.  \n4. **Elevated LDH:** Indicates **cellular injury** in the lung parenchyma.  \n5. **Weight Loss & Poor Feeding:** Chronic hypoxemia and systemic inflammation lead to failure to thrive.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Fungal Attachment:** Pneumocystis attaches to **type I pneumocytes**, causing detachment and apoptosis, damaging the alveolar–capillary interface.  \n2. **Foamy Exudate Formation:** Intra-alveolar **protein-rich fluid** accumulates, impairing gas exchange.  \n3. **Impaired Host Defense:** In HIV, **CD4+ T-cell depletion** prevents effective clearance, allowing organism proliferation.  \n4. **Inflammatory Response:** Activated **alveolar macrophages** release cytokines (e.g., TNF-α), leading to further lung injury.  \n5. **Surfactant Dysfunction:** Exudative process disrupts surfactant, increasing surface tension and causing alveolar collapse and ground-glass appearance.\n\n---\n\n**Summary:**  \nPneumocystis jirovecii pneumonia in infants with HIV presents subacutely with **dry cough**, **hypoxemia**, **diffuse interstitial infiltrates**, and **elevated LDH**. Diagnosis is confirmed by **silver stain** or **PCR** on BAL fluid. Treatment with **TMP–SMX** and **adjunctive steroids** is essential, along with secondary prophylaxis and ART optimization."
},
{
  "text": "A 3-month-old boy is brought to the clinic for a 3-week history of a persistent, staccato cough and mild tachypnea. He has never had a fever. His mother reports the cough worsens at night and occasionally causes him to gag but never to vomit. He was born at term, has no significant past medical history, and is up to date on immunizations except for the pertussis booster. On exam, his respiratory rate is 50/min, oxygen saturation 94% on room air, and he has diffuse fine crackles bilaterally without wheezing. There is no conjunctivitis or rash. A CBC shows WBC 9,500/µL with 10% eosinophils. Chest x-ray reveals hyperinflation and bilateral perihilar interstitial infiltrates. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "RSV Bronchiolitis" },
    { "label": "B", "text": "Pertussis" },
    { "label": "C", "text": "Chlamydia trachomatis Pneumonia" },
    { "label": "D", "text": "Congenital Heart Disease (VSD)" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Chlamydia trachomatis Pneumonia**\n\n**Why it’s correct:**\nThis infant’s **afebrile**, **subacute** course with a **staccato cough**, **eosinophilia**, and **interstitial infiltrates** on chest x-ray are classic for **Chlamydia trachomatis pneumonia**, which typically presents between **4–12 weeks of age** after perinatal exposure. The absence of fever and the presence of eosinophils help distinguish it from other causes.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. RSV Bronchiolitis** – Usually affects infants **<2 months**, presents acutely with **wheezing**, **retractions**, and often fever after a brief URI prodrome. Our patient has crackles without wheezing and a chronic staccato cough.\n\n**B. Pertussis** – Characterized by **paroxysmal whooping cough**, **post-tussive emesis**, and marked lymphocytosis. This infant has no whoop or emesis and shows eosinophilia instead of lymphocytosis.\n\n**D. Congenital Heart Disease (VSD)** – A VSD may cause tachypnea and crackles from pulmonary overcirculation, but would present earlier, with **heart murmurs**, **hepatomegaly**, and failure to thrive; chest x-ray shows **pulmonary edema**, not interstitial infiltrates.\n\n---\n\n**Diagnostic Steps:**\n- **Initial Step:** Obtain a **detailed history** (age of onset, cough characteristics, feeding tolerance) and perform a **thorough respiratory exam**.\n- **Laboratory Tests:** CBC with differential to identify **eosinophilia**; pulse oximetry to assess oxygenation.\n- **Best Test:** **PCR for Chlamydia trachomatis** on a **nasopharyngeal swab** or **induced sputum**—highly sensitive and specific in the first weeks of illness.\n- **Additional Tests:** **Serology** for chlamydial-specific IgM/IgG can support diagnosis if PCR unavailable; repeat CXR if no improvement after treatment.\n\n---\n\n**Management:**\n1. **Oral Macrolide Antibiotic:** **Erythromycin** (50 mg/kg/day divided q6h for 14 days) or **azithromycin** (10 mg/kg day 1, then 5 mg/kg days 2–5).  \n2. **Supportive Care:** Ensure adequate **hydration**, monitor growth, and provide **nasal saline** for comfort.  \n3. **Monitor for Complications:** Watch for **hyponatremia** from SIADH and **bronchiolitis obliterans** as a late sequela.  \n4. **Preventive Measures:** Screen pregnant women for chlamydia and treat to reduce perinatal transmission.  \n5. **Follow-Up:** Reassess respiratory status in 1–2 weeks and consider repeat CXR if symptoms persist.\n\n---\n\n**Why Each Symptom Occurs in Chlamydia Pneumonia:**\n1. **Staccato Cough:** Inflammation of the **bronchiolar epithelium** produces a characteristic hacking cough.  \n2. **Afebrile Course:** Chlamydial infection does not elicit a strong pyrogenic response in infants.  \n3. **Fine Crackles:** **Interstitial infiltration** of lung parenchyma leads to crackles rather than wheezing.  \n4. **Eosinophilia:** Chlamydia triggers a **Th2 immune response**, recruiting eosinophils into the bloodstream.  \n5. **Hyperinflation:** **Air trapping** from small airway inflammation causes increased lung volumes on imaging.\n\n---\n\n**Pathophysiology Highlights:**\n1. **Perinatal Transmission:** Infant inhales infected birth canal secretions, leading to **respiratory mucosal infection**.  \n2. **Obligate Intracellular Growth:** Chlamydia replicates within **host epithelial cells**, evading extracellular defenses.  \n3. **Host Immune Response:** **Delayed hypersensitivity** and **Th2 cytokines (IL-5)** drive eosinophil recruitment and lung inflammation.  \n4. **Bronchiolar Inflammation:** Infection of **small airways** causes **interstitial pneumonitis** without alveolar consolidation.  \n5. **Cytokine-Mediated Injury:** **Tumor necrosis factor-α** and other mediators increase vascular permeability and contribute to symptoms.\n\n---\n\n**Summary:**\nChlamydia trachomatis pneumonia in infants presents with an **afebrile, subacute staccato cough**, **eosinophilia**, and **interstitial infiltrates**. Diagnosis is confirmed by **PCR** of respiratory specimens. Treatment with **macrolides** and supportive care leads to resolution, while prevention hinges on **maternal screening** and treatment during pregnancy."
},
{
  "text": "A 6-year-old boy presents to the pediatric emergency department with a 3-day history of high fever (up to 40°C), productive cough, and right-sided chest pain. He was diagnosed with influenza 10 days ago and seemed to be recovering until this week. On exam, he is toxic-appearing, tachypneic (respiratory rate 36/min), tachycardic (heart rate 130 bpm), and has oxygen saturation 92% on room air. Chest auscultation reveals **diminished breath sounds**, **bronchial breath sounds**, and **crackles** over the right upper and middle lung fields. A chest x-ray shows a **right upper lobe consolidation with a 3 cm cavitary lesion** and a small pleural effusion. Laboratory studies reveal WBC 20,000/µL with 85% neutrophils, CRP 150 mg/L, and a neutrophil left shift. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Streptococcus pneumoniae pneumonia" },
    { "label": "B", "text": "Mycoplasma pneumoniae infection" },
    { "label": "C", "text": "Staphylococcus aureus pneumonia" },
    { "label": "D", "text": "Aspiration pneumonia" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Staphylococcus aureus pneumonia**\n\n**Why it’s correct:**  \nThis child’s **post‐influenza** status, **high fever**, **toxic appearance**, **productive cough**, and **cavitary lesion** on chest x-ray are classic for **Staph aureus pneumonia**, a known complication following viral respiratory infection. The rapid onset of severe symptoms, neutrophilic leukocytosis, and pleural effusion further support this diagnosis.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Streptococcus pneumoniae pneumonia** – Typically causes **lobar consolidation** without cavitation in previously healthy children. The post‐viral timing and cavitary lesion favor staph rather than pneumococcus.\n\n**B. Mycoplasma pneumoniae infection** – Presents subacutely with **dry cough**, low‐grade fever, and **interstitial infiltrates** rather than cavitating consolidation and high-grade fevers.\n\n**D. Aspiration pneumonia** – Occurs in children with **neurologic impairment** or swallowing dysfunction, causes **dependent lung segment** infiltrates (e.g., right lower lobe), and does not usually produce rapid cavitation in an otherwise healthy child.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Detailed history (recent influenza, symptom onset) and focused exam (vital signs, lung auscultation).  \n- **Laboratory Tests:** Obtain **CBC with differential**, **CRP**, **blood cultures**, and **sputum culture** (if obtainable).  \n- **Best Test:** **Chest CT** if complicated pneumonia is suspected—to delineate **abscess**, **empyema**, or **necrosis**.  \n- **Pleural Fluid Analysis:** If pleural effusion is significant, perform **thoracentesis** for Gram stain, culture, and chemistry to guide therapy.\n\n---\n\n**Management:**  \n1. **Empiric IV Antibiotics:** Start **nafcillin** (or oxacillin) or **cefazolin** plus **clindamycin** (for toxin suppression) to cover MSSA; consider **vancomycin** if MRSA is suspected.  \n2. **Drainage of Effusion/Abscess:** Perform **chest tube** or **video-assisted thoracoscopic surgery (VATS)** for pleural drainage or abscess debridement if present.  \n3. **Supportive Care:** Oxygen supplementation, hydration, and antipyretics. Monitor for respiratory distress and hemodynamic stability.  \n4. **Repeat Imaging:** Follow-up chest x-ray or ultrasound to ensure resolution of effusion and cavity.  \n5. **Duration of Therapy:** Continue IV antibiotics for **2–3 weeks**, transitioning to oral therapy based on culture results and clinical improvement.\n\n---\n\n**Why Each Symptom Occurs in Staph aureus Pneumonia:**  \n1. **High Fever & Toxic Appearance:** **Exotoxins** and **cytokine release** drive systemic inflammation.  \n2. **Productive Cough & Crackles:** **Purulent sputum** and consolidation produce crackles on auscultation.  \n3. **Cavitary Lesion:** **Tissue necrosis** from bacterial toxins and intense neutrophilic response leads to abscess formation.  \n4. **Pleural Effusion:** **Exudative fluid** accumulates due to increased vascular permeability in the pleural space.  \n5. **Neutrophilic Leukocytosis:** Bone marrow releases neutrophils in response to **severe bacterial infection**.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Post-Viral Susceptibility:** **Influenza‐induced epithelial damage** and impaired mucociliary clearance allow Staph aureus to invade lung parenchyma.  \n2. **Toxin Production:** **Panton-Valentine leukocidin (PVL)** and other toxins cause **neutrophil lysis**, tissue necrosis, and cavitation.  \n3. **Biofilm Formation:** Staph aureus can form **biofilms** in the pleural space, complicating clearance.  \n4. **Protease-Mediated Damage:** Secreted proteases degrade **extracellular matrix**, facilitating abscess formation.  \n5. **Inflammatory Cascade:** Recruitment of neutrophils and release of **matrix metalloproteinases** contribute to lung destruction and empyema.\n\n---\n\n**Summary:**  \nStaphylococcus aureus pneumonia in children often follows influenza, presenting with **high fevers**, **toxic appearance**, **cavitary consolidation**, and **pleural effusion**. Diagnosis relies on imaging (chest x-ray, CT), cultures, and fluid analysis. Management includes **anti‐staphylococcal antibiotics**, **drainage**, and supportive care. Pathophysiology centers on **post‐viral epithelial damage**, **toxin‐mediated necrosis**, and a robust **neutrophilic response** leading to cavitation."
},
{
  "text": "An 8-year-old boy presents with a 10-day history of persistent dry cough, low-grade fevers, and malaise. He complains of mild headache and a sore throat, but denies wheezing or chest pain. He attends a summer camp and several classmates recently had “colds.” On exam, his temperature is 37.8 °C, heart rate 88 bpm, respiratory rate 20/min, and oxygen saturation 98% on room air. Lung auscultation reveals **scattered bilateral crackles** without wheezing. Throat exam is unremarkable. Laboratory studies show WBC 11,000/µL with 70% lymphocytes, ESR 25 mm/hr, CRP 12 mg/L, and a positive **cold agglutinin** titer. A chest x-ray demonstrates bilateral perihilar interstitial infiltrates with patchy areas of consolidation. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Typical bacterial pneumonia (Streptococcus pneumoniae)" },
    { "label": "B", "text": "Pertussis" },
    { "label": "C", "text": "Mycoplasma pneumoniae infection (Atypical pneumonia)" },
    { "label": "D", "text": "Viral pneumonia (RSV)" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Mycoplasma pneumoniae infection (Atypical pneumonia)**\n\n**Why it’s correct:**\nThis patient’s **subacute onset** of a **dry cough**, **low-grade fever**, **mild headache**, and **interstitial pattern** on chest x-ray, plus a positive **cold agglutinin** titer, are all characteristic of **atypical (Mycoplasma) pneumonia**. Lymphocytic predominance on CBC and relatively mild elevation of inflammatory markers further support an atypical etiology rather than a fulminant bacterial infection.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Typical bacterial pneumonia (Streptococcus pneumoniae)** – Presents with **acute high fever**, **productive cough**, **lobar consolidation** on x-ray, and **neutrophilic leukocytosis**. This patient’s presentation is more indolent with interstitial infiltrates.\n\n**B. Pertussis** – Characterized by **paroxysmal cough** with inspiratory “whoop,” posttussive emesis, and lymphocytosis. Our patient has no whooping, no vomiting, and has a normal lymphocyte percentage for an atypical infection.\n\n**D. Viral pneumonia (RSV)** – Usually affects children under 2 years old and presents with **bronchiolitis**: tachypnea, retractions, wheezing, and diffuse crackles. An 8-year-old with no wheezing is unlikely to have RSV pneumonia.\n\n---\n\n**Diagnostic Steps:**\n\n- **Initial Step:** Detailed **history** (duration of symptoms, exposures) and **physical exam** focusing on lung auscultation to distinguish crackles from wheezes.\n- **Best Test:** **PCR for Mycoplasma pneumoniae** on a nasopharyngeal swab or throat specimen provides the most specific and rapid confirmation.\n- **Additional Tests:** **Cold agglutinin titer** (supportive but nonspecific), **serology** for Mycoplasma-specific IgM/IgG (diagnostic when rising titers are seen), and **repeat chest imaging** if clinical status worsens.\n\n---\n\n**Management:**\n\n1. **Macrolide Antibiotics:** **Azithromycin** (10 mg/kg on day 1, then 5 mg/kg on days 2–5) is first-line in children under 8.\n2. **Supportive Care:** Adequate **hydration**, **antipyretics** (acetaminophen or ibuprofen), and **rest**.\n3. **Monitor for Complications:** Watch for development of **cold agglutinin–mediated hemolytic anemia**, which may require **transfusion** if severe.\n4. **School Exclusion:** Keep home until 24 hours after starting antibiotics to prevent spread.\n5. **Follow-Up:** Reassess in 48–72 hours to ensure clinical improvement and repeat CXR only if symptoms persist or worsen.\n\n---\n\n**Why Each Symptom Occurs in Mycoplasma Pneumonia:**\n\n1. **Dry Cough:** Caused by inflammation of the **bronchial epithelium** without significant mucus hypersecretion.\n2. **Low-Grade Fever:** **Cytokine release** from immune response to intracellular pathogen drives mild pyrexia.\n3. **Headache and Malaise:** Systemic **immune activation** leads to generalized symptoms.\n4. **Interstitial Infiltrates:** **Peribronchial and interstitial inflammation** results in a reticulonodular pattern on x-ray rather than lobar consolidation.\n5. **Cold Agglutinins:** Cross-reactive antibodies against Mycoplasma lipoproteins cause **cold-induced hemagglutination** in vitro.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Lack of Cell Wall:** Mycoplasma pneumoniae resists β-lactams and adheres tightly to respiratory epithelium via the **P1 adhesin**.\n2. **Epithelial Injury:** Attachment leads to **oxidative damage** and loss of ciliary function, impairing mucociliary clearance.\n3. **Immune-Mediated Damage:** Host **T-cell–mediated response** and immune complex formation contribute to tissue inflammation.\n4. **Cold Agglutinin Production:** Shared antigens between Mycoplasma and RBCs trigger **IgM antibodies** that agglutinate erythrocytes at low temperatures.\n5. **Extrapulmonary Manifestations:** Immune cross-reactivity can cause **arthralgias**, **skin eruptions**, and **neurologic complications** in severe cases.\n\n---\n\n**Summary:**\nAtypical pneumonia due to Mycoplasma presents with a **subacute dry cough**, **low-grade fever**, and **interstitial radiographic findings** in school-aged children. Diagnosis relies on **PCR** or **serology**, and treatment is with **macrolide antibiotics** and supportive measures."
},
{
  "text": "A 30-week–gestation male infant is born via emergency cesarean section for maternal preeclampsia. At birth he is floppy and requires positive-pressure ventilation. Within minutes he develops **tachypnea** (RR 80/min), **expiratory grunting**, **nasal flaring**, and **intercostal retractions**. His SpO₂ is 85% on room air despite free-flow oxygen. On auscultation, breath sounds are **clear but diminished** bilaterally. A chest x-ray shows **low lung volumes**, a **ground-glass** appearance, and **air bronchograms**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neonatal respiratory distress syndrome (hyaline membrane disease)" },
    { "label": "B", "text": "Transient tachypnea of the newborn (TTN)" },
    { "label": "C", "text": "Meconium aspiration syndrome" },
    { "label": "D", "text": "Early-onset neonatal pneumonia" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Neonatal respiratory distress syndrome (hyaline membrane disease)**  \n\n**Why it’s correct:**  \nThis premature infant presents within minutes of birth with **grunting**, **nasal flaring**, **retractions**, and **ground-glass** CXR findings—all classic for surfactant deficiency leading to **alveolar collapse** and **hyaline membrane formation** in RDS.  \n\n---  \n**Why the other options are incorrect:**  \n\n**B. Transient tachypnea of the newborn (TTN)** – Occurs in term or late preterm infants with **fluid-retention** findings (perihilar streaking) and usually improves within 48–72 hours without surfactant therapy.  \n\n**C. Meconium aspiration syndrome** – Presents in post-term infants with **meconium-stained amniotic fluid**, patchy infiltrates, and often significant air trapping or pneumothorax rather than uniform ground-glass.  \n\n**D. Early-onset neonatal pneumonia** – Can mimic RDS, but usually has **fever**, **leukocytosis**, and CXR showing **airspace consolidation** rather than diffuse ground-glass.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** **Stabilize ABCs**, provide **CPAP** or intubation as needed, and assess severity using the **Downes score**.  \n2. **Pulse Oximetry & Blood Gases:** Monitor oxygenation and CO₂ retention to guide respiratory support.  \n3. **Chest Radiograph (Best Test):** Confirms the **ground-glass** appearance, **air bronchograms**, and **low lung volumes** of RDS.  \n4. **Lung Ultrasound:** May show “**white lung**” pattern supportive of RDS.  \n5. **Surfactant Level Assessment:** Research tool; in practice, clinical and radiographic findings suffice.  \n\n---  \n**Management:**  \n1. **Antenatal Steroids:** If time allows, administer **betamethasone** to mothers at risk for preterm delivery to accelerate fetal surfactant production.  \n2. **Exogenous Surfactant:** Instill directly via endotracheal tube immediately after birth or upon diagnosis to reduce surface tension.  \n3. **Continuous Positive Airway Pressure (CPAP):** Maintains **functional residual capacity** and prevents alveolar collapse.  \n4. **Mechanical Ventilation:** Use low tidal volumes and **PEEP** to minimize barotrauma in severe cases.  \n5. **Supportive Care:** Maintain **thermoregulation**, **fluid balance**, and **nutrition**; monitor for complications (PDA, bronchopulmonary dysplasia).  \n\n---  \n**Why Each Symptom Occurs in RDS:**  \n1. **Grunting:** Infant generates **expiratory positive pressure** to stent open alveoli.  \n2. **Nasal Flaring:** Indicates **increased effort** to reduce airway resistance.  \n3. **Intercostal Retractions:** Due to **high work of breathing** against noncompliant lungs.  \n4. **Ground-Glass CXR:** Reflects **diffuse atelectasis** and proteinaceous hyaline membranes.  \n5. **Hypoxemia:** **V/Q mismatch** from collapsed alveoli impairs gas exchange.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Surfactant Deficiency:** Type II pneumocytes are immature in preterm infants, reducing **dipalmitoyl phosphatidylcholine** in alveoli.  \n2. **Increased Surface Tension:** Leads to **alveolar collapse** (atelectasis) at end expiration.  \n3. **Hyaline Membrane Formation:** Plasma proteins leak into alveoli and mix with necrotic debris to form **protein-rich membranes**.  \n4. **Decreased Lung Compliance:** Requires higher pressures to ventilate, risking **barotrauma**.  \n5. **Pulmonary Vascular Resistance:** Atelectasis increases resistance, causing **shunting** and **persistent pulmonary hypertension** if severe.\n\n---  \n**Summary:**  \nNeonatal RDS presents in preterm infants with **respiratory distress** immediately after birth, characteristic **radiographic** findings, and responds to **antenatal steroids**, **exogenous surfactant**, and **CPAP** with careful ventilatory support. Effective management reduces **morbidity** and **mortality** in this vulnerable population."
},
{
  "text": "A 4-year-old boy from a household with a recently treated tuberculosis case presents with a 3-week history of **persistent productive cough**, **unintended weight loss** (1.5 kg), **night sweats**, and **low-grade fevers**. He denies hemoptysis but has become progressively fatigued and less active. On exam, his temperature is 37.8 °C, and he has **cervical lymphadenopathy** and **diffuse crackles** in the right upper lung field. A chest x-ray shows **right upper lobe infiltrates** with **hilar lymphadenopathy**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Mycoplasma pneumoniae infection" },
    { "label": "B", "text": "Bordetella pertussis infection" },
    { "label": "C", "text": "Pulmonary tuberculosis" },
    { "label": "D", "text": "Asthma exacerbation" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Pulmonary tuberculosis**\n\n**Why it’s correct:**  \nThis child’s **subacute productive cough** persisting for three weeks, combined with **weight loss**, **night sweats**, **low-grade fevers**, and a known **close TB exposure**, along with physical findings of **cervical lymphadenopathy** and CXR showing **upper lobe infiltrates** with **hilar adenopathy**, is classic for **pulmonary tuberculosis**.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Mycoplasma pneumoniae infection** – Typically presents with a **subacute dry cough**, diffuse interstitial infiltrates on imaging, and often a higher fever initially; it does not cause night sweats, significant weight loss, or hilar lymphadenopathy, and his TB exposure history wouldn’t yield a positive TST/IGRA.\n\n**B. Bordetella pertussis infection** – Characterized by **paroxysmal whooping cough**, posttussive vomiting, and lymphocytosis; systemic constitutional symptoms like night sweats and weight loss are uncommon, and imaging is usually normal or shows peribronchial thickening.\n\n**D. Asthma exacerbation** – Presents with **wheezing**, episodic dyspnea, and no constitutional symptoms. Asthma does not cause fever, night sweats, or radiographic lymphadenopathy.\n\n---\n\n**Diagnostic Steps:**  \n\n- **Initial Step:** Obtain a **detailed history** (TB exposure, BCG vaccination) and perform a **focused exam** for lymphadenopathy and respiratory signs.  \n- **Tuberculin Skin Test (TST) or IGRA:** Screen for latent TB infection; a positive result supports exposure.  \n- **Chest X-Ray (Best Initial Test):** Identify **hilar lymphadenopathy**, **Ghon focus**, or **upper lobe infiltrates**.  \n- **Sputum/Gastric Aspirate AFB Smear and Culture (Best Test):** Collect samples for **acid-fast bacilli** smear, culture, and **PCR** to confirm M. tuberculosis.  \n- **Additional Tests:** Consider **CT chest** if x-ray is inconclusive and **HIV testing** due to immunosuppression risk.\n\n---\n\n**Management:**  \n\n1. **RIPE Therapy:** Administer **Rifampin**, **Isoniazid** (with pyridoxine), **Pyrazinamide**, and **Ethambutol** daily for 2 months, followed by **Rifampin + Isoniazid** for 4 more months.  \n2. **Directly Observed Therapy (DOT):** Ensure adherence and monitor for drug toxicity.  \n3. **Airborne Precautions:** Isolate until the patient is non-infectious (typically 2 weeks of treatment).  \n4. **Supportive Care:** Provide **nutritional support**, monitor liver function, and ensure growth parameters improve.  \n5. **Contact Tracing & Prophylaxis:** Screen household contacts and give **Isoniazid prophylaxis** to those with latent infection.\n\n---\n\n**Why Each Symptom Occurs in Tuberculosis:**  \n\n1. **Persistent Cough:** **Granulomatous inflammation** in the airways stimulates cough receptors.  \n2. **Weight Loss & Anorexia:** **Chronic cytokine release** (TNF-α) increases metabolic demand and suppresses appetite.  \n3. **Night Sweats:** **Cytokine-mediated** thermoregulation changes during granuloma turnover elevate nighttime temperatures.  \n4. **Low-Grade Fevers:** **Cell-mediated immune response** produces intermittent fevers.  \n5. **Lymphadenopathy:** **Mycobacterial drainage** to regional lymph nodes causes enlargement (scrofula).\n\n---\n\n**Pathophysiology Highlights:**  \n\n1. **Inhalation & Macrophage Uptake:** M. tuberculosis enters alveoli and is phagocytosed but survives by preventing phagosome-lysosome fusion.  \n2. **Cell-Mediated Immunity:** **Th1 response** activates macrophages to form **granulomas** that wall off bacilli.  \n3. **Caseation Necrosis:** Central necrosis within granulomas leads to tissue destruction and potential cavitation.  \n4. **Lymphatic Spread:** Bacilli disseminate to hilar lymph nodes, causing **hilar adenopathy** visible on imaging.  \n5. **Reactivation Potential:** Latent bacilli within granulomas can reactivate if immunity wanes, perpetuating disease.\n\n---\n\n**Summary:**  \nPulmonary tuberculosis in children presents insidiously with **chronic cough**, **constitutional symptoms**, and characteristic radiographic findings. Diagnosis requires **TST/IGRA**, **chest imaging**, and **microbiologic confirmation**. Effective management with **RIPE therapy**, DOT, and contact prophylaxis is essential to prevent spread and complications."
},
{
  "text": "A 16-day-old female infant presents with a 24-hour history of **fever** (up to 38.9 °C), **lethargy**, and **poor feeding**. Her parents note two brief episodes of **arm jerking** last night. She was term, with an uncomplicated vaginal delivery; the mother’s GBS screen was negative and no intrapartum antibiotics were given. On exam her heart rate is 170 bpm, respiratory rate 60 /min, and SpO₂ 97% on room air. She is irritable, with a **bulging anterior fontanelle** and a weak cry. A head ultrasound is unremarkable. Lumbar puncture yields **turbid CSF** with opening pressure 240 mmH₂O, WBC 1 800/µL (92% neutrophils), protein 200 mg/dL, glucose 20 mg/dL (serum 90 mg/dL), and **Gram-negative rods** on Gram stain. CSF culture grows **pink colonies on MacConkey agar**, which are **motile** at 37 °C and **indole-positive**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Escherichia coli K1 meningitis" },
    { "label": "B", "text": "Group B Streptococcus meningitis" },
    { "label": "C", "text": "Listeria monocytogenes meningitis" },
    { "label": "D", "text": "Haemophilus influenzae type b meningitis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Escherichia coli K1 meningitis**  \n\n**Why it’s correct:**  \nThis infant’s late-onset neonatal meningitis, presenting at 16 days with **fever**, **bulging fontanelle**, and **seizure activity**, and CSF showing **neutrophilic pleocytosis**, **hypoglycorrhachia**, and **Gram-negative rods**, is consistent with *E. coli* K1. The key culture features—**lactose-fermenting pink colonies** on MacConkey agar, **motility**, and **indole positivity**—confirm *E. coli* rather than other Gram-negative pathogens.  \n\n---  \n**Why the other options are incorrect:**  \n\n**B. Group B Streptococcus meningitis** – Would show **Gram-positive cocci in chains**, CAMP-test positivity, and is bacitracin-resistant, not Gram-negative rods.  \n\n**C. Listeria monocytogenes meningitis** – Presents with **Gram-positive rods** on smear, tumbling motility at 25 °C, and tumbling movement; this case has Gram-negative rods.  \n\n**D. Haemophilus influenzae type b meningitis** – Appears as **small pleomorphic Gram-negative coccobacilli**, requires X and V factors on chocolate agar, and does not ferment lactose on MacConkey.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize airway, breathing, circulation; obtain **blood and CSF cultures** promptly.  \n2. **Lumbar Puncture (Best Test):** Analyze **CSF cell count**, **glucose**, **protein**, **Gram stain**, and **culture** to identify bacterial meningitis and the organism.  \n3. **Blood Cultures:** Positive in many cases and guide antibiotic choice.  \n4. **Biochemical Testing:** Confirm lactose fermentation on MacConkey, **motility**, and **indole** production to differentiate *E. coli* K1.  \n5. **PCR or Antigen Detection:** Useful if prior antibiotics compromise culture yield.  \n\n---  \n**Management:**  \n1. **Empiric Antibiotics:** Begin **ampicillin** plus a **third-generation cephalosporin** (cefotaxime) immediately after cultures to cover *E. coli*, GBS, and Listeria.  \n2. **Targeted Therapy:** De-escalate to **ceftriaxone** or **cefotaxime** for *E. coli* once sensitivities are known, typically for **21 days**.  \n3. **Supportive Care:** Maintain hydration and electrolytes; monitor for and treat seizures with **phenobarbital** or **levetiracetam**.  \n4. **Adjunctive Dexamethasone:** Not routinely used for Gram-negative rods but consider to reduce neurologic complications in select cases.  \n5. **Follow-Up:** Audiology screening and neurodevelopmental assessment due to risk of hearing loss and deficits.  \n\n---  \n**Why Each Symptom Occurs in E. coli Meningitis:**  \n1. **Fever:** Immune response to **endotoxin (LPS)** triggers cytokine release, raising hypothalamic set point.  \n2. **Bulging Fontanelle:** Increased **intracranial pressure** from inflammatory exudate in the CSF space.  \n3. **Poor Feeding & Irritability:** Meningeal inflammation causes discomfort and irritability, impairing feeding.  \n4. **Neutrophilic Pleocytosis:** **Innate immune activation** recruits neutrophils to the CSF to phagocytose bacteria.  \n5. **Hypoglycorrhachia:** Bacterial metabolism and impaired glucose transport lower CSF glucose levels.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Capsular K1 Antigen:** The polysaccharide capsule evades complement-mediated killing, facilitating bloodstream survival and BBB invasion.  \n2. **LPS Endotoxin:** Activates toll-like receptor 4, triggering a **proinflammatory cascade** that increases BBB permeability.  \n3. **BBB Disruption:** Bacterial factors and inflammation disrupt tight junctions, allowing bacterial and immune cell entry into CSF.  \n4. **Neutrophil Migration:** Neutrophils release **elastase**, **proteases**, and **reactive oxygen species**, which kill bacteria but also damage neural tissue.  \n5. **Cytokine-Mediated Injury:** High levels of **TNF-α**, **IL-1**, and **IL-6** perpetuate vasogenic edema and can lead to long-term neurologic sequelae."
},
{
  "text": "A previously healthy 7-year-old girl presents to the emergency department with a 12-hour history of **high fever** (up to 40.2 °C), **severe headache**, and **vomiting**. She now complains of **neck stiffness** and her mother notes a new **pinpoint, non-blanching rash** on her trunk and lower extremities. On exam she is febrile, tachycardic (HR 140 bpm), and hypotensive (BP 85/50 mmHg). She is alert but irritable, with a positive Brudzinski’s sign. A rapid bedside rash test shows petechiae that do not blanch under pressure. A lumbar puncture is performed after a normal head CT, yielding **turbid CSF** with opening pressure 260 mmH₂O, WBC 3 200/µL (95% neutrophils), protein 220 mg/dL, glucose 30 mg/dL (serum 100 mg/dL), and **Gram-negative kidney-bean diplococci** on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Streptococcus pneumoniae meningitis" },
    { "label": "C", "text": "Haemophilus influenzae type b meningitis" },
    { "label": "D", "text": "Enteroviral (aseptic) meningitis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Neisseria meningitidis meningitis**\n\n**Why it’s correct:**  \nThis child’s **acute onset** of **high fever**, **meningeal signs** (headache, vomiting, neck stiffness), and the characteristic **petechial, non-blanching rash**, combined with CSF showing **neutrophilic pleocytosis**, **low glucose**, **high protein**, and **Gram-negative diplococci**, are classic for **meningococcal meningitis**.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Streptococcus pneumoniae meningitis** – Gram stain would demonstrate **Gram-positive lancet-shaped diplococci**; petechial rash is uncommon.  \n\n**C. Haemophilus influenzae type b meningitis** – Shows **Gram-negative coccobacilli** and typically occurs in incompletely immunized toddlers; rash is rare and often has more systemic signs of bacteremia.  \n\n**D. Enteroviral meningitis** – CSF shows **lymphocytic pleocytosis**, **normal glucose**, **mild protein elevation**, and **no organisms** on Gram stain; rash, if present, is blanching and systemic signs are milder.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Stabilize ABCs**, obtain **blood cultures**, and start **empiric antibiotics** immediately after cultures.  \n2. **Empiric Therapy:** Begin **IV ceftriaxone** (or cefotaxime) plus **vancomycin**, and add **dexamethasone** before or with the first dose to reduce neurologic complications.  \n3. **Lumbar Puncture (Best Test):** CSF analysis including cell count, glucose, protein, Gram stain, and culture confirms bacterial meningitis and identifies the pathogen.  \n4. **Latex Agglutination or PCR:** Rapid detection of **meningococcal capsule antigens** in CSF can expedite diagnosis.  \n5. **Neuroimaging:** Head CT prior to LP if signs of **raised intracranial pressure** (papilledema, focal deficits) are present; otherwise not routinely required.\n\n---\n\n**Management:**  \n1. **Targeted Antibiotics:** Once *N. meningitidis* is identified and sensitivities return, narrow therapy to **IV penicillin G** or **ampicillin** for 7–10 days.  \n2. **Adjunctive Dexamethasone:** Continue for 4 days to reduce risk of hearing loss and neurologic sequelae.  \n3. **Supportive Care:** Maintain **hemodynamic stability** with IV fluids and vasopressors if needed; monitor in the ICU for **septic shock**.  \n4. **Chemoprophylaxis of Contacts:** Administer **rifampin** or **ciprofloxacin** to close household and daycare contacts to eradicate nasopharyngeal carriage.  \n5. **Vaccination:** Ensure age-appropriate **meningococcal conjugate vaccine** (MenACWY) and consider **MenB** vaccine according to local guidelines.\n\n---\n\n**Why Each Symptom Occurs in Meningococcal Meningitis:**  \n1. **Fever:** **Endotoxin (LPS)** from *N. meningitidis* triggers a **cytokine storm** (TNF-α, IL-1) raising the hypothalamic set point.  \n2. **Headache & Vomiting:** **Meningeal inflammation** and increased intracranial pressure stimulate pain and the vomiting center.  \n3. **Neck Stiffness:** Irritation of **pain-sensitive meninges** causes resistance to neck flexion (positive Kernig’s/Brudzinski’s signs).  \n4. **Petechial Rash:** **Endothelial injury** by endotoxin leads to small-vessel thrombosis and capillary leakage.  \n5. **Hypotension & Tachycardia:** **Septicemia** with vasodilation and capillary leak causes distributive shock, prompting compensatory tachycardia.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** *N. meningitidis* adheres via **type IV pili** to the oropharyngeal epithelium, evading mucosal defenses.  \n2. **Invasion & Bacteremia:** Encapsulated strains resist complement and phagocytosis, entering the bloodstream to seed the meninges.  \n3. **Blood–Brain Barrier Penetration:** Bacteria cross the BBB via **transcellular** or **paracellular** routes, aided by proteases that disrupt tight junctions.  \n4. **Endotoxin-Mediated Damage:** **Lipooligosaccharide** triggers widespread **inflammation**, **coagulopathy**, and **vascular leak** leading to shock and rash.  \n5. **Inflammatory Cascade in CSF:** Recruitment of neutrophils and release of **proteolytic enzymes** and reactive oxygen species damage neurons, contributing to neurological sequelae.\n\n---\n\n**Summary:**  \nNeisseria meningitidis meningitis presents with **rapid onset** of **fever**, **meningeal signs**, and a distinctive **petechial rash**. Prompt **CSF analysis**, **empiric antibiotics with dexamethasone**, and **supportive care**, along with **contact prophylaxis** and **vaccination**, are key to reducing mortality and preventing outbreaks."
},
{
  "text": "A 25-day-old female infant presents with a 2-day history of **fever**, **lethargy**, and **poor feeding**. Her mother reports two brief episodes of **jerking movements** of the arms last night. She was born at term via vaginal delivery; the mother’s GBS screen was negative, but she received no intrapartum antibiotics. On exam, her temperature is 38.7 °C, heart rate 180 bpm, respiratory rate 50 /min, and SpO₂ 96% on room air. She is irritable, with a **bulging anterior fontanelle** and a weak suck. Otoscopic and throat exams are normal. A head ultrasound is unremarkable. Lumbar puncture yields **turbid CSF** with opening pressure 220 mmH₂O, WBC 2,800/µL (90% neutrophils), protein 180 mg/dL, glucose 30 mg/dL (serum 80 mg/dL), and Gram-positive cocci in chains that are **bacitracin-resistant**, **PYR-positive**, and **CAMP-test-positive**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Listeria monocytogenes meningitis" },
    { "label": "B", "text": "Group B Streptococcus (Streptococcus agalactiae) meningitis" },
    { "label": "C", "text": "Escherichia coli K1 meningitis" },
    { "label": "D", "text": "Enteroviral meningitis" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Group B Streptococcus (Streptococcus agalactiae) meningitis**\n\n**Why it’s correct:**  \nThis late‐onset neonatal meningitis (7–90 days) presents with **fever**, **bulging fontanelle**, **poor feeding**, and **seizure activity**. The CSF shows **neutrophilic pleocytosis**, **elevated protein**, **low glucose**, and **Gram-positive cocci in chains** that are **bacitracin-resistant**, **PYR-positive**, and **CAMP-test-positive**, confirming **GBS**.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Listeria monocytogenes meningitis** – Gram-positive rods on smear; also often associated with maternal ingestion of unpasteurized dairy and more pronounced systemic signs.  \n\n**C. Escherichia coli K1 meningitis** – Gram-negative rods on Gram stain; K1 capsule strains predominate in early‐onset disease.  \n\n**D. Enteroviral meningitis** – CSF shows **lymphocytic** pleocytosis, **normal glucose**, **mild protein elevation**, and **no bacteria** on Gram stain; presents with milder symptoms and no seizures in most cases.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Stabilize ABCs**, obtain **blood cultures**, assess hydration, and check for **signs of increased intracranial pressure** (bulging fontanelle).  \n2. **Empiric Antibiotics:** Administer **ampicillin** (for GBS and Listeria coverage) plus a **third-generation cephalosporin** (cefotaxime or ceftriaxone) immediately after cultures.  \n3. **Lumbar Puncture (Best Test):** CSF analysis for **cell count**, **protein**, **glucose**, **Gram stain**, and **culture**.  \n4. **CAMP Test & Biochemical Identification:** **CAMP positivity** distinguishes GBS from other streptococci.  \n5. **Additional Tests:** **PCR** for bacterial antigens if Gram stain is inconclusive or prior antibiotic use might reduce culture yield.\n\n---\n\n**Management:**  \n1. **Targeted Antibiotics:** Once GBS is confirmed, continue **IV penicillin G** or **ampicillin** for **14–21 days**.  \n2. **Avoidance of Empiric Cephalosporin Monotherapy:** Cephalosporins alone may not fully cover Listeria; ampicillin is needed.  \n3. **Adjunctive Dexamethasone:** Consider in older infants (>1 month) for **pneumococcal** meningitis, but not routinely in GBS.  \n4. **Supportive Care:** **Maintain hydration**, **correct electrolytes**, control fever, and manage seizures with **antiepileptic agents** as needed.  \n5. **Follow-Up:** Monitor for **hearing loss** and **neurodevelopmental sequelae** with audiology and developmental assessments.\n\n---\n\n**Why Each Symptom Occurs:**  \n1. **Fever:** **GBS cell wall components** trigger proinflammatory cytokines (IL-1, TNF-α).  \n2. **Bulging Fontanelle:** **Increased intracranial pressure** from meningeal inflammation and exudate.  \n3. **Poor Feeding & Irritability:** **Meningeal irritation** causes discomfort and decreased oral intake.  \n4. **Seizures:** **Inflammatory mediators** and increased pressure lower the seizure threshold.  \n5. **Neutrophilic Pleocytosis:** **Innate immune response** recruits neutrophils into the CSF to combat bacteria.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Vertical & Horizontal Transmission:** Late‐onset GBS often results from **nosocomial or maternal sources** postnatally, colonizing the infant’s mucosa.  \n2. **Capsular Polysaccharide:** The **type III capsule** inhibits phagocytosis and complement-mediated killing.  \n3. **Blood–Brain Barrier Crossing:** Bacterial surface proteins and toxins disrupt tight junctions, allowing CSF invasion.  \n4. **Cytokine Cascade:** Bacterial products activate microglia and astrocytes, releasing **inflammatory cytokines** that increase BBB permeability and edema.  \n5. **Neurotoxicity:** Neutrophil degranulation releases **proteases** and **reactive oxygen species**, damaging neural tissue and leading to potential long‐term deficits.\n\n---\n\n**Summary:**  \nGroup B Streptococcus meningitis in infants presents with **fever**, **bulging fontanelle**, and **seizures**. Diagnosis is via **CSF analysis** and **CAMP-positive**, bacitracin-resistant, Gram-positive cocci in chains. Management requires **ampicillin-based therapy**, supportive care, and close follow-up for sequelae."
},
{
  "text": "A 10-month-old boy is brought to the emergency department by his parents with a 2-day history of high fever (up to 39.5 °C), irritability, and poor feeding. They also report two episodes of non‐bilious vomiting and that he has been unusually sleepy. He is up to date on vaccines except for the pneumococcal conjugate series (missed last dose). On exam, his heart rate is 160 bpm, respiratory rate 38/min, and SpO₂ 98% on room air. He is fussy and difficult to console, with a **bulging anterior fontanelle** and a weak cry when moved. Otoscopic and oropharyngeal exams are unremarkable. A non‐contrast head CT is normal. A lumbar puncture yields **turbid CSF** with opening pressure 280 mmH₂O, WBC 2,200/µL (90% neutrophils), protein 220 mg/dL, glucose 25 mg/dL (serum 100 mg/dL), and Gram‐positive, **alpha‐hemolytic, optochin‐sensitive, lancet-shaped diplococci** on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Streptococcus pneumoniae meningitis" },
    { "label": "C", "text": "Enteroviral meningitis" },
    { "label": "D", "text": "Herpes simplex encephalitis" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Streptococcus pneumoniae meningitis**\n\n**Why it’s correct:**  \nThis infant’s presentation of **high fever**, **irritability**, **poor feeding**, and a **bulging fontanelle** are classic for pediatric meningitis. The CSF profile—**neutrophilic pleocytosis**, **elevated protein**, **low glucose**—confirms bacterial meningitis. **Alpha-hemolytic, optochin-sensitive, lancet-shaped diplococci** on Gram stain are pathognomonic for **Streptococcus pneumoniae**.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis meningitis** – Presents similarly but shows **Gram-negative kidney-bean diplococci**, often with a **petechial or purpuric rash** and a more fulminant course.  \n\n**C. Enteroviral meningitis** – CSF shows **lymphocytic pleocytosis**, **normal glucose**, and **mild protein elevation**, with **no bacteria** on Gram stain. Fever may be present, but the CSF profile rules out a viral etiology.  \n\n**D. Herpes simplex encephalitis** – Typically causes **altered mental status**, **seizures**, and **focal neurologic deficits**. CSF shows **lymphocytes**, **erythrocytes**, and **PCR-positive HSV DNA**, not neutrophils or bacteria.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Stabilize ABCs**, obtain **blood cultures**, and assess for **signs of increased intracranial pressure** (bulging fontanelle, altered mental status).  \n2. **Empiric Antibiotics:** Begin **IV vancomycin** plus a **third-generation cephalosporin** immediately after cultures.  \n3. **Lumbar Puncture (Best Test):** Analyze **CSF cell count**, **protein**, **glucose**, and perform **Gram stain and culture**.  \n4. **PCR Testing:** Use **CSF PCR** for **common pathogens** (pneumococcus, meningococcus, HSV) when Gram stain is negative or atypical.  \n5. **Neuroimaging:** **Head CT** before LP if there are **focal signs**, **papilledema**, or **seizures** to rule out mass lesion.\n\n---\n\n**Management:**  \n1. **Targeted Antibiotics:** Once sensitivities return, de-escalate to **high-dose IV penicillin** or **ceftriaxone** for **10–14 days** against *S. pneumoniae*.  \n2. **Adjunctive Dexamethasone:** Administer before or with the first antibiotic dose to reduce **risk of hearing loss** and **neurologic complications**.  \n3. **Supportive Care:** Maintain **fluid and electrolyte balance**, control fever, and monitor **neurologic status** in the ICU.  \n4. **Seizure Prophylaxis:** If seizures occur, treat with appropriate **anticonvulsants**.  \n5. **Prevention:** Recommend **pneumococcal vaccination** (PCV13) for close contacts and ensure the patient completes the vaccine series.\n\n---\n\n**Why Each Symptom Occurs in Pneumococcal Meningitis:**  \n1. **Fever:** Bacterial **cell wall components** (peptidoglycan, teichoic acids) induce **proinflammatory cytokines** (IL-1, TNF-α).  \n2. **Irritability & Poor Feeding:** **Meningeal inflammation** increases intracranial pressure, causing discomfort and lethargy.  \n3. **Bulging Fontanelle:** Elevation of **intracranial pressure** transmits force to the open fontanelle.  \n4. **Neutrophilic Pleocytosis:** **Innate immune response** recruits neutrophils into the CSF to phagocytose bacteria.  \n5. **Hypoglycorrhachia:** Bacteria and immune cells **consume glucose**, and inflammation impairs **glucose transport** across the blood–CSF barrier.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** *S. pneumoniae* adheres to epithelial cells via **pili** and **choline-binding proteins**, evading mucosal defenses.  \n2. **Bloodstream Invasion:** Encapsulated strains resist complement and phagocytosis, entering the bloodstream and seeding the meninges.  \n3. **Blood–Brain Barrier Crossing:** Bacterial **pneumolysin** and **hydrogen peroxide** disrupt tight junctions, allowing CSF invasion.  \n4. **CSF Inflammatory Cascade:** Bacterial components in CSF trigger **complement activation** and **neutrophil degranulation**, releasing proteases and ROS that damage brain tissue.  \n5. **Neurologic Injury:** Increased intracranial pressure and **vascular compromise** lead to **ischemia**, **edema**, and potential **long-term sequelae** such as hearing loss and cognitive deficits.\n\n---\n\n**Summary:**  \nStreptococcus pneumoniae meningitis in infants presents with **fever**, **bulging fontanelle**, and **meningeal signs**, with CSF showing **neutrophils**, **low glucose**, and **Gram-positive diplococci**. Early **empiric antibiotics**, **dexamethasone**, and supportive care are critical, and **vaccination** is key for prevention."
},
{
  "text": "A 5-year-old boy presents with a 2-day history of **low-grade fever**, **crampy periumbilical abdominal pain**, and **diarrhea** that began watery but progressed to **bloody stools**. He denies vomiting. Four days ago he ate an **undercooked pork sausage** at a county fair. On exam he is afebrile (38.2 °C), with mild tachycardia and a soft, mildly tender abdomen, especially in the right lower quadrant. No rebound or guarding is present. He has tender, non‐mobile mesenteric lymph nodes on palpation. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute appendicitis" },
    { "label": "B", "text": "Intussusception" },
    { "label": "C", "text": "Mesenteric adenitis" },
    { "label": "D", "text": "Yersinia enterocolitica infection" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Yersinia enterocolitica infection**\n\n**Why it’s correct:**  \nYersinia enterocolitica often follows ingestion of **undercooked pork** and presents with **fever**, **bloody diarrhea**, and **RLQ pain** from **mesenteric lymphadenitis**, which mimics appendicitis but lacks peritoneal signs. Tender mesenteric nodes and a benign abdominal exam point to Yersinia rather than surgical causes.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Acute appendicitis** – Presents with **steady**, **sharp RLQ pain**, anorexia, and often **fever**, with **peritoneal signs** (rebound tenderness, guarding). Diarrhea is uncommon and mesenteric nodes are not tender.  \n\n**B. Intussusception** – Characterized by **paroxysms of severe colicky pain**, **leg‐drawing**, and **“currant‐jelly” stools**, with a palpable **sausage‐shaped mass**; this child’s pain is constant and milder.  \n\n**C. Mesenteric adenitis** – Causes RLQ pain and fever but typically follows an **upper respiratory infection**, with **non‐bloody diarrhea** and no clear food exposure. While nodes are tender, the presence of bloody stools favors Yersinia.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** (food exposures, timing) and **focused exam** of abdomen and lymph nodes.  \n2. **Laboratory Tests:** **CBC**, **CRP/ESR** to assess inflammation; stool guaiac to confirm bleeding.  \n3. **Stool Culture (Best Test):** Culture on **CIN agar** at 25 °C to isolate **Y. enterocolitica**; confirm with **biochemical testing** or **PCR**.  \n4. **Ultrasound:** May show **mesenteric lymphadenopathy** and exclude appendicitis by visualizing a normal appendix.  \n5. **Additional Tests:** **CT scan** only if diagnosis remains uncertain or to assess complications.\n\n---\n\n**Management:**  \n1. **Supportive Care:** **Hydration** with oral rehydration solution; correct electrolytes.  \n2. **Antibiotic Therapy:** For **severe** cases or immunocompromised patients, use **trimethoprim–sulfamethoxazole** or **doxycycline** for 7–10 days.  \n3. **Avoid Unnecessary Surgery:** Confirm diagnosis before considering appendectomy.  \n4. **Pain Control:** **Acetaminophen** for discomfort; **avoid NSAIDs** if dehydration is present.  \n5. **Follow-Up:** Monitor for **prolonged fever**, **arthralgias**, or **erythema nodosum**, which may occur as immune sequelae.\n\n---\n\n**Why Each Symptom Occurs in Yersinia Infection:**  \n1. **Low-Grade Fever:** Bacterial invasion of **mesenteric lymph nodes** triggers cytokine release (IL-1, TNF-α).  \n2. **Crampy Abdominal Pain:** **Inflammation** and **enlargement** of mesenteric lymph nodes cause visceral pain, especially in the RLQ.  \n3. **Bloody Diarrhea:** **Mucosal invasion** and **ulceration** of the ileum and colon lead to bleeding.  \n4. **Mesenteric Lymphadenitis:** Bacteria replicate in **Peyer’s patches**, causing node tenderness and edema.  \n5. **Absence of Guarding:** Inflammation is **lymphoid**, not peritoneal, sparing the peritoneal lining from irritative signs.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Ingestion & Survival:** Yersinia survives **gastric acid** and enters the **terminal ileum**, binding M cells in Peyer’s patches.  \n2. **Invasion of M Cells:** The bacteria trigger **phagocytosis** by M cells, escaping into the lamina propria.  \n3. **Replication in Lymph Nodes:** Yersinia multiplies within **macrophages** in mesenteric lymph nodes, causing lymphadenitis.  \n4. **Enterotoxin Production:** Some strains produce **Yst toxin**, which stimulates **cyclic GMP**, leading to fluid secretion and diarrhea.  \n5. **Immune Response:** Neutrophils and macrophages release **inflammatory mediators**, causing local tissue damage and mucosal bleeding.\n\n---\n\n**Summary:**  \nYersinia enterocolitica infection in children can mimic appendicitis with **RLQ pain**, **fever**, and **bloody diarrhea** after **undercooked pork** exposure. Diagnosis rests on **stool culture** (CIN agar) or **PCR**, and management is primarily **supportive** with antibiotics reserved for severe cases."
},
{
  "text": "An 18-month-old girl is brought to the emergency department with a 24-hour history of **sudden-onset profuse non-bloody vomiting** followed by **watery diarrhea** (8–10 stools/day). She has no fever. Her mother reports a recent outbreak of “stomach flu” at her daycare 2 days ago. Over the past 12 hours, she has had **few wet diapers**, a **sunken fontanelle**, and **dry mucous membranes**. On exam: T 37.0 °C, HR 140 bpm, RR 28/min, BP 80/40 mmHg, capillary refill 4 s. Abdominal exam is benign. A stool sample is negative for rotavirus antigen and bacterial culture, but **RT-PCR is positive for norovirus**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Rotavirus gastroenteritis" },
    { "label": "B", "text": "Staphylococcal food poisoning" },
    { "label": "C", "text": "Norovirus gastroenteritis" },
    { "label": "D", "text": "Enterotoxigenic E. coli infection" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Norovirus gastroenteritis**\n\n**Why it’s correct:**  \nNorovirus typically causes a **sudden onset of profuse vomiting** with subsequent **watery, non-bloody diarrhea**, often in **daycare outbreaks**, without high fever. The lack of blood in stool, negative rotavirus antigen, and positive norovirus RT-PCR confirm the diagnosis.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Rotavirus gastroenteritis** – Usually presents in **unvaccinated** infants with **fever**, **more prominent diarrhea**, and positive rotavirus antigen. Vomiting and diarrhea last longer (5–7 days).\n\n**B. Staphylococcal food poisoning** – Causes **vomiting only** (due to preformed toxin) within 1–6 hours of ingestion; diarrhea is minimal or absent and there is no daycare outbreak pattern.\n\n**D. Enterotoxigenic E. coli infection** – Leads to **traveler’s diarrhea** with watery stools, but rarely causes vomiting or rapid dehydration in toddlers, and is associated with travel or contaminated water rather than daycare outbreaks.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Assess degree of **dehydration** (fontanelle, mucous membranes, cap refill) and vital signs.  \n2. **Laboratory Tests:** Check **serum electrolytes**, **BUN/Cr**, and **venous blood gas** for acidosis.  \n3. **Stool Studies (Best Test):** **RT-PCR for norovirus** from stool confirms viral gastroenteritis.  \n4. **Exclusion Tests:** Negative **rotavirus antigen** and bacterial stool cultures help rule out other pathogens.  \n5. **Osmotic Gap Calculation:** If needed, to differentiate **secretory** versus **osmotic** diarrhea.\n\n---\n\n**Management:**  \n1. **Oral Rehydration Therapy (ORT):** Use **WHO-recommended ORS**, giving small, frequent sips to correct fluid and electrolyte losses.  \n2. **IV Fluids:** For **severe dehydration** or if ORT fails, administer **isotonic saline** boluses (20 mL/kg) and correct electrolytes.  \n3. **Zinc Supplementation:** 10 mg daily for infants to reduce the duration and severity of diarrhea.  \n4. **Nutrition:** Continue **age-appropriate feeding**; avoid prolonged fasting.  \n5. **Infection Control:** Enforce **hand hygiene** and isolate symptomatic children to prevent spread.\n\n---\n\n**Why Each Symptom Occurs in Norovirus Gastroenteritis:**  \n1. **Profuse Vomiting:** Viral infection of the **small intestinal enterocytes** triggers an emetogenic response.  \n2. **Watery Diarrhea:** Loss of absorptive surface with **malabsorption** and **secretory fluid loss** from infected enterocytes.  \n3. **Dehydration Signs:** **Osmotic and secretory diarrhea** exceed fluid intake, leading to hypovolemia.  \n4. **Absence of Fever:** Norovirus elicits a milder systemic inflammatory response compared to rotavirus.  \n5. **Rapid Onset:** Norovirus’s **low infectious dose** and high viral shedding produce explosive outbreaks.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Attachment to Enterocytes:** Norovirus binds **histo-blood group antigens** on enterocytes, leading to cell death.  \n2. **Villous Blunting:** Infection causes **villus atrophy**, reducing absorptive capacity.  \n3. **Chloride Secretion:** Activation of intracellular signaling leads to **chloride and water secretion**, contributing to diarrhea.  \n4. **Immune Evasion:** Rapid antigenic variation allows evasion of immune memory, facilitating outbreaks.  \n5. **Mucosal Inflammation:** Mild inflammatory mediator release increases **intestinal permeability** and fluid loss.\n\n---\n\n**Summary:**  \nNorovirus gastroenteritis presents in toddlers with **sudden vomiting**, **watery diarrhea**, and **dehydration** during daycare outbreaks. Diagnosis is confirmed by **stool RT-PCR**, and management focuses on **oral or IV rehydration**, **zinc supplementation**, and infection control."
},
{
  "text": "An 8-month-old boy, unvaccinated against rotavirus, presents in mid-winter with a 3-day history of **profuse watery diarrhea** (10 episodes/day) and **non-bilious vomiting**. He has had a low-grade fever (38.0 °C) but no blood or mucus in the stool. Over the past 24 hours he has become listless with **poor urine output** and **dry diapers**. On exam: weight loss of 8% from baseline, **sunken anterior fontanelle**, dry mucous membranes, capillary refill 4 seconds, tachycardia 160 bpm, respiratory rate 40/min, and blood pressure 70/40 mmHg. Abdomen is soft without masses. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Rotavirus gastroenteritis" },
    { "label": "B", "text": "Salmonella enteritis" },
    { "label": "C", "text": "Giardia lamblia infection" },
    { "label": "D", "text": "Cow’s milk protein allergy" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Rotavirus gastroenteritis**\n\n**Why it’s correct:**  \nThis infant’s **profuse, watery** non-bloody diarrhea in the winter months, **vomiting**, and rapid onset of **dehydration** in an unvaccinated child are classic for **rotavirus**, especially given recent daycare exposures. Rotavirus commonly causes **villous atrophy** in the small intestine leading to secretory diarrhea and significant fluid loss.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Salmonella enteritis** – Typically presents with **higher fevers**, **abdominal pain**, and often **bloody** or **mucoid** stools. Dehydration can occur but the stool character and systemic signs differ.  \n\n**C. Giardia lamblia infection** – Causes **chronic**, **foul-smelling**, **greasy (steatorrheic)** diarrhea rather than acute, high-volume watery stools, and often occurs in older children.  \n\n**D. Cow’s milk protein allergy** – Presents with **chronic** loose stools, sometimes with **blood** or mucus, and often **eczema** or atopic history; not with acute profuse dehydration in an 8-month-old.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Clinical assessment of **dehydration severity** (weight change, fontanelle, mucous membranes, capillary refill).  \n2. **Laboratory Tests:** **Serum electrolytes**, **BUN/Cr**, **venous blood gas** to assess metabolic acidosis.  \n3. **Stool Studies (Best Test):** **Rotavirus antigen** by ELISA or rapid immunochromatographic assay confirms diagnosis.  \n4. **Stool Culture:** Reserved for suspected bacterial pathogens if **blood** or **pus** present.  \n5. **Osmotic Gap:** If in doubt, calculate stool osmotic gap to distinguish **secretory** from **osmotic** diarrhea.\n\n---\n\n**Management:**  \n1. **Oral Rehydration Therapy (ORT):** Use WHO-recommended **oral rehydration solution**; small, frequent sips to correct fluid and electrolyte losses.  \n2. **IV Fluids:** For **severe dehydration** or if ORT fails, administer **isotonic saline** boluses (20 mL/kg) and correct electrolyte imbalances.  \n3. **Zinc Supplementation:** 10–20 mg daily for 10–14 days to reduce duration and severity.  \n4. **Nutrition:** Continue **age-appropriate feeding**; avoid prolonged fasting or lactose-heavy formulas.  \n5. **Prevention:** **Rotavirus vaccination** (two- or three-dose series) in infancy to prevent severe disease.\n\n---\n\n**Why Each Symptom Occurs:**  \n1. **Watery Diarrhea:** **NSP4 toxin** of rotavirus induces **chloride secretion** and inhibits absorption in enterocytes.  \n2. **Vomiting:** **Upper gut involvement** and enteric nervous system stimulation cause emesis.  \n3. **Dehydration Signs:** **Transmembrane fluid loss** exceeds intake, leading to sunken fontanelle and poor perfusion.  \n4. **Metabolic Acidosis:** Loss of bicarbonate-rich fluids in stool results in **hyperchloremic metabolic acidosis**.  \n5. **Poor Urine Output:** **Hypovolemia** reduces renal perfusion and urine formation.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Viral Entry:** Rotavirus infects **mature enterocytes** on villous tips, causing **cell lysis** and villous blunting.  \n2. **NSP4 Enterotoxin:** Stimulates **intracellular calcium**, triggering **chloride secretions** and disrupting tight junctions.  \n3. **Malabsorption:** Loss of **brush-border enzymes** leads to **osmotic diarrhea** from unabsorbed disaccharides.  \n4. **Inflammatory Response:** Local **cytokine release** increases intestinal permeability and motility.  \n5. **Immune Memory:** Secretory **IgA** in the gut eventually limits infection, but infants have immature mucosal immunity, leading to severe disease without vaccination.\n\n---\n\n**Summary:**  \nRotavirus gastroenteritis in infants presents with **acute, profuse watery diarrhea**, **vomiting**, and rapid **dehydration**. Diagnosis is by **stool antigen assay**, and management focuses on **rehydration**, **zinc supplementation**, and continuation of feeding. **Vaccination** is the key preventive measure against severe rotavirus disease."
},
{
  "text": "A 3-day-old male infant is noted to be progressively **cyanotic** and **tachypneic** despite supplemental oxygen. He was born at term via uncomplicated delivery, with birth weight 3.2 kg. On exam his heart rate is 165 bpm, respiratory rate 70/min, and SpO₂ 75% on 100% O₂. He has **single S₂**, no murmurs, and a faint systolic ejection click. He is active but feeds poorly and sweats with exertion. A hyperoxia test shows minimal rise in PaO₂. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Tetralogy of Fallot" },
    { "label": "B", "text": "Transposition of the Great Vessels" },
    { "label": "C", "text": "Total Anomalous Pulmonary Venous Return" },
    { "label": "D", "text": "Truncus Arteriosus" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Transposition of the Great Vessels**\n\n**Why it’s correct:**  \nTransposition of the great vessels (TGA) presents in the **first days of life** with **severe cyanosis** refractory to oxygen, **tachypnea**, and a **single S₂** (due to anterior aortic placement). The **hyperoxia test** shows minimal improvement in PaO₂ because pulmonary and systemic circulations are in parallel rather than in series, preventing adequate oxygenation without mixing.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Tetralogy of Fallot** – Causes **cyanotic spells** but typically has a harsh **systolic ejection murmur**, “boot-shaped” heart on x-ray, and oxygen saturations improve somewhat with crying or squatting; TGA has minimal oxygen response and no murmur.\n\n**C. Total Anomalous Pulmonary Venous Return (TAPVR)** – Presents with cyanosis and respiratory distress, but usually with **pulmonary edema** and a **diastolic** rumble from increased flow; a “snowman” sign on x-ray differentiates it.\n\n**D. Truncus Arteriosus** – Causes cyanosis with a **single S₂** but also a **loud systolic murmur** from truncal valve regurgitation or VSD flow; pulmonary overcirculation leads to heart failure rather than isolated cyanosis.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize airway and breathing; administer **prostaglandin E₁** to keep the ductus arteriosus open for mixing.  \n2. **Hyperoxia Test:** Distinguishes intracardiac from pulmonary shunts; in TGA, PaO₂ rises minimally.  \n3. **Chest X-ray:** May show **egg-on-a-string** cardiac silhouette in TGA.  \n4. **Echocardiogram (Best Test):** Definitively visualizes **aorta arising from RV** and **pulmonary artery from LV**, confirms diagnosis and any associated lesions (ASD/VSD).  \n5. **Electrocardiogram:** Often normal but can help rule out other etiologies.\n\n---\n\n**Management:**  \n1. **Prostaglandin E₁ Infusion:** Maintains **ductal patency** to allow pulmonary–systemic mixing and improve oxygenation.  \n2. **Balloon Atrial Septostomy (Rashkind Procedure):** Creates/enlarges an **ASD** for intracardiac mixing.  \n3. **Arterial Switch Operation (Jatene Procedure):** Performed in the first 1–2 weeks of life to restore **normal ventricular–arterial connections**.  \n4. **Preoperative Care:** Supportive with **inotropes**, **afterload management**, and careful fluid balance.  \n5. **Long-Term Follow-Up:** Monitor for **coronary artery complications**, arrhythmias, and ventricular function.\n\n---\n\n**Why Each Symptom Occurs in TGA:**  \n1. **Cyanosis:** Parallel circulation prevents oxygenated blood from reaching systemic circulation without mixing.  \n2. **Tachypnea:** Compensatory response to systemic hypoxemia.  \n3. **Single S₂:** Anterior aorta overshadows the pulmonary component; only one semilunar valve sound is prominent.  \n4. **Poor Feeding & Sweating:** Inadequate systemic output and hypoxia increase work of feeding and sympathetic drive.  \n5. **Minimal Hyperoxia Response:** Lack of intracardiac mixing means increased FiO₂ fails to raise arterial oxygen.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Parallel Circulation:** Malposition of the aorta and pulmonary artery results in two separate circuits: systemic venous return recirculates to body, and pulmonary venous return recirculates to lungs.  \n2. **Dependence on Shunts:** **Ductus arteriosus** and **foramen ovale** are critical for mixing; closure leads to profound hypoxemia.  \n3. **Left Ventricular Pressure:** LV supports pulmonary circulation initially; after switch surgery, LV must sustain systemic pressure.  \n4. **Coronary Artery Translocation:** In arterial switch, coronary arteries must be reimplanted onto the neoaorta, with risk of ischemia if compromised.  \n5. **Acidosis & Hypoxia:** Poor systemic oxygen delivery leads to anaerobic metabolism and metabolic acidosis, further depressing myocardial function.\n\n---\n\n**Summary:**  \nTransposition of the great vessels in neonates causes **early, severe cyanosis**, **single S₂**, and minimal response to oxygen. Prompt diagnosis with **echocardiography**, **prostaglandin E₁ infusion**, **balloon atrial septostomy**, and timely **arterial switch surgery** are essential for survival and long-term outcomes."
},
{
  "text": "A 2-year-old boy presents in late winter with a 48-hour history of **hoarse, barky cough**, **low-grade fever**, and **progressive inspiratory stridor**. His mother reports the cough worsens at night and he has become increasingly fussy during feeds. On exam, he is tachypneic (respiratory rate 48/min) with **subcostal and intercostal retractions**, mild hypoxia (SpO₂ 91% on room air), and a **harsh inspiratory sound** but no drooling or toxic appearance. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute epiglottitis" },
    { "label": "B", "text": "Foreign body aspiration" },
    { "label": "C", "text": "Bacterial tracheitis" },
    { "label": "D", "text": "Viral croup (Laryngotracheobronchitis)" }
  ],
  "correct": "D",
  "explanation": "**Correct Answer: D. Viral croup (Laryngotracheobronchitis)**\n\n**Why it’s correct:**  \nThis toddler’s **barky cough**, **inspiratory stridor**, **low-grade fever**, and **night-time worsening** are classic for viral croup caused by parainfluenza viruses. The lack of drooling, toxic appearance, and focal findings supports a subglottic viral process rather than a bacterial or obstructive cause.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Acute epiglottitis** – Presents with **high fever**, **drooling**, **tripod posture**, and a toxic appearance; drooling and severe distress are absent here.  \n\n**B. Foreign body aspiration** – Onset is **sudden**, often with a choking event, asymmetric breath sounds, and no preceding prodrome of cough or low-grade fever.  \n\n**C. Bacterial tracheitis** – Children are more toxic, with **high fever**, **purulent secretions**, and do not respond to nebulized epinephrine; our patient has a viral prodrome and mild systemic signs.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Assess **airway, breathing, circulation**, administer **humidified oxygen**, and score severity (e.g., Westley score).  \n2. **Clinical Diagnosis:** Primarily based on **history** and **physical exam**; imaging is not routinely needed.  \n3. **Best Test:** In atypical or severe cases, **AP neck radiograph** showing the **steeple sign** (subglottic narrowing) confirms the diagnosis.  \n4. **Additional Tests:** **Pulse oximetry** and, if severe, a **capillary blood gas** to assess for CO₂ retention.  \n5. **Avoid:** Do not perform invasive airway exams (laryngoscopy) without preparation for intubation.\n\n---\n\n**Management:**  \n1. **Corticosteroids:** Single dose of **dexamethasone** (0.15–0.6 mg/kg) reduces mucosal edema.  \n2. **Nebulized Epinephrine:** **Racemic or L-epinephrine** provides rapid but temporary relief by vasoconstricting subglottic mucosa.  \n3. **Supportive Care:** **Hydration**, **humidiﬁed air**, and a **calm environment** to reduce distress.  \n4. **Monitoring:** Observe for **rebound stridor** after epinephrine; admit if moderate-to-severe or if hypoxia persists.  \n5. **Intubation:** Reserve for **impending respiratory failure** despite therapy.\n\n---\n\n**Why Each Symptom Occurs in Croup:**  \n1. **Barky Cough:** **Subglottic inflammation** creates turbulent airflow through a narrowed airway.  \n2. **Inspiratory Stridor:** Air passing through the **edematous subglottic space** produces a high-pitched sound.  \n3. **Night-Time Worsening:** Circadian dips in **endogenous corticosteroids** and elevated histamine exacerbate edema overnight.  \n4. **Low-Grade Fever:** Viral replication induces a mild inflammatory response.  \n5. **Retractions:** Increased effort against airway narrowing causes **intercostal and subcostal muscle use**.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Parainfluenza Virus Infection:** The virus infects **laryngeal epithelial cells**, leading to edema.  \n2. **Subglottic Narrowing:** The pediatric airway is narrowest at the **cricoid ring**; edema here greatly increases resistance (Poiseuille’s law).  \n3. **Mucus Hypersecretion:** **Goblet cell activation** adds secretions to the inflamed airway.  \n4. **Inflammatory Mediators:** **Cytokines** (IL-1, TNF-α) increase vascular permeability and cell infiltration.  \n5. **Self-Limited Course:** Inflammation peaks by day 3–5 and resolves as adaptive immunity clears the virus."
},
{
  "text": "An 18-month-old boy, who received a single dose of MMR at 12 months, presents in late winter with a 5-day history of high fever (up to 40 °C), **cough**, **coryza**, and **conjunctivitis**. On day 3 of illness he developed tiny **white spots** on his buccal mucosa. On day 5 he developed a **ﬁne erythematous maculopapular rash** that began on his face and behind his ears, then spread downward to his trunk and extremities, becoming confluent on the face. He now has a temperature of 39.5 °C, bilateral non-purulent conjunctival injection, and a **blanching rash** as described. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Roseola Infantum (HHV-6)" },
    { "label": "B", "text": "Rubella" },
    { "label": "C", "text": "Measles (Rubeola)" },
    { "label": "D", "text": "Scarlet Fever" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Measles (Rubeola)**\n\n**Why it’s correct:**  \nThis child’s classic “**three C’s**”—**cough**, **coryza**, and **conjunctivitis**—followed by **Koplik spots** on the buccal mucosa and a **cephalocaudal maculopapular rash** that becomes confluent on the face are pathognomonic for measles. The timeline (prodrome of respiratory symptoms, Koplik spots on day 3, rash on day 5) and the rash distribution (starting at the hairline) are textbook for rubeola.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Roseola Infantum (HHV-6)** – Presents with **high fever** lasting 3–5 days followed by a **sudden rash** as the fever subsides. There is no cough, coryza, conjunctivitis, or Koplik spots, and the rash is **rose-pink maculopapular** on the trunk, not starting on the face.\n\n**B. Rubella** – Causes a **milder, pink maculopapular rash** that spreads rapidly from face to trunk, often with **posterior auricular lymphadenopathy** and **Forchheimer spots**, but lacks a prodromal “three C’s” and Koplik spots, and the rash is not confluent on the face.\n\n**D. Scarlet Fever** – Features a **sandpaper rash**, **Pastia’s lines**, and a **strawberry tongue** after streptococcal pharyngitis, with high fever and a **scarlatiniform** texture. Respiratory prodrome and Koplik spots are absent.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Clinical diagnosis based on the **prodrome**, **Koplik spots**, and **rash pattern**. Obtain detailed **vaccination history** and **exposure risks**.  \n2. **Best Test:** **Measles-specific IgM serology** or **RT-PCR** from throat swab/urine collected within 3 days of rash onset for confirmation.  \n3. **Additional Tests:** **CBC** may show lymphopenia; **LFTs** can be mildly elevated.  \n4. **Isolation:** Confirmed or suspected cases require **airborne isolation** to prevent nosocomial spread.  \n5. **Contact Tracing:** Identify and provide **post-exposure prophylaxis** (MMR vaccine within 72 h or immunoglobulin within 6 days) to susceptible contacts.\n\n---\n\n**Management:**  \n1. **Supportive Care:** Encourage **hydration**, **antipyretics** (acetaminophen or ibuprofen), and **humidified air** for cough.  \n2. **Vitamin A Supplementation:** **20 000 IU** orally once daily for 2 days (per WHO guidelines) to reduce morbidity and mortality.  \n3. **Monitor for Complications:** Watch for **otitis media**, **pneumonia**, and **encephalitis**; obtain a chest x-ray if respiratory distress develops.  \n4. **Antibiotics:** Reserve for **secondary bacterial infections**, not for measles itself.  \n5. **Public Health Measures:** Report to **public health authorities** and ensure **airborne precautions** in healthcare settings.\n\n---\n\n**Why Each Symptom Occurs in Measles:**  \n1. **Coryza & Cough:** Viral replication in the **respiratory epithelium** and mucosal inflammation trigger sneezing and cough.  \n2. **Conjunctivitis:** Infection of **conjunctival epithelial cells** leads to vascular congestion and injection.  \n3. **Koplik Spots:** Localized **viral cytopathic effect** and immune response produce tiny white lesions on the buccal mucosa.  \n4. **High Fever:** **Cytokine release** (IL-1, TNF-α) from infected cells raises the hypothalamic set point.  \n5. **Maculopapular Rash:** **T-cell–mediated immune response** against infected endothelial cells in the dermis leads to erythematous, maculopapular eruption.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Paramyxovirus Entry:** Measles virus binds to **CD150 (SLAM)** on dendritic cells and activated lymphocytes, facilitating dissemination.  \n2. **Viremia:** The virus spreads systemically via infected immune cells to the **skin**, **respiratory tract**, and **other organs**.  \n3. **Immune Suppression:** Transient **lymphopenia** and impaired T-cell function predispose to **secondary infections**.  \n4. **Endothelial Infection:** Infection of **dermal capillary endothelial cells** and subsequent immune attack produce the classic rash.  \n5. **Plaque Formation:** Koplik spots represent **localized foci of necrosis** and exudate in the buccal mucosa before the rash appears.\n\n---\n\n**Summary:**  \nMeasles in children presents with a distinctive prodrome of **cough, coryza, conjunctivitis**, followed by **Koplik spots** and a **cephalocaudal maculopapular rash**. Diagnosis is clinical, confirmed by **IgM serology** or **PCR**. Management is **supportive** with **vitamin A**, and strict **isolation** and **public health measures** are essential to prevent outbreaks."
},
{
  "text": "A 14-month-old boy is brought to the emergency department with a 2-day history of **intermittent, severe, crampy periumbilical abdominal pain**. His mother reports that he suddenly cries and draws his knees to his chest every 30–60 minutes, then appears lethargic between episodes. He has had several episodes of **non-bilious vomiting** and passed two **“currant-jelly” stools** in the past day. On exam during an episode, he is tachycardic and cries out in pain; between episodes his abdomen is soft, and you palpate a **sausage-shaped mass** in the right upper quadrant. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Midgut volvulus due to malrotation" },
    { "label": "B", "text": "Pyloric stenosis" },
    { "label": "C", "text": "Intussusception" },
    { "label": "D", "text": "Henoch–Schönlein Purpura" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Intussusception**  \n\n**Why it’s correct:**  \nIntussusception classically presents in infants and toddlers with **colicky, intermittent abdominal pain**, **drawing up of the legs**, **vomiting**, and **currant-jelly stools** from mucosal sloughing. The presence of a **sausage-shaped abdominal mass** in the right upper quadrant during asymptomatic periods is highly specific.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Midgut volvulus due to malrotation** – Presents with **bilious vomiting**, acute abdominal distension, and peritonitis rather than intermittent colicky pain with lethargic intervals and currant-jelly stools.\n\n**B. Pyloric stenosis** – Occurs at **3–6 weeks** of age with **projectile non-bilious vomiting**, visible peristalsis, and an “olive” mass; not with colicky pain or bloody stools in a 14-month-old.\n\n**D. Henoch–Schönlein Purpura** – Manifests with **palpable purpura**, **arthralgias**, and **abdominal pain**, but the pain is constant rather than colicky, and stools are not typically bloody-mucoid in large volume; a rash would be present.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Obtain a **focused history** (onset, character of pain, stool description) and perform a **physical exam** for palpable mass and signs of dehydration.  \n- **Imaging (Best Test):** **Ultrasound** of the abdomen demonstrating the **target (doughnut) sign** or **pseudokidney sign** confirms intussusception.  \n- **Adjunct:** **Abdominal X-ray** may show **air-fluid levels** or **absence of gas** in the right lower quadrant but is less sensitive.  \n- **Contrast Enema:** **Air-contrast** or **hydrostatic (saline) enema** under fluoroscopy or ultrasound is both **diagnostic and therapeutic**.  \n- **Laboratory Tests:** **CBC** and **electrolytes** to assess for dehydration and inflammation; not required for diagnosis but guide resuscitation.\n\n---\n\n**Management:**  \n1. **Resuscitation:** Begin **IV fluids** and correct electrolyte imbalances.  \n2. **Nonoperative Reduction:** Perform a **fluoroscopic air-contrast enema** or **ultrasound-guided saline enema** to reduce the intussusception in stable patients.  \n3. **Surgical Intervention:** Indicated if **nonoperative reduction fails**, if there is **peritonitis**, or if a **pathologic lead point** is suspected (e.g., Meckel diverticulum).  \n4. **Post-Reduction Care:** Monitor for **recurrence** (up to 10%) with serial abdominal exams and observation for 24 hours.  \n5. **Recurrence Prevention:** Evaluate for possible **lead points** (ultrasound, Meckel’s scan) in recurrent cases.\n\n---\n\n**Why Each Symptom Occurs in Intussusception:**  \n1. **Colicky Pain:** **Peristaltic waves** against an invaginated segment cause intermittent, severe cramping.  \n2. **Drawing Up Legs:** **Visceral pain relief posture** as the child attempts to reduce bowel stretching.  \n3. **Vomiting:** **Proximal obstruction** leads to accumulation and retrograde flow of gastric contents.  \n4. **Currant-Jelly Stool:** **Mucosal ischemia and sloughing** mixed with blood and mucus from the trapped segment.  \n5. **Sausage-Shaped Mass:** The **telescoped bowel segment** forms a palpable, elongated mass in the abdomen.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Telescoping of Bowel:** A proximal segment (intussusceptum) invaginates into the distal segment (intussuscipiens), dragging mesentery and vessels.  \n2. **Venous and Lymphatic Obstruction:** Invagination compresses venous outflow, leading to **edema**, **hemorrhage**, and **mucus accumulation**.  \n3. **Arterial Compromise:** Prolonged vascular compression causes **ischemia** and risk of **necrosis** and perforation.  \n4. **Lead Point Initiation:** In older children, a **pathologic lead point** (e.g., Meckel diverticulum, polyp) triggers abnormal peristalsis and intussusception.  \n5. **Inflammatory Response:** **Ischemia and tissue injury** elicit inflammatory mediators that worsen edema and promote further telescoping."
},
{
  "text": "A 12-year-old girl presents with a 6-month history of **recurrent, exercise-induced syncope**. Episodes occur during swimming lessons or gymnastics practice, last about 1–2 minutes, and she regains consciousness spontaneously without confusion. There is no incontinence or tonic-clonic activity. Her maternal uncle died suddenly at age 20 while jogging. On exam she is euvolemic, heart rate 58 bpm at rest, and blood pressure 110/70 mmHg. A resting ECG shows a **corrected QT interval (QTc) of 520 ms** with normal QRS morphology. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Congenital long QT syndrome" },
    { "label": "B", "text": "Vasovagal syncope" },
    { "label": "C", "text": "Hypertrophic cardiomyopathy" },
    { "label": "D", "text": "Juvenile absence epilepsy" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Congenital long QT syndrome**\n\n**Why it’s correct:**  \nThis patient has **exercise-triggered syncope**, a **prolonged QTc (>500 ms)** on ECG, and a **family history** of sudden death—classic for congenital long QT syndrome, which predisposes to **torsades de pointes** and transient loss of consciousness under sympathetic stimulation.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Vasovagal syncope** – Typically provoked by **emotional stress**, prolonged standing, or pain, with prodromal symptoms (nausea, pallor) and gradual recovery; resting ECG is normal.  \n\n**C. Hypertrophic cardiomyopathy** – May cause exertional syncope, but exam often reveals a **harsh systolic murmur** and ECG shows **LVH** or deep Q waves; QT interval is normal.  \n\n**D. Juvenile absence epilepsy** – Characterized by **brief staring spells** with 3 Hz spike-and-wave discharges on EEG, not true syncope, and no QT prolongation on ECG.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Obtain a **detailed history** (triggering factors, duration, recovery) and perform a **resting ECG** to measure the QTc.  \n2. **Best Test:** **Exercise stress test** to observe QT dynamics and provoke arrhythmias (QT fails to shorten with exercise or paradoxically prolongs).  \n3. **Holter Monitoring:** To detect **intermittent torsades** or other arrhythmias in daily life.  \n4. **Genetic Testing:** Screen for **KCNQ1, KCNH2, SCN5A** mutations to confirm subtype and guide family screening.  \n5. **Echocardiogram:** Rule out structural heart disease (e.g., HCM) if clinical suspicion remains.\n\n---\n\n**Management:**  \n1. **Beta-Blockers:** **Nadolol** or **propranolol** to blunt sympathetic triggers and reduce arrhythmia risk.  \n2. **Activity Restriction:** Avoid **competitive sports** and triggers like swimming alone.  \n3. **Left Cardiac Sympathetic Denervation:** Consider in refractory cases or those intolerant of β-blockers.  \n4. **Implantable Cardioverter-Defibrillator (ICD):** For patients with **syncope despite β-blockers** or documented ventricular arrhythmias.  \n5. **Family Screening:** ECG and genetic testing for first-degree relatives.\n\n---\n\n**Why Each Symptom Occurs:**  \n1. **Exercise-Induced Syncope:** **Adrenergic surge** triggers early afterdepolarizations in prolonged repolarization, leading to torsades and transient loss of output.  \n2. **Prolonged QTc:** Delayed ventricular repolarization due to **ion channel mutations** increases risk of afterdepolarizations.  \n3. **Normal QRS/QT Morphology:** QRS widening is not seen; problem lies in **delayed phase 3 repolarization**.  \n4. **Family History:** Congenital LQTS is **autosomal dominant**, so sudden death in a close relative is common.  \n5. **Absence of Postictal Confusion:** Pure cardiac syncope lacks neuronal recovery phase seen in epilepsy.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Ion Channel Mutations:** Mutations in **KCNQ1 (LQT1)**, **KCNH2 (LQT2)**, or **SCN5A (LQT3)** impair **IKs/IKr or INa currents**, prolonging action potential.  \n2. **Early Afterdepolarizations:** Prolonged action potentials allow **re-entry of Ca²⁺ or Na⁺**, triggering premature ventricular complexes.  \n3. **Torsades de Pointes:** Polymorphic ventricular tachycardia due to **reentrant circuits** in areas of heterogenous repolarization.  \n4. **Adrenergic Sensitivity:** Sympathetic stimulation **enhances trigger activity**, especially in LQT1 during exercise.  \n5. **Heterogeneous Repolarization:** Regional differences in **transmural action potentials** create a substrate for re-entry arrhythmias."
},
{
  "text": "A 6-month-old male presents in midwinter with a 3-day history of **nasal congestion**, **low-grade fever**, and a progressively worsening **cough**. His mother notes episodes of **tachypnea** and poor feeding. On exam, he is tachypneic with **nasal flaring**, **intercostal retractions**, and oxygen saturation of 91% on room air. Auscultation reveals **diffuse fine crackles** and **wheezes**, without focal consolidation. He has no history of choking, atopy, or prior wheezing. A chest x-ray shows **hyperinflation** and **peribronchial thickening** but no lobar consolidation. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute bronchiolitis" },
    { "label": "B", "text": "Acute asthma exacerbation" },
    { "label": "C", "text": "Bacterial pneumonia" },
    { "label": "D", "text": "Foreign body aspiration" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Acute bronchiolitis**\n\n**Why it’s correct:**  \nThis infant’s presentation in **winter**, with **upper respiratory prodrome**, **progressive cough**, **tachypnea**, **retractions**, and diffuse crackles and wheezes, is classic for **bronchiolitis**. The chest x‐ray findings of **hyperinflation** and **peribronchial thickening**, coupled with the absence of focal consolidation, support a viral lower airway infection rather than bacterial pneumonia.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Acute asthma exacerbation** – Asthma in this age group is rare without a history of recurrent wheezing or atopy. Asthma exacerbations usually present with **prolonged expiratory wheezes**, not prominent crackles, and respond dramatically to bronchodilators.\n\n**C. Bacterial pneumonia** – Characterized by **high fever**, **focal crackles**, and **lobar consolidation** on imaging. This patient has only low-grade fever, diffuse findings, and no consolidation.\n\n**D. Foreign body aspiration** – Typically causes **sudden onset** of cough or choking, with **asymmetric breath sounds** or localized wheeze, and may show focal hyperinflation or air trapping on x‐ray. Our patient’s diffuse involvement and gradual onset argue against aspiration.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Obtain a **detailed history** (timing, viral prodrome, feeding), assess **vital signs**, and perform a **focused respiratory exam**.  \n2. **Pulse Oximetry:** Monitor oxygen saturation; start **supplemental oxygen** if <92%.  \n3. **Nasopharyngeal Swab (Best Test):** **RSV PCR** to identify the causative virus, useful for cohorting and prognosis.  \n4. **Chest X-ray:** Already performed to exclude other causes; shows **hyperinflation**, **peribronchial thickening**, no lobar consolidation.  \n5. **Capillary Blood Gas:** In severe cases to assess **CO₂ retention** and guide respiratory support.\n\n---\n\n**Management:**  \n1. **Supportive Care:** **Hydration** and **nasal suctioning** to clear secretions and improve feeding.  \n2. **Oxygen Therapy:** Maintain SpO₂ ≥ 92% with **humidified oxygen** or **nasal cannula**.  \n3. **Bronchodilators:** A **trial of nebulized albuterol** may be considered, but routine use is not recommended without clear response.  \n4. **Advanced Support:** In severe cases, use **high-flow nasal cannula** or **noninvasive ventilation**; intubation rarely required.  \n5. **Palivizumab Prophylaxis:** For high-risk infants (premature, congenital heart disease) during RSV season.\n\n---\n\n**Why Each Symptom Occurs in Bronchiolitis:**  \n1. **Nasal Congestion:** Viral infection induces **mucosal edema** and increased secretions in the upper airway.  \n2. **Tachypnea & Retractions:** **Small airway obstruction** from edema and mucus increases work of breathing.  \n3. **Diffuse Crackles:** **Bronchiolar inflammation** and fluid-filled alveoli produce fine inspiratory crackles.  \n4. **Wheezing:** Airflow limitation through **narrowed bronchioles** creates expiratory wheezes.  \n5. **Poor Feeding:** Increased **respiratory effort** and congestion make suckling and swallowing difficult.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **RSV Infection of Bronchioles:** The virus infects and damages **ciliated epithelial cells**, impairing mucociliary clearance.  \n2. **Inflammatory Response:** **Neutrophils and lymphocytes** infiltrate the bronchioles, releasing cytokines that worsen edema.  \n3. **Mucus Hypersecretion:** Goblet cell activation leads to **increased mucus**, further narrowing airways.  \n4. **Bronchiole Obstruction:** **Cell debris, mucus, and edema** occlude small airways, causing air trapping and hyperinflation.  \n5. **Ventilation–Perfusion Mismatch:** Obstructed bronchioles create areas of the lung with **poor ventilation**, leading to hypoxemia."
},
{
  "text": "A 2-year-old girl is brought to the pediatric clinic for a 3-week history of **unilateral foul-smelling nasal discharge** and intermittent **epistaxis** from her right nostril. Her parents report that they initially thought it was a cold, but it has persisted despite saline rinses and a course of antibiotics prescribed for presumed sinusitis. She denies fever or cough but occasionally rubs her nose and winces as if in discomfort. On exam, she is well-appearing with normal growth. Nasal inspection reveals **granulation tissue** and crusting in the right anterior nare, with limited airflow on that side. The left nostril is unremarkable. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute Bacterial Sinusitis" },
    { "label": "B", "text": "Allergic Rhinitis" },
    { "label": "C", "text": "Foreign Body in Nose" },
    { "label": "D", "text": "Juvenile Nasopharyngeal Angiofibroma" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Foreign Body in Nose**  \n\n**Why it’s correct:**  \nA **persistent, unilateral**, **foul-smelling discharge** with **granulation tissue** and epistaxis in a toddler is virtually pathognomonic for a retained **nasal foreign body**. The failure to respond to antibiotics and the absence of systemic signs further support a local obstructive cause rather than a diffuse infection or allergy.  \n\n---  \n**Why the other options are incorrect:**  \n\n**A. Acute Bacterial Sinusitis** – Presents with **bilateral** nasal congestion, purulent discharge, and often **fever** and facial pain. Granulation tissue and unilateral findings are atypical.  \n\n**B. Allergic Rhinitis** – Causes **bilateral** clear rhinorrhea, sneezing, and itching, with pale, boggy turbinates—not **foul odor**, epistaxis, or granulation.  \n\n**D. Juvenile Nasopharyngeal Angiofibroma** – Occurs in **adolescent males**, presents with profuse epistaxis and nasal obstruction, but is extremely rare in a 2-year-old girl and would not cause a malodorous discharge.\n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Obtain a **focused history** (onset, character of discharge, attempted remedies) and perform a **thorough nasal exam** with a nasal speculum and headlight or otoscope.  \n2. **Anterior Rhinoscopy (Best Test):** Direct visualization of the **nasal cavity** under good illumination to identify and locate the foreign body.  \n3. **Imaging (if needed):** A **plain nasal radiograph** if the object is suspected to be radiopaque or if visualization is limited.  \n4. **Endoscopic Evaluation:** **Rigid or flexible endoscopy** by ENT if initial exam is inconclusive or removal is anticipated to be difficult.  \n5. **Avoid Blind Probing:** Do not use blind curettes or hooks; always visualize the object before attempting removal to prevent trauma or aspiration.\n\n---  \n**Management:**  \n1. **Removal under Visualization:** Use **alligator forceps** or a **crocodile clamp** under direct vision (headlight or endoscope). Techniques like the **mother’s kiss** can be tried in cooperative toddlers.  \n2. **Topical Anesthesia & Vasoconstriction:** Apply **lidocaine with epinephrine** to minimize pain and bleeding.  \n3. **Avoid General Anesthesia (if possible):** Reserve **anesthesia** for uncooperative patients or when objects are deeply lodged.  \n4. **Post-Removal Care:** Inspect the nostril for residual fragments, treat any mucosal abrasions with **saline** and **topical antibiotic ointment**, and monitor for rebleeding.  \n5. **Prevention & Education:** Counsel caregivers to keep small objects out of reach and supervise play.\n\n---  \n**Why Each Symptom Occurs:**  \n1. **Foul-Smelling Discharge:** Retained object causes **stagnation and bacterial overgrowth**, leading to malodorous secretions.  \n2. **Unilateral Epistaxis:** **Local mucosal trauma** from the foreign body and resulting granulation tissue cause intermittent bleeding.  \n3. **Granulation Tissue Formation:** Chronic irritation induces **angiogenesis and fibroblast proliferation** around the object.  \n4. **Limited Airflow:** Obstruction of the nasal passage by the foreign body reduces airflow and may cause snoring or mouth breathing.  \n5. **Lack of Systemic Signs:** Infection remains localized, so systemic features like fever are absent unless secondary sinusitis develops.\n\n---  \n**Pathophysiology Highlights:**  \n1. **Mechanical Obstruction:** The foreign body physically blocks the nasal airway, causing **stasis of secretions**.  \n2. **Local Inflammation:** Mucosal contact triggers **release of cytokines** (IL-1, TNF-α) and recruitment of neutrophils.  \n3. **Microbial Colonization:** Stagnant secretions become a nidus for **bacterial growth**, producing foul odor and leukocyte infiltration.  \n4. **Tissue Response:** Chronic inflammation leads to **granulation tissue** formation, which can further embed the object and bleed easily.  \n5. **Secondary Complications:** Prolonged impaction can evolve into **sinusitis**, **otitis media**, or **nasal septal perforation** if not promptly addressed."
},
{
  "text": "A 5-year-old boy presents with a 2-year history of **recurrent respiratory infections** (including *Pseudomonas* pneumonia), **chronic productive cough**, and **failure to thrive** despite a good appetite. His mother also reports **foul-smelling, bulky stools** and episodes of **nasal congestion** with occasional epistaxis. On exam, he has **digital clubbing**, **bilateral crackles** and wheezes on lung auscultation, and **pale, moist mucous membranes**. His BMI is at the 5th percentile. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Primary ciliary dyskinesia" },
    { "label": "B", "text": "Common variable immunodeficiency" },
    { "label": "C", "text": "Cystic Fibrosis" },
    { "label": "D", "text": "Alpha-1 Antitrypsin Deficiency" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Cystic Fibrosis**  \n\n**Why it’s correct:**  \nThis child’s combination of **recurrent sinopulmonary infections**, particularly with *Pseudomonas*, **chronic productive cough**, **failure to thrive** despite high caloric intake, and **steatorrhea** from pancreatic insufficiency is hallmark for **cystic fibrosis**. The presence of **digital clubbing** and **nasal congestion** (due to nasal polyps) further supports CF over the other differentials.  \n\n---  \n**Why the other options are incorrect:**  \n\n**A. Primary ciliary dyskinesia** – Causes recurrent respiratory infections and sometimes situs inversus, but does **not** cause pancreatic insufficiency, steatorrhea, or failure to thrive.  \n\n**B. Common variable immunodeficiency** – Leads to recurrent infections but typically presents later and lacks **GI malabsorption** and **nasal polyps**.  \n\n**D. Alpha-1 Antitrypsin Deficiency** – Can cause early emphysema and liver disease, but does not present with **steatorrhea**, **pancreatic insufficiency**, or **nasal polyps** in childhood.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Perform a **quantitative pilocarpine iontophoresis sweat test** – the standard screening test for CF (elevated sweat chloride >60 mmol/L).  \n2. **Best Test:** Confirm with **genetic testing** for **CFTR gene mutations** (e.g., ΔF508).  \n3. **Pulmonary Evaluation:** Obtain **pulmonary function tests** (FEV₁ reduction) and **chest CT** to assess bronchiectasis.  \n4. **Pancreatic Assessment:** Check **fecal elastase** (low) and serum **trypsinogen** levels.  \n5. **Additional Studies:** Screen for **nasal polyps** via ENT exam and evaluate for **liver function** and **vitamin deficiencies** (A, D, E, K).  \n\n---  \n**Management:**  \n1. **Airway Clearance:** Regular **chest physiotherapy** and inhaled **hypertonic saline** to mobilize mucus.  \n2. **Inhaled Medications:** **Dornase alfa** (DNase) to reduce sputum viscosity; **inhaled tobramycin** for chronic *Pseudomonas* suppression.  \n3. **Pancreatic Enzyme Replacement:** **Pancrelipase** with each meal to improve nutrient absorption and weight gain.  \n4. **Nutritional Support:** High-calorie, high-fat diet with **fat-soluble vitamin** supplementation.  \n5. **CFTR Modulators:** **Ivacaftor**, **lumacaftor/ivacaftor**, or **elexacaftor/tezacaftor/ivacaftor** depending on confirmed CFTR mutations.  \n\n---  \n**Why Each Symptom Occurs in CF:**  \n1. **Recurrent Infections & Bronchiectasis:** **Viscous airway secretions** impair mucociliary clearance, allowing bacterial colonization and lung damage.  \n2. **Failure to Thrive:** **Malabsorption** from pancreatic insufficiency leads to calorie and fat-soluble vitamin deficiencies.  \n3. **Steatorrhea:** Lack of pancreatic lipase prevents fat digestion, causing **bulky, foul-smelling stools**.  \n4. **Digital Clubbing:** Chronic hypoxia and inflammation stimulate **vascular changes** in the nail beds.  \n5. **Nasal Polyps & Congestion:** Thickened mucus obstructs sinus drainage, leading to **polyp formation** and sinusitis.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **CFTR Mutation:** Defective **chloride channel** leads to **reduced chloride and water secretion** in epithelial cells.  \n2. **Dehydrated Secretions:** Thick, sticky mucus accumulates in **lungs**, **pancreas**, and **sinuses**, impairing organ function.  \n3. **Pancreatic Duct Obstruction:** Mucus blocks **pancreatic exocrine ducts**, causing enzyme deficiency and fibrotic destruction.  \n4. **Salt Imbalance:** Impaired **sweat gland** reabsorption of sodium and chloride leads to **salty sweat** and risk of dehydration.  \n5. **Inflammatory Cascade:** Chronic infection triggers **neutrophil-dominated inflammation**, releasing elastase and reactive oxygen species, perpetuating tissue damage."
},
{
  "text": "A 10-year-old boy presents with a 5-day history of **high fever**, **severe headache**, and **muscle aches**. He returned from helping his family clean a flooded barn 10 days ago. Over the past two days, he’s developed **red eyes**, **dark urine**, and **yellowing of his skin**. On exam, he is febrile to 39.5 °C, tachycardic, and has conjunctival injection without discharge. His sclerae and skin are jaundiced, and his calves are exquisitely tender to palpation. Laboratory studies show: WBC 14,500/µL, platelets 85,000/µL, creatinine 2.0 mg/dL, BUN 38 mg/dL, total bilirubin 5.2 mg/dL (direct 2.8), AST 140 U/L, ALT 115 U/L, and urinalysis with **2+ protein**, **1+ blood** but only 2 RBCs/hpf. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Dengue hemorrhagic fever" },
    { "label": "B", "text": "Viral hepatitis A" },
    { "label": "C", "text": "Leptospirosis (Weil’s disease)" },
    { "label": "D", "text": "Typhoid fever" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Leptospirosis (Weil’s disease)**\n\n**Why it’s correct:**  \nThis patient’s **biphasic illness**—initial fever, headache, myalgias—followed by **conjunctival injection**, **jaundice**, **renal impairment**, **thrombocytopenia**, and **calf tenderness** after freshwater/barn floodwater exposure is classic for **Weil’s disease**, the severe form of leptospirosis caused by *Leptospira interrogans*.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Dengue hemorrhagic fever** – Presents with **high fever**, **severe myalgias**, and often a **rash** and **hemoconcentration**, but typically has **leukopenia**, not neutrophilic leukocytosis, and no jaundice or significant renal failure.  \n\n**B. Viral hepatitis A** – Manifests with **jaundice**, **elevated transaminases**, and **pruritus**, but lacks the intense myalgias, conjunctival suffusion, thrombocytopenia, and renal dysfunction seen here.  \n\n**D. Typhoid fever** – Features **step-ladder fever**, **abdominal pain**, and **rose spots**, with **relative bradycardia** and no conjunctival injection, calf pain, or prominent jaundice/renal failure.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Obtain a detailed **exposure history** (freshwater, animals), perform a **focused exam** (conjunctiva, liver, muscle tenderness), and order **CBC**, **renal and liver panel**, and **urinalysis**.  \n- **Best Test:** **Microscopic agglutination test (MAT)** for leptospira-specific antibodies; **PCR** on blood or urine early in disease.  \n- **Additional Tests:** **Culture** of blood or CSF in specialized EMJH medium (slow), **dark-field microscopy** for spirochetes in fluid samples if available.  \n\n---\n\n**Management:**  \n1. **Antibiotic Therapy:** **IV penicillin G** or **ceftriaxone** for severe disease; **doxycycline** for mild cases or prophylaxis in exposed individuals.  \n2. **Supportive Care:** Aggressive **IV fluids**, **electrolyte correction**, and **monitoring** of renal and hepatic function.  \n3. **Renal Support:** **Dialysis** if acute kidney injury is severe.  \n4. **Monitoring:** Serial **CBC**, **coagulation**, **LFTs**, and **renal panels** to detect complications.  \n5. **Prevention:** Educate on **avoiding contaminated water**, using **protective clothing**, and consider **doxycycline prophylaxis** for high-risk exposures.\n\n---\n\n**Why Each Symptom Occurs:**  \n1. **High Fever & Myalgias:** Spirochetemia and cytokine release (IL-1, TNF-α) cause systemic inflammation and severe muscle pain.  \n2. **Conjunctival Injection:** Vascular endothelial injury by leptospiral toxins leads to capillary dilatation in the conjunctiva.  \n3. **Jaundice & Elevated LFTs:** Hepatic invasion and immune-mediated hepatocyte injury impair bilirubin conjugation.  \n4. **Renal Impairment & Proteinuria:** Tubulointerstitial nephritis from direct spirochete invasion and hypovolemia.  \n5. **Thrombocytopenia:** Consumptive coagulopathy and platelet activation by endotoxins.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Spirochetal Entry:** Leptospira penetrates abraded skin or mucosa, spreading via the bloodstream.  \n2. **Endothelial Damage:** Bacterial lipoproteins and hemolysins injure capillary endothelium, leading to hemorrhage and suffusion.  \n3. **Immune Complex Deposition:** Formation of antigen–antibody complexes deposits in tissues, exacerbating organ damage.  \n4. **Hepatorenal Injury:** Direct invasion and immune-mediated cytotoxicity damage liver and kidney tubules.  \n5. **Inflammatory Cascade:** Activation of macrophages and neutrophils releases ROS and proteases, contributing to multi-organ dysfunction.\n\n---\n\n**Summary:**\nLeptospirosis in children can progress to **Weil’s disease**, marked by **hepatorenal failure**, **conjunctival suffusion**, and **myalgias** after freshwater exposure. Diagnosis relies on **MAT** or **PCR**, and early **antibiotic therapy** with penicillin or ceftriaxone plus **supportive care** reduces morbidity and mortality."
},
{
  "text": "A 12-year-old girl presents with a 6-month history of recurrent, crampy periumbilical abdominal pain occurring at least twice weekly. The pain is often relieved by defecation and is associated with episodes of both diarrhea and constipation, as well as occasional mucus in the stool. She denies weight loss, growth delay, blood in stools, fevers, or nocturnal symptoms. Her school attendance has declined due to pain. Physical examination is unremarkable with normal growth parameters. Laboratory tests show normal CBC, ESR, CRP, negative celiac serologies, and normal thyroid function. Stool calprotectin is within normal limits. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Crohn’s Disease" },
    { "label": "B", "text": "Lactose Intolerance" },
    { "label": "C", "text": "Irritable Bowel Syndrome (IBS)" },
    { "label": "D", "text": "Celiac Disease" }
  ],
  "correct": "C",
  "explanation": "**Why it’s correct:**\n\nThis patient meets the **Rome IV criteria for IBS**, with **recurrent abdominal pain** for at least 1 day per week for the past 6 months, associated with **changes in stool frequency and form**, and **relief with defecation**. The absence of red flags (weight loss, growth delay, bleeding, inflammatory markers) and normal exclusionary tests (calprotectin, celiac serology) support a functional disorder rather than organic pathology.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. Crohn’s Disease** – Would present with **growth failure**, **weight loss**, **chronic inflammation** (elevated ESR/CRP), and possibly blood in the stool or perianal disease. Imaging or endoscopy would show mucosal ulceration or strictures.\n\n**B. Lactose Intolerance** – Causes **postprandial bloating**, **diarrhea**, and **gas**, but does not typically produce **crampy pain relieved by defecation** or alternating constipation, nor mucus in the stool.\n\n**D. Celiac Disease** – Presents with **malabsorption**, **weight loss**, **iron deficiency anemia**, and positive **anti-tissue transglutaminase antibodies**. Our patient’s serologies and growth parameters are normal.\n\n---\n\n**Diagnostic Steps:**\n\n1. **Initial Step:** Thorough **history** and **physical exam** to assess red flags and Rome IV symptom criteria.\n2. **Laboratory Exclusion:** Check **CBC**, **ESR/CRP**, **celiac serologies**, **thyroid function**, and **stool calprotectin** to rule out organic disease.\n3. **Breath Tests:** Perform a **lactose hydrogen breath test** if lactose intolerance still suspected after initial workup.\n4. **Colonoscopy:** Reserved for patients with red flags or abnormal initial tests; not indicated here.\n5. **Diagnostic Criteria:** Confirm IBS diagnosis based on Rome IV criteria when organic causes are excluded.\n\n---\n\n**Management:**\n\n1. **Dietary Modification:** Trial of a **low-FODMAP diet**, ensuring adequate fiber intake to regulate bowel habits.\n2. **Psychosocial Support:** **Cognitive-behavioral therapy** and stress management to address the gut–brain axis component.\n3. **Pharmacotherapy:** Use **antispasmodics** (e.g., hyoscine) for pain, **osmotic laxatives** for constipation-predominant symptoms, or **loperamide** for diarrhea-predominant symptoms.\n4. **Probiotics:** Consider **Bifidobacterium** or **Lactobacillus** strains to modulate gut microbiota.\n5. **Regular Follow-Up:** Monitor growth, symptom control, and quality of life; adjust therapy as needed.\n\n---\n\n**Why Each Symptom Occurs in IBS:**\n\n1. **Abdominal Pain:** **Visceral hypersensitivity** causes exaggerated pain perception to normal gut stimuli.  \n2. **Relief with Defecation:** Altered **colon motility** reduces distension-related pain post-defecation.  \n3. **Altered Stool Frequency/Form:** **Dysregulated gut motility** leads to accelerated or delayed transit time.  \n4. **Mucus in Stool:** Increased **mucosal secretion** from low-grade mucosal immune activation.  \n5. **Bloating/Distension:** **Gas retention** due to abnormal fermentation and transit.\n\n---\n\n**Pathophysiology Highlights:**\n\n1. **Gut–Brain Axis Dysfunction:** Abnormal **bidirectional signaling** amplifies stress responses and motility changes.  \n2. **Visceral Hypersensitivity:** Heightened **nociceptor** responsiveness in the gut wall leads to pain from normal distension.  \n3. **Altered Motility Patterns:** **Migrating motor complex** and **colonic phasic contractions** are dysrhythmic, causing diarrhea or constipation.  \n4. **Microbiome Alterations:** **Dysbiosis** with reduced beneficial bacteria and increased gas-producing organisms contributes to symptoms.  \n5. **Low-Grade Mucosal Immune Activation:** Increased **mast cells** and **cytokines** in the intestinal mucosa promote secretion and sensitivity."
},
{
  "text": "A 3-month-old boy presents with a 6-week history of **persistent regurgitation** and **irritability** after feeds. His mother reports he often **arches his back**, cries inconsolably during and after feeds, and has had two episodes of brief apnea following vomiting. He has not gained weight appropriately, dropping from the 50th to the 10th percentile. On exam, he is alert but fussy, with mild **snoring** and intermittent **wheezing** on chest auscultation. Abdominal exam is soft, with no palpable masses. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Pyloric Stenosis" },
    { "label": "B", "text": "Cow’s Milk Protein Allergy" },
    { "label": "C", "text": "Gastroesophageal Reflux Disease (GERD)" },
    { "label": "D", "text": "Laryngomalacia" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Gastroesophageal Reflux Disease (GERD)**\n\n**Why it’s correct:**  \nThis infant’s presentation of **daily regurgitation**, **Sandifer-like arching** of the back, **poor weight gain**, and **respiratory symptoms** (wheezing, brief apnea) is classic for **GERD** in early infancy. The absence of projectile vomiting, blood or mucus in the stool, and a normal abdominal exam further support reflux rather than surgical or allergic etiologies.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Pyloric Stenosis** – Presents at **3–6 weeks** with **projectile nonbilious vomiting**, a palpable **olive-shaped pylorus**, and no respiratory symptoms or arching refractory to feeds. This infant’s vomiting is non-projectile and associated with apnea and arching rather than olive mass.  \n\n**B. Cow’s Milk Protein Allergy** – May cause **bloody stools**, **eczema**, or **atopic features**, and vomiting is often accompanied by blood or mucus. This child has clear vomitus, no rash, and negative stool guaiac.  \n\n**D. Laryngomalacia** – Typically presents with **inspiratory stridor** that worsens with feeding or supine position, without significant vomiting or poor weight gain due to reflux; arching is not a feature.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** of feeding patterns, vomiting characteristics, and growth chart review; focused **physical exam** including airway (stridor), chest, and abdomen.  \n2. **Trial of Conservative Measures:** Empiric **thickened feeds**, **upright positioning** after feeds, and **smaller, more frequent feeds**—if symptoms improve, this supports GERD.  \n3. **Best Test:** **24-hour pH probe with impedance** monitoring to quantify reflux episodes and correlate with symptoms.  \n4. **Adjunct Imaging:** **Upper GI series** if anatomical obstruction is suspected (e.g., malrotation) or to exclude strictures.  \n5. **Endoscopy:** Reserved for refractory cases or alarm features (e.g., gastrointestinal bleeding, severe esophagitis) to assess mucosal damage and obtain biopsies.\n\n---\n\n**Management:**  \n1. **Conservative Measures:** **Thicken feeds** with rice cereal, keep infant **upright 30 minutes** post-feed, and avoid overfeeding.  \n2. **Pharmacotherapy:** If symptoms persist and interfere with growth, start a **proton pump inhibitor** (e.g., omeprazole) or an **H₂-receptor antagonist** (e.g., ranitidine) to reduce acid exposure.  \n3. **Prokinetic Agents:** Consider **metoclopramide** for delayed gastric emptying under specialist guidance, monitoring for side effects.  \n4. **Monitor Growth:** Weekly weight checks until feeding improves and weight gain normalizes.  \n5. **Surgical Referral:** In severe cases with failure to thrive or apnea, consult pediatric surgery for **Nissen fundoplication**.\n\n---\n\n**Why Each Symptom Occurs in GERD:**  \n1. **Regurgitation:** **Transient lower esophageal sphincter relaxations** allow gastric contents to reflux into the esophagus.  \n2. **Arching (Sandifer Syndrome):** Reflux-induced **esophageal pain** triggers dystonic posturing to relieve discomfort.  \n3. **Poor Weight Gain:** Reflux leads to **feed aversion**, vomiting, and increased caloric loss.  \n4. **Wheezing/Apnea:** Microaspiration of refluxed material into the airway causes **bronchospasm** and **apneic spells** in infants.  \n5. **Irritability:** Repeated esophageal acid exposure results in **esophagitis**, causing chronic discomfort and fussiness.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Transient LES Relaxation:** In infants, a **hypotonic lower esophageal sphincter** predisposes to physiologic reflux.  \n2. **Delayed Gastric Emptying:** Slower **gastric motility** prolongs retention of feeds, increasing reflux episodes.  \n3. **Esophageal Clearance Deficit:** Immature **peristaltic reflexes** reduce acid clearance from the esophagus.  \n4. **Mucosal Barrier Immaturity:** Infant esophageal epithelium is more susceptible to **acid injury**, leading to inflammation.  \n5. **Visceral Hypersensitivity:** Repeated acid exposure lowers the **pain threshold**, causing exaggerated symptoms and protective posturing."
},
{
  "text": "A 10-day-old male newborn presents to the neonatal intensive care unit with a 12-hour history of **recurrent bilious vomiting**, **abdominal distension**, and **lethargy**. He was born at term via uncomplicated vaginal delivery. He has not passed stool in the past 8 hours and appears dehydrated. On exam, he is tachycardic, hypotensive, has cool, mottled skin, a distended and tender abdomen, and diminished bowel sounds. An orogastric tube returns greenish fluid. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Intussusception" },
    { "label": "B", "text": "Hirschsprung Disease" },
    { "label": "C", "text": "Midgut Volvulus due to Malrotation" },
    { "label": "D", "text": "Pyloric Stenosis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Midgut Volvulus due to Malrotation**\n\n**Why it’s correct:**  \nThis neonate has a classic presentation of **malrotation with midgut volvulus**: acute onset of **bilious vomiting**, **abdominal distension**, **feeding intolerance**, and signs of **hemodynamic instability**. The greenish return on orogastric suction indicates an obstruction distal to the ampulla of Vater. The combination of volvulus-induced **vascular compromise** and obstruction matches this diagnosis.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Intussusception** – Presents in older infants (6–36 months) with **colicky abdominal pain**, **currant jelly stools**, and a palpable “sausage” mass. Bilious vomiting in a 10-day-old is atypical.  \n\n**B. Hirschsprung Disease** – Causes **chronic constipation**, **delayed meconium**, and abdominal distension from birth. Vomiting is nonbilious and presentation is more insidious, without acute hemodynamic collapse.  \n\n**D. Pyloric Stenosis** – Occurs at 3–6 weeks of age with **projectile nonbilious vomiting**, visible peristalsis, and an “olive” mass. Bilious vomiting and shock are not features.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Fluid resuscitation** and **electrolyte correction** (IV isotonic fluids), place **NG tube** for decompression, and stabilize airway/breathing/circulation.  \n2. **Plain Abdominal Radiograph:** Assess for **air-fluid levels**, **free air**, and **generalized obstruction**.  \n3. **Upper Gastrointestinal (UGI) Series (Best Test):** Demonstrates a **corkscrew** appearance of the duodenum and jejunum, confirming malrotation with volvulus.  \n4. **Abdominal Ultrasound:** May show the **whirlpool sign** (twisted superior mesenteric vessels) if UGI is unavailable or in unstable infants.  \n5. **Laboratory Tests:** Monitor **blood count**, **lactate**, and **coagulation** to assess for ischemia and sepsis.\n\n---\n\n**Management:**  \n1. **Emergency Ladd Procedure:** Surgical detorsion of the volvulus, division of Ladd bands, broadening of the mesenteric base, and placement of the small bowel on the right and colon on the left.  \n2. **Resection of Necrotic Bowel:** If ischemic segments are nonviable, perform resection with primary anastomosis or stoma formation.  \n3. **Preoperative Care:** Continue **IV fluids**, **antibiotics** (covering gram-negative enterics and anaerobes), and **nasogastric decompression**.  \n4. **Postoperative Care:** Monitor for **short-bowel syndrome**, ensure **nutritional support**, and prevent **adhesive obstruction**.  \n5. **Follow-Up:** Serial growth assessments and evaluation for **malabsorption** if extensive resection occurred.\n\n---\n\n**Why Each Symptom Occurs in Midgut Volvulus:**  \n1. **Bilious Vomiting:** Obstruction distal to the ampulla prevents bile from entering the intestine, causing green vomitus.  \n2. **Abdominal Distension:** Trapped gas and fluid proximal to the volvulus dilate the stomach and small bowel.  \n3. **Feeding Intolerance & Lethargy:** Ischemia reduces perfusion, leading to systemic toxicity and poor feeding.  \n4. **Hemodynamic Instability:** Bowel necrosis and bacterial translocation induce **sepsis** and **hypovolemia**.  \n5. **Diminished Bowel Sounds:** Ischemic bowel becomes atonic, reducing peristalsis and audible sounds.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Malrotation:** Failure of the midgut to rotate **270° counterclockwise** around the superior mesenteric artery (SMA) during embryogenesis results in a **narrow mesenteric base**.  \n2. **Ladd Bands:** Fibrous peritoneal bands from the cecum cross and obstruct the distal duodenum.  \n3. **Volvulus:** A narrow mesenteric pedicle allows the small intestine to twist around the SMA, causing **arterial occlusion** and ischemia.  \n4. **Ischemia–Reperfusion Injury:** Twisting and untwisting generate free radicals, exacerbating mucosal damage and risk of necrosis.  \n5. **Bacterial Translocation:** Mucosal barrier breakdown allows gut flora into the bloodstream, leading to **sepsis** and **multiorgan dysfunction**.\n\n---\n\n**Summary:**  \nMidgut volvulus due to malrotation presents in neonates with **acute bilious vomiting**, **abdominal distension**, and **signs of shock**. Rapid diagnosis via **UGI series** and emergent **Ladd procedure** with possible bowel resection are essential to prevent high morbidity and mortality."
},
{
  "text": "An 8-month-old girl is brought to the clinic for a 2-month history of an intensely pruritic rash. It began on her cheeks and has spread to her neck, wrists, and the creases of her elbows and knees. She is irritable, has difficulty sleeping, and occasionally scratches until her skin bleeds. Her mother has a history of eczema and allergic asthma. On exam, the skin is **xerotic** with **erythematous, scaly patches** and **excoriations**, especially in the **antecubital** and **popliteal fossae**, and there is early **lichenification**. No mucosal or systemic signs are present. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Allergic Contact Dermatitis" },
    { "label": "B", "text": "Scabies" },
    { "label": "C", "text": "Atopic Dermatitis" },
    { "label": "D", "text": "Psoriasis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Atopic Dermatitis**\n\n**Why it’s correct:**  \nThis infant presents with the classic features of **atopic dermatitis** (eczema): intense **pruritus**, **xerosis**, a **flexural distribution** (antecubital and popliteal fossae), a strong **family history of atopy**, and progression from erythematous papules to **lichenification** due to chronic scratching. The absence of burrows, widespread papules, or sharply demarcated plaques distinguishes it from other dermatoses.\n\n---  \n**Why the other options are incorrect:**  \n\n**A. Allergic Contact Dermatitis** – Usually has a **localized** distribution exactly corresponding to contact with an allergen (e.g., shoes, jewelry), with **sharply demarcated** redness and vesicles. It is less commonly generalized in infants and lacks the chronic flexural pattern.\n\n**B. Scabies** – Presents with **intense nocturnal pruritus**, papules and burrows in the **finger webs**, wrists, and axillae, but not primarily flexural eczema with xerosis. Scratching in scabies often leads to secondary crusted papules rather than lichenification.\n\n**D. Psoriasis** – Infantile psoriasis can appear as **well-demarcated, silvery-scaling plaques** on extensor surfaces and scalp. It does not cause severe pruritus or excoriations to the same extent, and the distribution differs (extensor > flexural).\n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** (onset, family atopy, triggers) and **physical exam** focusing on rash distribution and severity.  \n2. **Clinical Diagnosis:** Atopic dermatitis is a **clinical diagnosis**; no lab test is required for typical cases.  \n3. **Serum IgE/Allergy Testing:** If severe or unclear, measure **total and specific IgE** or perform **skin prick tests** to identify triggers.  \n4. **Patch Testing:** For suspected contact allergens if distribution is atypical.  \n5. **Skin Biopsy:** Reserved for **atypical** or treatment-resistant cases to exclude other dermatoses.\n\n---  \n**Management:**  \n1. **Emollients:** Liberal, **fragrance-free moisturizers** twice daily to restore skin barrier.  \n2. **Topical Corticosteroids:** **Low- to mid-potency** (e.g., hydrocortisone 1%) applied to active lesions for short courses.  \n3. **Topical Calcineurin Inhibitors:** **Tacrolimus** or **pimecrolimus** for sensitive areas (face, folds) to reduce steroid exposure.  \n4. **Antihistamines:** **Sedating H1-blockers** (e.g., diphenhydramine at bedtime) to reduce nocturnal scratching.  \n5. **Trigger Avoidance & Wet Wraps:** Identify and avoid irritants (wool, harsh soaps); use **wet wrap therapy** in severe flares.  \n6. **Systemic Therapy:** For refractory cases, consider **dupilumab** (≥6 years) or **systemic immunosuppressants** under specialist care.\n\n---  \n**Why Each Symptom Occurs in Atopic Dermatitis:**  \n1. **Pruritus:** **Histamine** and **IL-31** from Th2 cells stimulate itch fibers.  \n2. **Xerosis:** **Filaggrin mutation** and lipid deficiency increase **transepidermal water loss**.  \n3. **Erythema & Scaling:** **Inflammatory cytokines** (IL-4, IL-13) induce keratinocyte proliferation and scaling.  \n4. **Excoriations & Lichenification:** Chronic **itch–scratch cycle** leads to skin thickening and accentuated skin markings.  \n5. **Flexural Distribution:** Constant **skin-fold friction** and moisture retention exacerbate lesions in flexural areas.\n\n---  \n**Pathophysiology Highlights:**  \n1. **Skin Barrier Dysfunction:** **Filaggrin gene mutations** weaken the stratum corneum, allowing allergen and microbe penetration.  \n2. **Type 2 Immune Skewing:** **Th2 cytokines** (IL-4, IL-5, IL-13) drive IgE production and eosinophil recruitment.  \n3. **Microbial Dysbiosis:** **Staphylococcus aureus colonization** exacerbates inflammation via superantigens.  \n4. **Neuroimmune Itch Pathway:** **IL-31** and **substance P** sensitize peripheral nerves, perpetuating itching.  \n5. **Chronic Inflammation & Remodeling:** Repeated flares lead to **fibroblast activation**, **fibrosis**, and persistent hyperreactivity of the skin."
},
{
  "text": "A 4-year-old boy presents with a 3-day history of high fever (up to 39.8 °C), tenesmus, and progressively worsening abdominal cramps. He attends daycare, where several children recently had “stomach flu.” His mother reports the onset of **small-volume, mucoid, bloody stools** (8–10 times/day) and an episode of a generalized tonic–clonic seizure last night. On exam, he appears ill, is tachycardic, and has diffuse abdominal tenderness without peritoneal signs. He is mildly dehydrated. A stool guaiac test is positive, and fecal leukocytes are noted. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Enterohemorrhagic Escherichia coli (EHEC) infection" },
    { "label": "B", "text": "Salmonella Typhi infection" },
    { "label": "C", "text": "Shigella dysenteriae infection" },
    { "label": "D", "text": "Campylobacter jejuni infection" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Shigella dysenteriae infection**\n\n**Why it’s correct:**  \nShigella causes an **invasive colitis** characterized by **high fever**, **tenesmus**, **frequent small-volume bloody–mucoid stools**, and can trigger **febrile seizures** in young children. The presence of fecal leukocytes and recent daycare exposure further support Shigella.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. EHEC infection** – Presents with **bloody diarrhea** but usually **low-grade or no fever** and carries a risk of **hemolytic uremic syndrome**; fecal leukocytes may be absent and seizures are less common acutely.  \n\n**B. Salmonella Typhi infection** – Causes **step-wise fevers**, **abdominal pain**, and **rose spots**, with **nonbloody** diarrhea or constipation. It typically has **no fecal leukocytes** and seizures are uncommon.  \n\n**D. Campylobacter jejuni infection** – Produces **bloody diarrhea** and fever but stool is often **larger volume**, with more prominent **crampy pain** and an incubation of ~2–5 days; tenesmus and seizures are less characteristic.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Obtain a **thorough history** (daycare exposure, onset, stool characteristics) and perform a **physical exam** focusing on hydration and abdominal findings.  \n2. **Stool Studies:** Send for **stool culture**, **enteric pathogen PCR**, and **fecal leukocyte analysis**.  \n3. **Best Test:** **Stool culture on Hektoen enteric agar** to isolate Shigella and perform **serotyping**; PCR panels offer rapid identification.  \n4. **Adjunct Tests:** Check **complete blood count** and **electrolytes** to assess dehydration and systemic response; monitor for **HUS** with platelet count, LDH, and renal function if EHEC is suspected.\n\n---\n\n**Management:**  \n1. **Rehydration:** **Oral rehydration solution** for mild dehydration; **IV fluids** if severe.  \n2. **Antibiotics:** In severe Shigella, treat with **trimethoprim–sulfamethoxazole** or **azithromycin** to shorten duration and prevent shedding.  \n3. **Symptomatic Care:** Antipyretics for fever and **avoid antimotility agents** (e.g., loperamide) which can worsen invasive diarrhea.  \n4. **Seizure Management:** Treat febrile seizures per protocol; monitor neurological status.  \n5. **Infection Control:** **Strict hand hygiene** and exclusion from daycare until **48 hours after antibiotic initiation** to prevent spread.\n\n---\n\n**Why Each Symptom Occurs in Shigella Infection:**  \n1. **High Fever:** **Inflammatory cytokines** (IL-1, TNF-α) released in response to mucosal invasion.  \n2. **Tenesmus:** **Rectal mucosal ulceration** and inflammation trigger painful straining.  \n3. **Mucoid, Bloody Stools:** **Invasion of colonic epithelium** leads to mucosal necrosis, bleeding, and exudate.  \n4. **Abdominal Cramps:** **Enterotoxin and cytotoxin** production irritates enteric nerves and smooth muscle.  \n5. **Febrile Seizure:** **High fever** and **endotoxin release** can lower the seizure threshold in young children.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Mucosal Invasion:** Shigella uses a **type III secretion system** to invade **M cells** in Peyer’s patches and enter enterocytes.  \n2. **Cell-to-Cell Spread:** **IcsA-mediated actin polymerization** allows bacteria to move laterally, evading immune detection.  \n3. **Shiga Toxin:** S. dysenteriae produces **Shiga toxin** that inhibits protein synthesis in epithelial cells and can cause **HUS**.  \n4. **Inflammatory Response:** Neutrophil recruitment to the lamina propria leads to **crypt abscesses** and tissue destruction.  \n5. **Mucosal Ulceration:** Focal areas of necrosis and ulceration result from **direct cytotoxicity** and immune-mediated injury.\n\n---\n\n**Summary:**  \nShigella dysenteriae infection presents with **high fever**, **tenesmus**, **small-volume bloody–mucoid diarrhea**, and potential **febrile seizures** in young children. Diagnosis is via **stool culture** or **PCR**, and management includes **rehydration**, **appropriate antibiotics**, and **supportive care**, with emphasis on **infectious precautions**."
},
{
  "text": "A 6-year-old boy with known sickle cell disease (functional asplenia) presents with a 2-day history of high fever (39.5 °C), severe headache, and one witnessed generalized tonic‐clonic seizure. He now complains of neck stiffness and photophobia. On exam, he is febrile, tachycardic, and irritable. He holds his head stiffly and has a positive Kernig’s sign. There is no rash. A non‐contrast head CT is normal. Lumbar puncture yields cloudy CSF with opening pressure 260 mmH₂O, WBC 2,200/µL (92% neutrophils), protein 210 mg/dL, glucose 30 mg/dL (serum glucose 100 mg/dL), and Gram‐positive, α‐hemolytic, optochin‐sensitive, lancet‐shaped diplococci on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Streptococcus pneumoniae meningitis" },
    { "label": "C", "text": "Haemophilus influenzae type b meningitis" },
    { "label": "D", "text": "Enteroviral meningitis" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Streptococcus pneumoniae meningitis**\n\n**Why it’s correct:**  \nThis child’s **acute presentation** with **fever**, **seizure**, **meningeal signs** (neck stiffness, photophobia), and CSF showing **neutrophilic pleocytosis**, **high protein**, **low glucose**, and **Gram-positive, α-hemolytic, optochin-sensitive lancet diplococci** is diagnostic for **pneumococcal meningitis**. His **functional asplenia** from sickle cell disease further increases susceptibility to encapsulated organisms like *S. pneumoniae*.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis meningitis** – Presents similarly but Gram stain shows **kidney-bean shaped, Gram-negative diplococci**, not Gram-positive organisms.  \n\n**C. Haemophilus influenzae type b meningitis** – Would show **pleomorphic Gram-negative coccobacilli** on CSF smear; also Hib incidence is very low in immunized children (and prophylaxis in asplenic).  \n\n**D. Enteroviral meningitis** – Causes a **lymphocytic pleocytosis**, **normal glucose**, and **normal or mildly elevated protein**, with no organisms on Gram stain.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize ABCs, obtain **blood cultures**, and perform a **neurologic exam** for signs of increased intracranial pressure (ICP).  \n2. **Neuroimaging (if indicated):** Non-contrast head CT before LP if focal deficits or papilledema are present.  \n3. **Lumbar Puncture (Best Test):** CSF cell count/differential, glucose, protein, Gram stain, and culture.  \n4. **Rapid Antigen Testing:** **BinaxNOW®** for pneumococcal antigen can expedite diagnosis.  \n5. **Antibiotic Sensitivity:** Once cultured, perform **MIC testing** to guide definitive therapy.\n\n---\n\n**Management:**  \n1. **Empiric Antibiotics:** IV **vancomycin** plus a **third-generation cephalosporin** (ceftriaxone or cefotaxime) to cover resistant *S. pneumoniae* and other pathogens.  \n2. **Targeted Therapy:** De-escalate to high-dose **ceftriaxone** alone once susceptibility confirms.  \n3. **Adjunctive Dexamethasone:** Administer before or with the first antibiotic dose to reduce **inflammatory neurologic injury**.  \n4. **Supportive Care:** IV fluids, fever control, seizure management, and ICP monitoring.  \n5. **Prevention:** For asplenic patients, ensure **pneumococcal conjugate and polysaccharide vaccines**, plus **penicillin prophylaxis** as indicated.\n\n---\n\n**Why Each Symptom Occurs in Pneumococcal Meningitis:**  \n1. **High Fever & Irritability:** Bacterial **cell wall components** (teichoic acids, peptidoglycan) provoke **cytokine release** (IL-1, TNF-α).  \n2. **Seizure:** **Inflammation** lowers the seizure threshold via **cytokines and increased ICP**.  \n3. **Neck Stiffness & Photophobia:** **Meningeal inflammation** irritates pain-sensitive structures around the brain.  \n4. **CSF Changes:** **Bacterial metabolism** consumes glucose and damages the blood–CSF barrier, raising protein.  \n5. **Lancet Diplococci on Gram Stain:** Characteristic *S. pneumoniae* morphology and α-hemolysis on blood agar.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** *S. pneumoniae* adheres via **pili and choline-binding proteins**, evading local defenses.  \n2. **Invasion & Bacteremia:** Encapsulated strains resist phagocytosis, enter bloodstream, and seed the meninges.  \n3. **Blood–Brain Barrier Crossing:** Bacterial **pneumolysin** and **hydrogen peroxide** disrupt tight junctions, allowing entry into CSF.  \n4. **Inflammatory Cascade:** CSF invasion triggers release of **cytokines** and **chemoattractants**, recruiting neutrophils that release **matrix metalloproteinases**, exacerbating damage.  \n5. **Complications:** Inflammatory edema and vasculitis can lead to **hydrocephalus**, **infarction**, and **sensorineural hearing loss** if not promptly treated.\n\n---\n\n**Summary:**  \nPneumococcal meningitis in asplenic children presents acutely with **fever**, **seizures**, **meningeal signs**, and CSF revealing **neutrophils**, **low glucose**, and **lancet diplococci**. Rapid **CSF analysis**, **empiric antibiotics** (vancomycin + cephalosporin), and **dexamethasone** are critical. **Vaccination** and **prophylaxis** are key preventive measures in high-risk patients."
},
{
  "text": "A 4-year-old girl, recently emigrated from India, presents with a 2-week history of low-grade fever, headache, and intermittent vomiting. Over the past 3 days she has become increasingly lethargic and has begun stumbling when she walks. There is no neck stiffness or photophobia. On exam, her temperature is 38.0 °C, heart rate 110 bpm, and respiratory rate 20/min. She is somnolent but arousable, with **cranial nerve VI palsy** on the right, ataxic gait, and papilledema. A contrast-enhanced MRI shows **basal meningeal enhancement** and **hydrocephalus**. A lumbar puncture yields clear fluid with opening pressure 300 mm H₂O, WBC 120 µL (85% lymphocytes), protein 220 mg/dL, glucose 35 mg/dL (serum glucose 100 mg/dL), and acid-fast bacilli on Ziehl–Neelsen stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Enteroviral (aseptic) meningitis" },
    { "label": "C", "text": "Tuberculous meningitis" },
    { "label": "D", "text": "Listeria monocytogenes meningitis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Tuberculous meningitis**  \n\n**Why it’s correct:**  \nThis child’s **subacute onset** over weeks, **basal meningeal enhancement**, **hydrocephalus**, **cranial nerve palsy**, and CSF showing **lymphocytic pleocytosis**, **high protein**, **low glucose**, and **acid-fast bacilli** are pathognomonic for **Mycobacterium tuberculosis** infection of the meninges.  \n\n---  \n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis meningitis** – Presents **acutely** with high fever, nuchal rigidity, and often a petechial rash. CSF shows **neutrophilic pleocytosis**, **very low glucose**, and **Gram-negative diplococci**, not lymphocytes or AFB.  \n\n**B. Enteroviral (aseptic) meningitis** – Usually presents with fever and headache but is **self-limited**, with **normal or mildly elevated protein**, **normal glucose**, and **lymphocytic pleocytosis** without enhancement on MRI or AFB.  \n\n**D. Listeria monocytogenes meningitis** – Occurs in neonates or immunocompromised hosts, presents more acutely, and CSF shows **Gram-positive rods**, not AFB; also lacks basal enhancement and hydrocephalus.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize airway/breathing/circulation, obtain **travel and exposure history**, and perform a **neurologic exam** (cranial nerves, gait, papilledema).  \n2. **Neuroimaging (Best Initial Test):** **Contrast MRI or CT** before LP when raised intracranial pressure or focal signs (cranial palsy, hydrocephalus) are present.  \n3. **Lumbar Puncture:** Measure **opening pressure**, send CSF for **cell count**, **protein**, **glucose**, **AFB smear**, **culture**, and **PCR for MTB**.  \n4. **Chest Imaging:** **Chest x-ray** to look for a primary pulmonary focus or miliary pattern.  \n5. **Tuberculin Skin Test / IGRA:** To support systemic TB infection, though may be negative early.  \n\n---  \n**Management:**  \n1. **RIPE Therapy:** **Rifampin, Isoniazid (with pyridoxine), Pyrazinamide, and Ethambutol** for at least **2 months**, followed by **INH + RIF** for **10 more months**.  \n2. **Adjunctive Corticosteroids:** **Dexamethasone** for 4–6 weeks to reduce meningeal inflammation and risk of neurologic sequelae.  \n3. **Neurosurgical Intervention:** **Ventriculoperitoneal shunt** if hydrocephalus is severe or medical management fails.  \n4. **Supportive Care:** Manage **electrolytes**, **nutrition**, and monitor for **drug toxicity** (hepatic, ocular).  \n5. **Public Health Measures:** **Contact tracing** and **INH prophylaxis** for close contacts.  \n\n---  \n**Why Each Symptom Occurs in Tuberculous Meningitis:**  \n1. **Basal Meningeal Enhancement & Cranial Palsies:** **Granulomatous inflammation** at the base of the brain leads to exudate in the cisterns, compressing cranial nerves.  \n2. **Hydrocephalus:** Exudate obstructs **CSF flow** in the basal cisterns and aqueduct, raising intracranial pressure.  \n3. **Lymphocytic Pleocytosis:** **Cell-mediated immune response** predominated by T lymphocytes and macrophages.  \n4. **High Protein & Low Glucose:** **Increased BBB permeability** allows proteins into CSF; glucose is consumed by both bacteria and infiltrating cells.  \n5. **Myoclonic Jerks/Ataxia:** **Inflammation** of cerebellar and cortical pathways produces motor signs.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Hematogenous Spread:** MTB infects lungs, then spreads via bloodstream to the **meninges**, forming **Rich foci** in the subpial space.  \n2. **Granuloma Formation:** Activated macrophages and Th1 cells form **tuberculous granulomas**, which can rupture into CSF.  \n3. **Caseous Exudate:** The **caseous necrosis** of granulomas yields a thick basal exudate that impairs CSF circulation.  \n4. **Cytokine-Mediated Damage:** **IFN-γ**, **TNF-α**, and other cytokines perpetuate inflammation, leading to **neuronal injury**.  \n5. **Fibrosis & Scarring:** Chronic inflammation causes **arachnoid fibrosis**, worsening hydrocephalus and vascular compromise.  \n\n---  \n**Summary:**  \nPediatric tuberculous meningitis presents subacutely with **basal exudates**, **cranial nerve palsies**, **hydrocephalus**, and **lymphocytic CSF** with **acid-fast bacilli**. Early **neuroimaging**, **CSF analysis**, and prompt **RIPE therapy** plus **corticosteroids** are critical to reduce mortality and permanent neurologic deficits."
},
{
  "text": "A 2-year-old boy, incompletely immunized (missing Hib booster), presents with a 1-day history of high fever (39.8 °C), irritability, and refusal to stand. His parents note several episodes of non‐bilious vomiting and that he cries inconsolably when his neck is moved. On exam, he is febrile, tachycardic, and has a full, bulging fontanelle. He holds his neck stiffly and resists passive flexion (positive Brudzinski’s sign). There is no rash. A non‐contrast head CT is normal. Lumbar puncture yields turbid CSF with an opening pressure of 280 mmH₂O, WBC 2,800/µL (90% neutrophils), protein 230 mg/dL, glucose 25 mg/dL (serum glucose 100 mg/dL), and pleomorphic small gram‐negative coccobacilli on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Haemophilus influenzae type b meningitis" },
    { "label": "C", "text": "Enteroviral meningitis" },
    { "label": "D", "text": "Group B Streptococcus meningitis" }
  ],
  "correct": "B",
  "explanation": "**Correct Answer: B. Haemophilus influenzae type b meningitis**\n\n**Why it’s correct:**  \nThis toddler’s **acute high fever**, **meningeal signs** (neck stiffness, irritability), **bulging fontanelle**, and CSF findings of **neutrophilic pleocytosis**, **low glucose**, **high protein**, and **pleomorphic gram‐negative coccobacilli** are classic for **H. influenzae type b**. His **incomplete Hib immunization** puts him at risk.  \n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Neisseria meningitidis** – Presents similarly but Gram stain shows **kidney‐bean diplococci**, not pleomorphic coccobacilli.  \n\n**C. Enteroviral meningitis** – Yields **clear CSF**, **lymphocytic pleocytosis**, **normal glucose**, and no organisms on Gram stain.  \n\n**D. Group B Streptococcus** – Causes neonatal meningitis in infants **<3 months**, with **Gram‐positive cocci in chains**; this child is 2 years old with Gram‐negative rods.  \n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize ABCs, obtain **blood cultures**, then perform **lumbar puncture** unless contraindicated.  \n2. **CSF Analysis:** Cell count/differential, protein, glucose, and Gram stain.  \n3. **Culture & Identification:** Grow on **chocolate agar with X (hemin) and V (NAD)** factors; confirm with **capsular PRP antigen** or **PCR**.  \n4. **Antigen Detection:** **Latex agglutination** for Hib PRP in CSF can provide rapid diagnosis.  \n\n---\n\n**Management:**  \n1. **Empiric Antibiotics:** IV **ceftriaxone** or **cefotaxime** plus **vancomycin** until pathogen identified.  \n2. **Targeted Therapy:** Once Hib is confirmed, continue **ceftriaxone** alone for **7–10 days**.  \n3. **Adjunctive Dexamethasone:** Administer before or with first antibiotic dose to reduce **neurologic sequelae**.  \n4. **Supportive Care:** Maintain hydration, manage fever, and monitor intracranial pressure.  \n5. **Chemoprophylaxis of Contacts:** Give **rifampin** to household and daycare contacts to eradicate nasopharyngeal carriage.  \n\n---\n\n**Why Each Symptom Occurs in Hib Meningitis:**  \n1. **High Fever:** Bacterial endotoxin and cytokines (IL-1, TNF-α) elevate hypothalamic set point.  \n2. **Neck Stiffness & Irritability:** **Meningeal inflammation** irritates pain‐sensitive structures.  \n3. **Bulging Fontanelle:** Increased **intracranial pressure** from purulent exudate.  \n4. **Vomiting:** **Raised intracranial pressure** and meningeal irritation stimulate the vomiting center.  \n5. **Tachycardia & Hypotension:** Systemic inflammatory response and possible early **septicemia**.  \n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** Hib adheres to mucosa via **polysaccharide capsule (PRP)**, evading phagocytosis.  \n2. **Invasion & Bacteremia:** Organism crosses epithelium into bloodstream, resisting complement.  \n3. **Blood–Brain Barrier Penetration:** Hib uses **outer membrane proteins** to traverse endothelial cells into CSF.  \n4. **CSF Inflammation:** Bacterial components (LPS) trigger **neutrophil recruitment**, release of proteases, and increased **BBB permeability**.  \n5. **Potential for Sequelae:** Inflammatory mediators damage neurons and vasculature, leading to **hearing loss**, **seizures**, or **hydrocephalus** if untreated.  \n\n---\n\n**Summary:**  \nH. influenzae type b meningitis presents in incompletely vaccinated toddlers with **acute meningeal irritation**, **neutrophilic CSF pleocytosis**, and **pleomorphic gram‐negative coccobacilli**. Diagnosis relies on **CSF culture/PCR** and **antigen detection**; treatment includes **third‐generation cephalosporins**, **dexamethasone**, and **rifampin prophylaxis** for contacts."
},
{
  "text": "A 10-day-old male neonate is brought to the neonatal intensive care unit with a 2-day history of poor feeding, irritability, and episodes of high-pitched crying. His mother reports she consumed unpasteurized soft cheese during pregnancy. On exam, his temperature is 38.5 °C, heart rate 180 bpm, and respiratory rate 60/min. He has a bulging anterior fontanelle, mottled skin, and generalized hypotonia. He has occasional myoclonic jerks but no focal neurologic deficits. A blood culture is drawn, and lumbar puncture yields cloudy CSF with opening pressure 30 cm H₂O, WBC 1,200/µL (90% neutrophils), protein 350 mg/dL, glucose 20 mg/dL (serum glucose 80 mg/dL), and Gram-positive rods on direct smear. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Listeria monocytogenes meningitis" },
    { "label": "B", "text": "Group B Streptococcus meningitis" },
    { "label": "C", "text": "Escherichia coli K1 meningitis" },
    { "label": "D", "text": "Enterovirus meningitis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Listeria monocytogenes meningitis**\n\n**Why it’s correct:**  \nThis neonate’s **presentation in the second week of life**, **bulging fontanelle**, **neutrophilic CSF pleocytosis**, **low CSF glucose**, and **Gram-positive rods** point to **Listeria monocytogenes**, particularly given the history of **unpasteurized dairy exposure** in the mother and the organism’s ability to invade via the gastrointestinal tract and cross the blood–brain barrier in neonates.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Group B Streptococcus meningitis** – GBS is the most common cause of early-onset neonatal meningitis (within 0–6 days of life), but presents sooner than day 10 and shows **Gram-positive cocci in chains** on smear, not rods.\n\n**C. Escherichia coli K1 meningitis** – E. coli (Gram-negative rods) is a common late-onset pathogen but shows **Gram-negative bacilli** on CSF smear. Our smear reveals **Gram-positive rods**, ruling out E. coli.\n\n**D. Enterovirus meningitis** – Presents at 1–4 weeks of age with fever and irritability but typically yields **lymphocytic** rather than neutrophilic CSF pleocytosis, **normal glucose**, and **no organisms** on Gram stain.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Stabilize ABCs, obtain **blood cultures**, and perform a **focused neurologic exam** (fontanelle tension, irritability).  \n2. **Lumbar Puncture (Best Test):** CSF analysis for **cell count**, **differential**, **protein**, **glucose**, and **Gram stain** to identify the pathogen and pattern of inflammation.  \n3. **Blood and CSF Cultures:** Essential for definitive organism identification and antibiotic susceptibility.  \n4. **PCR Testing:** CSF **PCR for Listeria genes** can confirm diagnosis rapidly if available.  \n5. **Additional Labs:** **Complete blood count** (look for neutrophilia), **electrolytes**, and **liver function tests** to guide supportive care.\n\n---\n\n**Management:**  \n1. **Empiric Antibiotics:** **Ampicillin** plus **an aminoglycoside (gentamicin)** to cover Listeria and other neonatal pathogens pending culture results.  \n2. **Adjust Therapy:** Once Listeria is confirmed, continue **ampicillin** for at least **21 days**; may add **gentamicin** for the first 7–10 days for synergy.  \n3. **Supportive Care:** Maintain **normothermia**, **fluid and electrolyte balance**, and **seizure control** if needed.  \n4. **Monitor for Complications:** Watch for **hydrocephalus**, **abscess formation**, and **hearing loss**; obtain **cranial ultrasound** or MRI if complications are suspected.  \n5. **Prevention:** Educate pregnant women to **avoid unpasteurized dairy** and ensure appropriate **maternal screening** when indicated.\n\n---\n\n**Why Each Symptom Occurs in Listeria Meningitis:**  \n1. **Bulging Fontanelle:** Increased **intracranial pressure** from purulent CSF accumulation.  \n2. **Hypotonia & Irritability:** **Meningeal inflammation** and direct bacterial toxins irritate CNS tissues.  \n3. **Myoclonic Jerks:** **Neuronal hyperexcitability** in inflamed meninges can trigger seizures.  \n4. **Neutrophilic Pleocytosis:** **Bacterial invasion** stimulates innate immune response with neutrophil recruitment.  \n5. **Low CSF Glucose & High Protein:** **Consumption of glucose** by bacteria and increased **vascular permeability** allow protein-rich plasma to leak into CSF.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Ingestion & Translocation:** Listeria enters via the **gastrointestinal tract**, crosses the epithelial barrier using **internalin** proteins.  \n2. **Cell-to-Cell Spread:** The bacterium escapes the phagosome and uses **actin polymerization** (ActA) to propel itself into adjacent cells, evading humoral immunity.  \n3. **Placental & Blood–Brain Barrier Crossing:** Listeriolysin O disrupts host cell membranes, allowing **transcytosis** into the CNS and placenta.  \n4. **Intracellular Survival:** Listeria resists killing by **macrophages** and **neutrophils**, leading to sustained infection.  \n5. **Inflammatory Damage:** Host response releases **TNF-α**, **IL-1**, and **IFN-γ**, which, while controlling infection, also contribute to **meningeal injury** and increased intracranial pressure.\n\n---\n\n**Summary:**  \nNeonatal Listeria monocytogenes meningitis presents in the **second to third week** of life with **fever**, **bulging fontanelle**, **neutrophilic CSF**, and **Gram-positive rods**. Early recognition, **ampicillin-based therapy**, and supportive care are critical to reduce morbidity and mortality."
},
{
  "text": "A 5-year-old boy, incompletely immunized, presents with a 2-day history of high fever (up to 40 °C), severe headache, and two episodes of non‐bilious vomiting. He now complains of neck pain and photophobia, and his mother notes a new petechial rash on his trunk and lower extremities that does not blanch. On exam he is febrile, tachycardic, and hypotensive. He is alert but irritable, holds his neck stiffly (positive Brudzinski’s sign), and has scattered petechiae. A non‐contrast head CT is unremarkable. Lumbar puncture yields turbid fluid with opening pressure 280 mmH₂O, WBC 3,500/µL (95% neutrophils), protein 240 mg/dL, glucose 18 mg/dL (serum glucose 100 mg/dL), and gram‐negative kidney‐bean shaped diplococci on Gram stain. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Neisseria meningitidis meningitis" },
    { "label": "B", "text": "Enterovirus meningitis" },
    { "label": "C", "text": "Herpes simplex encephalitis" },
    { "label": "D", "text": "Kawasaki Disease" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Neisseria meningitidis meningitis**\n\n**Why it’s correct:**  \nThis child’s **acute presentation** with **high fever**, **meningeal signs** (neck stiffness, photophobia), **non‐blanching petechial rash**, and CSF showing **neutrophilic pleocytosis**, **low glucose**, **high protein**, and **gram‐negative diplococci** is classic for **meningococcal meningitis**.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Enterovirus meningitis** – Typically causes a **lymphocytic** CSF pleocytosis, normal or mildly elevated protein, normal glucose, and no bacteria on Gram stain. Rash, if present, is maculopapular and blanching.  \n\n**C. Herpes simplex encephalitis** – Presents with **altered mental status**, **focal neurologic deficits**, and often seizures. CSF shows lymphocytic predominance, RBCs, and PCR detection of HSV DNA.  \n\n**D. Kawasaki Disease** – Manifests with **prolonged fever**, **conjunctivitis**, **mucosal changes**, **rash**, and **cervical lymphadenopathy**, not with meningismus, neutrophilic CSF, or gram‐negative diplococci.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** **Stabilize airway, breathing, circulation**; obtain **blood cultures** before antibiotics; perform **rapid neurologic assessment**.  \n2. **Pneumatic Otoscopy & Skin Exam:** Evaluate for otitis media or petichiae.  \n3. **Lumbar Puncture (Best Test):** CSF analysis with cell count, differential, glucose, protein, Gram stain, and culture.  \n4. **CSF PCR:** For confirmation and identification of Neisseria meningitidis polysaccharide capsule.  \n5. **Adjunct Imaging:** CT head only if signs of raised intracranial pressure or focal neurologic deficits exist prior to LP.\n\n---\n\n**Management:**  \n1. **Empiric IV Antibiotics:** **Ceftriaxone** (100 mg/kg/day) plus **vancomycin** immediately after cultures, then narrow to ceftriaxone alone when sensitivity confirmed.  \n2. **Adjunctive Dexamethasone:** Administer before or with the first antibiotic dose to reduce neurologic complications.  \n3. **Supportive Care:** IV fluids, hemodynamic support for hypotension, seizure prophylaxis if needed, and monitoring in the ICU.  \n4. **Chemoprophylaxis for Contacts:** **Rifampin** or **ciprofloxacin** for close household and childcare contacts.  \n5. **Vaccination:** Ensure age‐appropriate **meningococcal conjugate vaccine** once acute illness resolves.\n\n---\n\n**Why Each Symptom Occurs in Meningococcal Meningitis:**  \n1. **Fever:** **Endotoxin (LPS)** triggers massive cytokine release (TNF-α, IL-1) raising hypothalamic set point.  \n2. **Neck Stiffness & Photophobia:** **Inflammation of the meninges** irritates pain-sensitive structures around the brain and spinal cord.  \n3. **Headache & Vomiting:** Increased **intracranial pressure** from inflammatory exudate stimulates the vomiting center.  \n4. **Petechial Rash:** **Endothelial damage** by meningococcal endotoxin leads to small‐vessel thrombosis and petechiae.  \n5. **Neutrophilic Pleocytosis & Hypoglycorrhachia:** **Bacterial metabolism** consumes CSF glucose, and neutrophils infiltrate to combat infection.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Nasopharyngeal Colonization:** Neisseria meningitidis adheres to mucosal cells via **type IV pili**, evading mucosal defenses.  \n2. **Invasion & Bacteremia:** Bacteria cross the epithelial barrier into the bloodstream, resisting complement via **capsular polysaccharide**.  \n3. **Meningeal Penetration:** Bacteremia allows passage across the **blood–brain barrier**, aided by bacterial proteases.  \n4. **Inflammatory Cascade:** CSF invasion triggers release of **proinflammatory cytokines**, increasing BBB permeability and recruiting leukocytes.  \n5. **Endothelial Injury & DIC:** Endotoxin‐mediated activation of coagulation leads to **microthrombi**, hemorrhage, and **petechiae**.\n\n---\n\n**Summary:**  \nMeningococcal meningitis presents acutely with **fever**, **meningeal signs**, **petechial rash**, and **neutrophilic CSF** with **gram‐negative diplococci**. Rapid diagnosis via **CSF analysis** and early empiric antibiotics with **ceftriaxone** and **vancomycin**, plus **dexamethasone**, are critical. **Contact prophylaxis** and **vaccination** are essential to prevent secondary cases."
},
{
  "text": "An 8-year-old girl presents with a 3-month history of daily sneezing, clear rhinorrhea, and recurrent itchy, watery eyes. Symptoms are worst in spring and when she plays outside in the grass. She also complains of an itchy nose and palate. She has no fever, purulent discharge, or cough. Her mother has eczema and allergic asthma. On exam, she has **pale, boggy nasal turbinates**, **allergic shiners**, and a transverse nasal crease. Lung exam is clear. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Chronic Sinusitis" },
    { "label": "B", "text": "Vasomotor (Nonallergic) Rhinitis" },
    { "label": "C", "text": "Allergic Rhinitis" },
    { "label": "D", "text": "Adenoid Hypertrophy" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Allergic Rhinitis**  \n\n**Why it’s correct:**  \nThis child’s **seasonal symptoms** of **sneezing**, **itchy nose and palate**, **clear rhinorrhea**, and **watery eyes**, combined with a family history of atopy, **pale boggy turbinates**, and allergic shiners, are classic for **IgE-mediated allergic rhinitis** triggered by pollens.  \n\n---  \n**Why the other options are incorrect:**  \n\n**A. Chronic Sinusitis** – Presents with **facial pain/pressure**, **purulent nasal discharge**, and often **fever**. Exam shows opaque turbinates and sinus tenderness, not pale boggy mucosa or itching.  \n\n**B. Vasomotor (Nonallergic) Rhinitis** – Causes **year-round congestion** and watery rhinorrhea, but **no itching**, ocular symptoms, or atopic exam findings. Triggers are non-allergic (e.g., temperature changes), not seasonal pollens.  \n\n**D. Adenoid Hypertrophy** – Leads to **nasal obstruction**, **mouth breathing**, and **snoring**, often in younger children. Turbinates may be normal, and there is no sneezing, itching, or ocular involvement.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** of symptom timing, triggers, and **family atopy**; thorough **nasal exam** with otoscope or endoscope.  \n2. **Best Test:** **Skin prick testing** for seasonal and perennial allergens to identify specific IgE sensitivities.  \n3. **Alternative Test:** **Serum-specific IgE (RAST)** if skin testing is contraindicated.  \n4. **Adjunct:** **Nasal cytology** (eosinophils on smear) supports allergic etiology if positive.  \n\n---  \n**Management:**  \n1. **Allergen Avoidance:** Keep windows closed during high pollen counts; use HEPA filters; wash clothes after outdoor play.  \n2. **Intranasal Corticosteroids:** **Fluticasone** or **mometasone** daily to reduce mucosal inflammation.  \n3. **Second-Generation Oral Antihistamines:** **Cetirizine** or **loratadine** for symptom relief, taken before pollen exposure.  \n4. **Intranasal Antihistamines/Decongestants:** For breakthrough symptoms (use decongestants <3 days to avoid rebound).  \n5. **Allergen Immunotherapy:** Subcutaneous or sublingual for persistent symptoms and prevention of asthma onset.  \n\n---  \n**Why Each Symptom Occurs in Allergic Rhinitis:**  \n1. **Sneezing:** Histamine stimulates **nasal sensory receptors**, triggering reflexive sneezing.  \n2. **Itchy Nose/Palate:** Mast cell degranulation releases **histamine** and **leukotrienes**, exciting itch fibers.  \n3. **Clear Rhinorrhea:** **Vascular permeability** causes plasma exudation into nasal passages.  \n4. **Watery Eyes:** **Conjunctival mast cells** degranulate, causing lacrimation.  \n5. **Nasal Congestion:** **Vasodilation** and **edema** of mucosal vessels block airflow.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Sensitization:** Allergen exposure leads to **Th2 cell activation** and **IgE class switching** in B cells.  \n2. **Mast Cell Degranulation:** Re-exposure causes cross-linking of IgE on mast cells, releasing **histamine**, **tryptase**, and **prostaglandins**.  \n3. **Early-Phase Response:** Mediators cause **vasodilation**, **vascular leak**, and **smooth muscle contraction** within minutes.  \n4. **Late-Phase Response:** **Eosinophils**, **basophils**, and **Th2 lymphocytes** infiltrate the mucosa hours later, perpetuating inflammation.  \n5. **Mucosal Remodeling:** Chronic inflammation leads to **glandular hyperplasia**, **fibrosis**, and persistent hyperresponsiveness."
},
{
  "text": "A 7-year-old boy presents with a 4-day history of **dark, tea-colored urine**, swelling around his eyes in the morning, and a headache. Three weeks ago he had an untreated skin infection on his leg that resolved spontaneously. On exam his blood pressure is 145/95 mmHg, he has **periorbital edema**, and 1+ pitting edema of his ankles. Urinalysis shows **3+ blood**, **2+ protein**, and numerous **RBC casts**. Serum C3 is low, C4 is normal, and anti–streptolysin O titer is elevated. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "IgA Nephropathy (Berger’s Disease)" },
    { "label": "B", "text": "Henoch–Schönlein Purpura" },
    { "label": "C", "text": "Post-streptococcal Glomerulonephritis (PSGN)" },
    { "label": "D", "text": "Membranoproliferative Glomerulonephritis" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Post-streptococcal Glomerulonephritis (PSGN)**\n\n**Why it’s correct:**  \nThis child’s presentation of **tea-colored urine**, **periorbital edema**, **hypertension**, and **RBC casts**, occurring **2–4 weeks** after a resolved streptococcal skin infection, with **low C3** and elevated ASO titer, is classic for PSGN. The timing after infection and complement consumption distinguish it from other glomerulopathies.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. IgA Nephropathy** – Presents with **synpharyngitic hematuria** (occurring concurrently with a URI), not weeks later. C3 levels are normal, and there is no latency period.  \n\n**B. Henoch–Schönlein Purpura** – Causes a small-vessel vasculitis with **palpable purpura**, **abdominal pain**, and **arthralgias**, along with IgA deposition in glomeruli. Our patient has no rash or GI symptoms.  \n\n**D. Membranoproliferative GN** – Presents insidiously with **persistent low C3**, **nephritic-nephrotic syndrome**, and often hypocomplementemia of both C3 and C4. The post-infectious latency and normalization of C3 in 6–8 weeks favor PSGN.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed history of recent infections and **blood pressure measurement**. Perform **urinalysis** to identify hematuria, proteinuria, and RBC casts.  \n2. **Complement Levels:** Measure **C3** and **C4**; isolated low C3 suggests PSGN.  \n3. **Serologies:** Check **ASO** and **anti–DNase B titers** to document recent streptococcal infection.  \n4. **Renal Ultrasound:** To exclude obstruction and assess kidney size if hypertension is severe or renal function is impaired.  \n5. **Renal Biopsy (Best Test):** Reserved for atypical cases; shows **granular “starry-sky” IgG/C3 deposition** on immunofluorescence and **subepithelial “hump”** deposits on electron microscopy.\n\n---\n\n**Management:**  \n- **Supportive Care:** **Salt restriction**, **diuretics** (e.g., furosemide) for edema, and **antihypertensives** (e.g., ACE inhibitors) to control blood pressure.  \n- **Fluid Management:** Careful fluid balance to avoid fluid overload or hypovolemia.  \n- **Antibiotic Therapy:** Treat any persistent streptococcal carriage with penicillin to prevent spread, though it does not alter PSGN course.  \n- **Monitoring:** Follow **renal function**, **blood pressure**, and **complement levels**; most children recover fully.  \n- **Referral:** Nephrology consultation for severe or rapidly progressive cases.\n\n---\n\n**Why Each Symptom Occurs in PSGN:**  \n1. **Tea-Colored Urine:** RBCs and hemoglobin leak through the glomerular basement membrane due to immune complex–mediated damage.  \n2. **Periorbital Edema:** Sodium and water retention from reduced glomerular filtration leads to fluid accumulation in dependent tissues.  \n3. **Hypertension:** Reduced GFR and salt retention activate the **renin–angiotensin–aldosterone system**, raising blood pressure.  \n4. **RBC Casts:** Damaged glomerular capillaries allow red cells to enter the tubules and form casts in the distal nephron.  \n5. **Low C3 Levels:** Complement is consumed by immune complex deposition in the glomeruli.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Immune Complex Deposition:** Antigen–antibody complexes from streptococcal antigens deposit in the **subepithelial space**, triggering inflammation.  \n2. **Complement Activation:** Classical pathway activation consumes **C3**, resulting in hypocomplementemia.  \n3. **Glomerular Hypercellularity:** Neutrophils and mesangial cells proliferate, causing **lobular glomerular appearance** on light microscopy.  \n4. **Subepithelial Humps:** Electron-dense deposits form characteristic **“humps”** on electron microscopy.  \n5. **Endothelial Injury:** Complement fragments (C3a, C5a) recruit inflammatory cells, leading to **capillary wall damage** and protein leakage.\n\n---\n\n**Summary:**  \nPost-streptococcal glomerulonephritis presents in children with **nephritic syndrome** several weeks after a streptococcal infection, featuring **hematuria**, **edema**, **hypertension**, and **low C3**. Diagnosis is clinical, supported by serology and, if needed, renal biopsy. Management is primarily **supportive**, focusing on blood pressure control, diuresis, and monitoring, with most patients achieving full recovery."
},
{
  "text": "An 18-month-old boy presents with a 3-day history of high fever (up to 39.5 °C), irritability, and incessant right ear tugging. He attends daycare and had a runny nose last week that resolved. He has difficulty sleeping and refuses to feed when lying flat. On exam, he is febrile and fussy. External ears are normal. Otoscopic examination of the right ear shows a **bulging, erythematous tympanic membrane** with **loss of landmarks** and **decreased mobility** on pneumatic otoscopy. The left ear is normal. There is no mastoid tenderness or lymphadenopathy. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Acute Otitis Media" },
    { "label": "B", "text": "Otitis Externa" },
    { "label": "C", "text": "Serous Otitis Media (Otitis Media with Effusion)" },
    { "label": "D", "text": "Acute Mastoiditis" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Acute Otitis Media**  \n\n**Why it’s correct:**  \nThe child’s presentation of **high fever**, **ear tugging**, **bulging/erythematous tympanic membrane**, and **decreased mobility** on pneumatic otoscopy are classic for **acute otitis media**, indicating pus behind the TM and middle ear inflammation.  \n\n---  \n**Why the other options are incorrect:**  \n\n**B. Otitis Externa** – Involves the **external canal**, with pain on tragal pressure, canal erythema, and often discharge. The TM is normal and pneumatic otoscopy is normal.  \n\n**C. Serous Otitis Media** – Characterized by a **retracted TM** with air-fluid levels or bubbles, but without erythema, bulging, or systemic signs (fever, irritability).  \n\n**D. Acute Mastoiditis** – Presents as a complication of AOM with **postauricular swelling**, **erythema**, and **tenderness** over the mastoid. Our patient has no mastoid findings.  \n\n---  \n**Diagnostic Steps:**  \n1. **Initial Step:** Detailed **history** (onset, fever, URI prodrome, daycare exposure) and **otoscopic exam** of both ears.  \n2. **Best Test:** **Pneumatic otoscopy** to assess TM mobility—poor mobility confirms middle ear effusion.  \n3. **Adjunct Test:** **Tympanometry** can quantify middle ear pressure if otoscopy is inconclusive.  \n4. **Culture/Tympanocentesis:** Reserved for severe, recurrent, or treatment-resistant cases to guide antibiotic therapy.  \n\n---  \n**Management:**  \n1. **Analgesia:** **Acetaminophen** or **ibuprofen** for pain and fever.  \n2. **Antibiotics:** **High-dose amoxicillin** (80–90 mg/kg/day divided BID) for 7–10 days. If recent amoxicillin use or resistant organisms suspected, add **clavulanate** or use **ceftriaxone** IM.  \n3. **Observation:** In children ≥2 years with mild symptoms, consider 48-hour watchful waiting if close follow-up is guaranteed.  \n4. **Follow-Up:** Re-examine in 48–72 hours to ensure resolution.  \n5. **Prevention:** Encourage **pneumococcal and influenza vaccination**, and consider **ear tubes** for ≥3 episodes in 6 months or ≥4 in 12 months.  \n\n---  \n**Why Each Symptom Occurs in AOM:**  \n1. **Fever:** Inflammatory cytokines (IL-1, TNF-α) released in response to middle ear infection raise the hypothalamic set point.  \n2. **Ear Tugging/Irritability:** Plication of the TM and pressure on the malleus irritate sensory branches of the trigeminal nerve.  \n3. **Bulging TM:** Accumulation of purulent fluid in the middle ear increases pressure behind the membrane.  \n4. **Decreased TM Mobility:** Effusion prevents normal TM vibration and movement when pressure is applied.  \n5. **Refusal to Feed Supine:** Lying flat increases middle ear pressure and pain.  \n\n---  \n**Pathophysiology Highlights:**  \n1. **Eustachian Tube Dysfunction:** In young children, a **horizontal, short tube** fails to drain middle ear fluid, predisposing to stasis.  \n2. **URI-Induced Inflammation:** Viral infections cause **mucosal edema**, blocking the Eustachian tube and allowing bacteria to ascend.  \n3. **Bacterial Overgrowth:** Common pathogens (S. pneumoniae, H. influenzae, M. catarrhalis) proliferate in the trapped fluid.  \n4. **Neutrophil Recruitment:** Innate immune cells migrate into the middle ear space, releasing enzymes and ROS that contribute to membrane damage.  \n5. **Biofilm Formation:** Recurrent infections lead to bacterial biofilms on the middle ear mucosa, promoting chronicity and antibiotic resistance."
},
{
  "text": "A 9-year-old girl from Southeast Asia presents with a 6-week history of insidious onset **productive cough**, **night sweats**, and **unintentional weight loss** (4 kg). She has intermittent low-grade fevers and complains of mild chest tightness. Her grandfather was treated for tuberculosis last year. On exam, she appears thin, with digital clubbing and **focal crackles** in the right upper lung field. Oxygen saturation is 96% on room air. A chest x-ray reveals **right upper lobe cavitation** with **hilar lymphadenopathy**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Streptococcus pneumoniae pneumonia" },
    { "label": "B", "text": "Mycoplasma pneumoniae infection" },
    { "label": "C", "text": "Primary Mycobacterium tuberculosis pneumonia" },
    { "label": "D", "text": "Aspiration pneumonia" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Primary Mycobacterium tuberculosis pneumonia**\n\n**Why it’s correct:**  \nThis child’s **chronic course** (6 weeks), systemic symptoms (**night sweats**, **weight loss**), **exposure history**, and **upper lobe cavitation** with hilar lymphadenopathy are classic for **primary tuberculosis**. The indolent nature, lack of response to broad-spectrum antibiotics, and radiographic findings point to M. tuberculosis rather than acute pathogens.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Streptococcus pneumoniae pneumonia** – Presents with **acute onset** high fever, pleuritic chest pain, and **lobar consolidation** without cavitation in immunocompetent children. This patient’s subacute timeline and cavitary lesion are atypical.\n\n**B. Mycoplasma pneumoniae infection** – Causes a **subacute dry cough**, low-grade fever, and **interstitial infiltrates** rather than cavitary consolidation. Exposure history and weight loss are also not typical.\n\n**D. Aspiration pneumonia** – Occurs in children with **neurologic impairment** or swallowing dysfunction and usually affects **dependent lung zones** (right lower lobe) with **localized consolidation** but not typically cavitation in a previously healthy child.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Detailed **history** (TB exposure, BCG status, symptom duration) and targeted **physical exam** (lymph nodes, clubbing).  \n- **Laboratory Tests:** **Tuberculin skin test (TST)** or **interferon-gamma release assay (IGRA)** to assess sensitization.  \n- **Best Test:** **Sputum or gastric aspirate PCR/culture** for M. tuberculosis—highly specific and confirms diagnosis.  \n- **Additional Tests:** **CT chest** if available, to delineate cavitary lesions and lymphadenopathy; **HIV testing** to assess immune status if risk factors present.\n\n---\n\n**Management:**  \n1. **First-Line Antitubercular Therapy:** **RIPE regimen**—Rifampin, Isoniazid, Pyrazinamide, and Ethambutol for 2 months, followed by Rifampin and Isoniazid for 4 months.  \n2. **Directly Observed Therapy (DOT):** Ensure adherence and monitor for side effects (e.g., hepatotoxicity).  \n3. **Supportive Care:** Nutritional support, vitamin D and pyridoxine (to prevent isoniazid neuropathy).  \n4. **Contact Tracing & Prophylaxis:** Screen household contacts and provide **isoniazid prophylaxis** for TST-positive or high-risk individuals.  \n5. **Follow-Up Imaging:** Repeat chest x-ray at 2 and 6 months to document radiographic improvement.\n\n---\n\n**Why Each Symptom Occurs in TB Pneumonia:**  \n1. **Chronic Productive Cough:** Mycobacterial infection induces **granulomatous inflammation** in airways.  \n2. **Night Sweats & Low-Grade Fevers:** **Cytokine release** (TNF-α, IL-1) during granuloma formation raises nighttime temperature.  \n3. **Weight Loss & Anorexia:** **Cachexia** from chronic inflammation and increased metabolic demand.  \n4. **Cavitation:** **Caseous necrosis** of lung parenchyma leads to cavity formation in upper lobes where oxygen tension is high.  \n5. **Hilar Lymphadenopathy:** **Primary Ghon focus** drains to regional lymph nodes, causing enlargement.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Inhalation of Droplet Nuclei:** M. tuberculosis is taken up by **alveolar macrophages** in the lung apex.  \n2. **Intracellular Survival:** The bacterium **prevents phagosome-lysosome fusion**, replicating within macrophages.  \n3. **Cell-Mediated Immunity:** **Th1 response** (IFN-γ, IL-12) activates macrophages and forms **granulomas** to contain infection.  \n4. **Caseous Necrosis:** Chronic inflammation leads to **tissue necrosis** and formation of the “cheese-like” core in granulomas.  \n5. **Reactivation Potential:** Cavities harbor viable bacilli that can reactivate if host immunity wanes.\n\n---\n\n**Summary:**  \nPrimary tuberculosis in children presents insidiously with **chronic cough**, **constitutional symptoms**, and characteristic **upper lobe cavitation** with **hilar adenopathy** on imaging. Diagnosis relies on **TST/IGRA** and **microbiologic confirmation**. Treatment with the **RIPE regimen** plus DOT and contact prophylaxis is essential to cure and prevent spread."
},
{
  "text": "A 3-month-old boy is brought to the clinic for a 3-week history of a persistent, **staccato cough** and **mild tachypnea**. He has never had a fever. His mother reports the cough worsens at night and occasionally causes him to gag but never to vomit. He was born at term, has no significant past medical history, and is up to date on immunizations except for the pertussis booster. On exam, his respiratory rate is 50/min, oxygen saturation 94% on room air, and he has **diffuse fine crackles** bilaterally without wheezing. There is no conjunctivitis or rash. A CBC shows WBC 9,500/µL with **10% eosinophils**. Chest x-ray reveals **hyperinflation** and **bilateral perihilar interstitial infiltrates**. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "RSV Bronchiolitis" },
    { "label": "B", "text": "Pertussis" },
    { "label": "C", "text": "Chlamydia trachomatis Pneumonia" },
    { "label": "D", "text": "Congenital Heart Disease (VSD)" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Chlamydia trachomatis Pneumonia**\n\n**Why it’s correct:**\nThis infant’s **afebrile**, **subacute** course with a **staccato cough**, **eosinophilia**, and **interstitial infiltrates** on chest x-ray are classic for **Chlamydia trachomatis pneumonia**, which typically presents between **4–12 weeks of age** after perinatal exposure. The absence of fever and the presence of eosinophils help distinguish it from other causes.\n\n---\n\n**Why the other options are incorrect:**\n\n**A. RSV Bronchiolitis** – Usually affects infants **<2 months**, presents acutely with **wheezing**, **retractions**, and often fever after a brief URI prodrome. Our patient has crackles without wheezing and a chronic staccato cough.\n\n**B. Pertussis** – Characterized by **paroxysmal whooping cough**, **post-tussive emesis**, and marked lymphocytosis. This infant has no whoop or emesis and shows eosinophilia instead of lymphocytosis.\n\n**D. Congenital Heart Disease (VSD)** – A VSD may cause tachypnea and crackles from pulmonary overcirculation, but would present earlier, with **heart murmurs**, **hepatomegaly**, and failure to thrive; chest x-ray shows **pulmonary edema**, not interstitial infiltrates.\n\n---\n\n**Diagnostic Steps:**\n- **Initial Step:** Obtain a **detailed history** (age of onset, cough characteristics, feeding tolerance) and perform a **thorough respiratory exam**.\n- **Laboratory Tests:** CBC with differential to identify **eosinophilia**; pulse oximetry to assess oxygenation.\n- **Best Test:** **PCR for Chlamydia trachomatis** on a **nasopharyngeal swab** or **induced sputum**—highly sensitive and specific in the first weeks of illness.\n- **Additional Tests:** **Serology** for chlamydial-specific IgM/IgG can support diagnosis if PCR unavailable; repeat CXR if no improvement after treatment.\n\n---\n\n**Management:**\n1. **Oral Macrolide Antibiotic:** **Erythromycin** (50 mg/kg/day divided q6h for 14 days) or **azithromycin** (10 mg/kg day 1, then 5 mg/kg days 2–5).  \n2. **Supportive Care:** Ensure adequate **hydration**, monitor growth, and provide **nasal saline** for comfort.  \n3. **Monitor for Complications:** Watch for **hyponatremia** from SIADH and **bronchiolitis obliterans** as a late sequela.  \n4. **Preventive Measures:** Screen pregnant women for chlamydia and treat to reduce perinatal transmission.  \n5. **Follow-Up:** Reassess respiratory status in 1–2 weeks and consider repeat CXR if symptoms persist.\n\n---\n\n**Why Each Symptom Occurs in Chlamydia Pneumonia:**\n1. **Staccato Cough:** Inflammation of the **bronchiolar epithelium** produces a characteristic hacking cough.  \n2. **Afebrile Course:** Chlamydial infection does not elicit a strong pyrogenic response in infants.  \n3. **Fine Crackles:** **Interstitial infiltration** of lung parenchyma leads to crackles rather than wheezing.  \n4. **Eosinophilia:** Chlamydia triggers a **Th2 immune response**, recruiting eosinophils into the bloodstream.  \n5. **Hyperinflation:** **Air trapping** from small airway inflammation causes increased lung volumes on imaging.\n\n---\n\n**Pathophysiology Highlights:**\n1. **Perinatal Transmission:** Infant inhales infected birth canal secretions, leading to **respiratory mucosal infection**.  \n2. **Obligate Intracellular Growth:** Chlamydia replicates within **host epithelial cells**, evading extracellular defenses.  \n3. **Host Immune Response:** **Delayed hypersensitivity** and **Th2 cytokines (IL-5)** drive eosinophil recruitment and lung inflammation.  \n4. **Bronchiolar Inflammation:** Infection of **small airways** causes **interstitial pneumonitis** without alveolar consolidation.  \n5. **Cytokine-Mediated Injury:** **Tumor necrosis factor-α** and other mediators increase vascular permeability and contribute to symptoms.\n\n---\n\n**Summary:**\nChlamydia trachomatis pneumonia in infants presents with an **afebrile, subacute staccato cough**, **eosinophilia**, and **interstitial infiltrates**. Diagnosis is confirmed by **PCR** of respiratory specimens. Treatment with **macrolides** and supportive care leads to resolution, while prevention hinges on **maternal screening** and treatment during pregnancy."
},
{
  "text": "A 4-year-old boy presents with a 3-day history of **crampy abdominal pain** and **diarrhea** that began as watery but turned **bloody** on day 2. He denies fever. Four days ago he ate an **undercooked hamburger** at a county fair. On exam he is afebrile, mildly tachycardic, and slightly dehydrated. His abdomen is soft with diffuse tenderness but no guarding. Stool guaiac is positive. Laboratory studies show WBC 8,500/µL, Hgb 12.3 g/dL, platelets 250,000/µL, BUN/Cr normal. A stool culture on **sorbitol-MacConkey agar** grows **colorless colonies** that agglutinate with O157 antiserum. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Enterohemorrhagic E. coli (EHEC) infection" },
    { "label": "B", "text": "Shigella dysenteriae infection" },
    { "label": "C", "text": "Salmonella enterica serotype Typhimurium" },
    { "label": "D", "text": "Campylobacter jejuni infection" }
  ],
  "correct": "A",
  "explanation": "**Correct Answer: A. Enterohemorrhagic E. coli (EHEC) infection**  \n\n**Why it’s correct:**  \nThis child’s **undercooked beef** exposure, **initially watery** then **bloody diarrhea** without fever, and **O157:H7** growth as **colorless colonies** on sorbitol-MacConkey agar that agglutinate with O157 antiserum are pathognomonic for **EHEC**, which produces **Shiga toxin** leading to mucosal injury.\n\n---\n\n**Why the other options are incorrect:**  \n\n**B. Shigella dysenteriae infection** – Causes invasive dysentery with **high fever**, **tenesmus**, and abundant **fecal leukocytes**. Shigella grows as pink colonies on MacConkey agar and does not ferment sorbitol.\n\n**C. Salmonella enterica serotype Typhimurium** – Presents with **fever**, **crampy pain**, and diarrhea that may be bloody, but stool cultures grow **non-lactose fermenting**, **H₂S-producing** colonies (black on XLD agar), not O157 antigen.\n\n**D. Campylobacter jejuni infection** – Typically presents with **fever**, severe **crampy pain**, and **bloody diarrhea**, but cultures require **microaerophilic conditions at 42 °C** and show **comma-shaped gram-negative rods**, not O157 E. coli.\n\n---\n\n**Diagnostic Steps:**  \n1. **Initial Step:** Obtain a **thorough history** (food exposures, timing) and assess **dehydration**.  \n2. **Stool Culture (Best Test):** Culture on **sorbitol-MacConkey agar** and serotype for **O157:H7**.  \n3. **Shiga Toxin Assay:** Perform **stool PCR** or **enzyme immunoassay** for **Shiga toxin 1 and 2** if available.  \n4. **Fecal Leukocytes & Lactoferrin:** Negative or minimal in EHEC unlike Shigella.  \n5. **Laboratory Monitoring:** Serial **CBC**, **LDH**, **renal function**, and **platelet count** to watch for **hemolytic uremic syndrome (HUS)**.\n\n---\n\n**Management:**  \n1. **Supportive Care Only:** **Aggressive fluid rehydration** and electrolyte replacement; avoid antimotility agents.  \n2. **No Antibiotics:** Antibiotics can increase **Shiga toxin release** and raise HUS risk.  \n3. **Avoid Antimotility Drugs:** Agents like loperamide can worsen colonic stasis and toxin absorption.  \n4. **Monitor for HUS:** Watch for **anemia**, **thrombocytopenia**, and **acute kidney injury**; initiate dialysis if needed.  \n5. **Public Health:** Report to **health authorities** and counsel on **safe food handling** to prevent outbreaks.\n\n---\n\n**Why Each Symptom Occurs in EHEC Infection:**  \n1. **Crampy Abdominal Pain:** **Shiga toxin–mediated endothelial injury** in colonic microvasculature causes ischemic pain.  \n2. **Bloody Diarrhea:** **Mucosal epithelial cell death** and capillary leakage lead to blood in stool.  \n3. **Lack of Fever:** Toxin-mediated damage triggers less systemic inflammation than invasive bacteria.  \n4. **Minimal Fecal Leukocytes:** EHEC is **non-invasive**, so neutrophil recruitment to lumen is limited.  \n5. **Colorless Colonies on SMAC:** **Inability to ferment sorbitol** differentiates O157:H7 from typical E. coli.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Shiga Toxin Production:** Bacteriophage-encoded **Stx1 and Stx2** bind to **Gb3 receptors** on enterocytes and renal endothelial cells, inactivating the **60S ribosomal subunit** and halting protein synthesis.  \n2. **Endothelial Injury:** **Vascular damage** in the colon causes microthrombi, ischemia, and bleeding.  \n3. **Non-invasive Mechanism:** Unlike Shigella, EHEC does not invade the epithelium; toxins cross the damaged mucosa to enter circulation.  \n4. **Risk of HUS:** Toxin-induced damage to renal glomerular endothelium leads to **microangiopathic hemolysis**, **thrombocytopenia**, and **acute renal failure**.  \n5. **Effacement of Brush Border:** Toxin-mediated apoptosis of **crypt and villus enterocytes** disrupts absorption and barrier function, perpetuating diarrhea.\n\n---\n\n**Summary:**  \nEnterohemorrhagic E. coli presents with **bloody diarrhea** following **undercooked beef**, **minimal fever**, and specific culture findings on **sorbitol-MacConkey agar**. Diagnosis is confirmed by **stool culture** and **Shiga toxin assays**. Management is **supportive only**, with vigilant monitoring for **HUS**, and prevention focuses on **food safety** and public health reporting.”"
},
{
  "text": "A 6-year-old boy presents to the pediatric emergency department with a 3-day history of high fever (up to 40°C), productive cough, and right-sided chest pain. He was diagnosed with influenza 10 days ago and seemed to be recovering until this week. On exam, he is toxic-appearing, tachypneic (respiratory rate 36/min), tachycardic (heart rate 130 bpm), and has oxygen saturation 92% on room air. Chest auscultation reveals **diminished breath sounds**, **bronchial breath sounds**, and **crackles** over the right upper and middle lung fields. A chest x-ray shows a **right upper lobe consolidation with a 3 cm cavitary lesion** and a small pleural effusion. Laboratory studies reveal WBC 20,000/µL with 85% neutrophils, CRP 150 mg/L, and a neutrophil left shift. What is the most likely diagnosis?",
  "options": [
    { "label": "A", "text": "Streptococcus pneumoniae pneumonia" },
    { "label": "B", "text": "Mycoplasma pneumoniae infection" },
    { "label": "C", "text": "Staphylococcus aureus pneumonia" },
    { "label": "D", "text": "Aspiration pneumonia" }
  ],
  "correct": "C",
  "explanation": "**Correct Answer: C. Staphylococcus aureus pneumonia**\n\n**Why it’s correct:**  \nThis child’s **post‐influenza** status, **high fever**, **toxic appearance**, **productive cough**, and **cavitary lesion** on chest x-ray are classic for **Staph aureus pneumonia**, a known complication following viral respiratory infection. The rapid onset of severe symptoms, neutrophilic leukocytosis, and pleural effusion further support this diagnosis.\n\n---\n\n**Why the other options are incorrect:**  \n\n**A. Streptococcus pneumoniae pneumonia** – Typically causes **lobar consolidation** without cavitation in previously healthy children. The post‐viral timing and cavitary lesion favor staph rather than pneumococcus.\n\n**B. Mycoplasma pneumoniae infection** – Presents subacutely with **dry cough**, low‐grade fever, and **interstitial infiltrates** rather than cavitating consolidation and high-grade fevers.\n\n**D. Aspiration pneumonia** – Occurs in children with **neurologic impairment** or swallowing dysfunction, causes **dependent lung segment** infiltrates (e.g., right lower lobe), and does not usually produce rapid cavitation in an otherwise healthy child.\n\n---\n\n**Diagnostic Steps:**  \n- **Initial Step:** Detailed history (recent influenza, symptom onset) and focused exam (vital signs, lung auscultation).  \n- **Laboratory Tests:** Obtain **CBC with differential**, **CRP**, **blood cultures**, and **sputum culture** (if obtainable).  \n- **Best Test:** **Chest CT** if complicated pneumonia is suspected—to delineate **abscess**, **empyema**, or **necrosis**.  \n- **Pleural Fluid Analysis:** If pleural effusion is significant, perform **thoracentesis** for Gram stain, culture, and chemistry to guide therapy.\n\n---\n\n**Management:**  \n1. **Empiric IV Antibiotics:** Start **nafcillin** (or oxacillin) or **cefazolin** plus **clindamycin** (for toxin suppression) to cover MSSA; consider **vancomycin** if MRSA is suspected.  \n2. **Drainage of Effusion/Abscess:** Perform **chest tube** or **video-assisted thoracoscopic surgery (VATS)** for pleural drainage or abscess debridement if present.  \n3. **Supportive Care:** Oxygen supplementation, hydration, and antipyretics. Monitor for respiratory distress and hemodynamic stability.  \n4. **Repeat Imaging:** Follow-up chest x-ray or ultrasound to ensure resolution of effusion and cavity.  \n5. **Duration of Therapy:** Continue IV antibiotics for **2–3 weeks**, transitioning to oral therapy based on culture results and clinical improvement.\n\n---\n\n**Why Each Symptom Occurs in Staph aureus Pneumonia:**  \n1. **High Fever & Toxic Appearance:** **Exotoxins** and **cytokine release** drive systemic inflammation.  \n2. **Productive Cough & Crackles:** **Purulent sputum** and consolidation produce crackles on auscultation.  \n3. **Cavitary Lesion:** **Tissue necrosis** from bacterial toxins and intense neutrophilic response leads to abscess formation.  \n4. **Pleural Effusion:** **Exudative fluid** accumulates due to increased vascular permeability in the pleural space.  \n5. **Neutrophilic Leukocytosis:** Bone marrow releases neutrophils in response to **severe bacterial infection**.\n\n---\n\n**Pathophysiology Highlights:**  \n1. **Post-Viral Susceptibility:** **Influenza‐induced epithelial damage** and impaired mucociliary clearance allow Staph aureus to invade lung parenchyma.  \n2. **Toxin Production:** **Panton-Valentine leukocidin (PVL)** and other toxins cause **neutrophil lysis**, tissue necrosis, and cavitation.  \n3. **Biofilm Formation:** Staph aureus can form **biofilms** in the pleural space, complicating clearance.  \n4. **Protease-Mediated Damage:** Secreted proteases degrade **extracellular matrix**, facilitating abscess formation.  \n5. **Inflammatory Cascade:** Recruitment of neutrophils and release of **matrix metalloproteinases** contribute to lung destruction and empyema.\n\n---\n\n**Summary:**  \nStaphylococcus aureus pneumonia in children often follows influenza, presenting with **high fevers**, **toxic appearance**, **cavitary consolidation**, and **pleural effusion**. Diagnosis relies on imaging (chest x-ray, CT), cultures, and fluid analysis. Management includes **anti‐staphylococcal antibiotics**, **drainage**, and supportive care. Pathophysiology centers on **post‐viral epithelial damage**, **toxin‐mediated necrosis**, and a robust **neutrophilic response** leading to cavitation."
}


    ];

    // Populate left sidebar with question numbers
    const sidebarList = document.getElementById('sidebar-list');
    questions.forEach((_, i) => {
      const li = document.createElement('li');
      const a  = document.createElement('a');
      a.href        = '#';
      a.textContent = i + 1;
      a.addEventListener('click', () => {
        current = i;
        renderQ(i);
        sidebar.classList.remove('open');
      });
      li.appendChild(a);
      sidebarList.appendChild(li);
    });

    let startTime = Date.now(), current = 0, results = [];
    const qText      = document.getElementById('question-text');
    const optsList   = document.getElementById('options-list');
    const explDiv    = document.getElementById('explanation');
    const sumDiv     = document.getElementById('results-summary');
    const counterDiv = document.getElementById('question-counter');
    const prevBtn    = document.getElementById('prev-btn');
    const nextBtn    = document.getElementById('next-btn');
    const submitBtn  = document.getElementById('submit-btn');
    const endBtn     = document.getElementById('end-btn');

    function renderQ(i) {
      const q = questions[i];
      counterDiv.textContent = `Question ${i+1} of ${questions.length}`;
      qText.innerHTML        = q.text.replace(/\n/g, '<br>');
      optsList.innerHTML     = '';
      q.options.forEach(o => {
        const lbl       = document.createElement('label');
        lbl.className   = 'option-label';
        lbl.innerHTML   = `<input type="radio" name="answer" value="${o.label}"> ${o.label}. ${o.text}`;
        optsList.appendChild(lbl);
      });
      explDiv.innerHTML      = '';       // clear explanation area
      sumDiv.style.display   = 'none';
      prevBtn.disabled       = i === 0;
      nextBtn.disabled       = true;
      submitBtn.disabled     = false;
    }

    submitBtn.addEventListener('click', () => {
      const sel = document.querySelector('input[name="answer"]:checked'); 
      if (!sel) return;
      const val  = sel.value;
      const corr = questions[current].correct;
      const ok   = val === corr;
      results[current] = ok;

      document.querySelectorAll('.option-label').forEach(lbl => {
        const inp = lbl.querySelector('input');
        lbl.classList.remove('correct-answer','wrong-answer');
        if (inp.value === corr) lbl.classList.add('correct-answer');
        if (inp.checked && !ok) lbl.classList.add('wrong-answer');
        inp.disabled = true;
      });

      // Convert **bold** to <strong> and preserve line breaks
      const rawExplanation = questions[current].explanation;
      const htmlified = convertMarkdownBold(rawExplanation).replace(/\n/g, '<br>');
      explDiv.innerHTML = htmlified;

      submitBtn.disabled = true;
      nextBtn.disabled   = false;
    });

    prevBtn.addEventListener('click', () => {
      if (current > 0) {
        current--;
        renderQ(current);
      }
    });

    nextBtn.addEventListener('click', () => {
      if (current < questions.length - 1) {
        current++;
        renderQ(current);
      }
    });

    endBtn.addEventListener('click', () => {
      const score    = results.filter(r => r).length;
      const total    = questions.length;
      const duration = Math.floor((Date.now() - startTime) / 1000);
      sumDiv.style.display = 'block';
      sumDiv.innerHTML = `<strong>Score: ${score}/${total} (${Math.round(score/total*100)}%)</strong><br>` +
                          `Time: ${Math.floor(duration/60)}m ${duration%60}s<br>` +
                          `<button onclick="location.href='index.html'">Back to Home</button>`;
    });

    // Render the first question on load
    renderQ(0);
  </script>
</body>
</html>
